General Information of Drug (ID: DMPM4SK)

Drug Name
Methamphetamine Drug Info
Synonyms
METHAMPHETAMINE; Metamfetamine; d-Deoxyephedrine; d-Desoxyephedrine; d-Methamphetamine; d-N-Methylamphetamine; Metamphetamine; L-Methamphetamine; d-Methylamphetamine; Methylamphetamine; d-Phenylisopropylmethylamine; N-Methylamphetamine; (S)-Methamphetamine; Norodin; (+)-Methylamphetamine; d-(S)-Methamphetamine; D-1-Phenyl-2-methylaminopropane; Metamfetaminum; Desyphed; (+)-N-Methylamphetamine; (S)-Methylamphetamine; (+)-(S)-Deoxyephedrine; Methyl-beta-phenylisopropylamine; 1-Phenyl-2-methylaminopropane; (S)-(+)-Deoxyephedrine; Crank; Desohyephedrine; Metamfetamina; Meth; Methamphetaminum; Speed; Stimulex; Crank [Street Name]; Crystal Meth; Crystal Meth [Street Name]; Desyphed hydrochloride; ICE [Street Name]; Metamfetamine [INN];Metamfetaminum [Latin]; Metanfetamina [Spanish]; Methamphetaminum [JP]; Speed [Street Name]; D-Deoxyephedrine; D-Desoxyephedrine; D-Methamphetamine; D-Methylamphetamine; D-Phenylisopropylmethylamine;Desoxyn (TN); Metamfetamina [INN-Spanish]; Metamfetamine (INN); Metamfetamine-m; Metamfetaminum [INN-Latin]; Metanfetamina [INN-Spanish]; Meth (Street Name); Methamphetaminum [INN-Latin]; D-N-Methylamphetamine; D-(S)-Methamphetamine; D-N,alpha-dimethylphenethylamine; Methamphetamine, its salts, isomers, and salts of its isomers; N-Methyl-beta-phenylisopropylamin; N-Methyl-beta-phenylisopropylamin [German]; N-Methyl-beta-phenylisopropylamine; D-1-Phenyl-2-methylaminopropan; D-1-Phenyl-2-methylaminopropan [German]; S-(+)-Methamphetamine; D-N,alpha-Dimethylphenethylamine; N-Methyl-1-phenyl-2-propanamine; Benzeneethanamine, N,alpha-dimethyl-, (S)-(9CI); Benzeneethanamine, N,alpha-dimethyl-, (alphaS)-(9CI); Phenethylamine, N,alpha-dimethyl-, (S)-(+)-(8CI); (+)-(S)-N-alpha-Dimethylphenethylamine; (+)-2-(N-Methylamino)-1-phenylpropane; (+)-N,alpha-Dimethyl-beta-phenylethylamine; (+)-N,alpha-Dimethylphenethylamine; (+)-methamphetamine; (2S)-N-methyl-1-phenylpropan-2-amine; (S)-(+)-Methamphetamine; (S)-(+)-N,alpha,dimethylphenethylamine; (S)-N,alpha-Dimethylbenzeneethanamine; (S)-N,alpha-Dimethylbenzeneethanoamine; (alphaS)-N,alpha-dimethylbenzeneethanamine; 1-Phenyl-2-methylamino-propan; 1-Phenyl-2-methylamino-propan [German]; 2S-(+)-Methamphetamine; Methamfetamine
Indication
Disease Entry ICD 11 Status REF
Anxiety Approved [1]
Attention deficit hyperactivity disorder 6A05.Z Approved [2]
Depression 6A70-6A7Z Approved [1]
Methamphetamine dependence 6C46.2 Approved [1]
Obesity 5B81 Approved [1]
Pain MG30-MG3Z Approved [3]
Sexually transmitted infection 1A9Z Approved [1]
Substance dependence Approved [1]
Therapeutic Class
Central Nervous System Stimulants
Cross-matching ID
PubChem CID
10836
ChEBI ID
CHEBI:6809
CAS Number
CAS 537-46-2
TTD Drug ID
DMPM4SK
VARIDT Drug ID
DR00256
INTEDE Drug ID
DR1036
ACDINA Drug ID
D00207

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
DTP
DME
DOT
Drug Status:
Approved Drug(s)
Clinical Trial Drug(s)
Discontinued Drug(s)
Investigative Drug(s)
Patented Agent(s)
Preclinical Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Propericiazine DME9JNL Psychiatric disorder 6E8Z Approved [12]
Methoxamine DMF5XQH Hypertension BA00-BA04 Approved [13]
Phendimetrazine DM6TS1N Obesity 5B81 Approved [14]
MEDETOMIDINE DMX9Y7V Pain MG30-MG3Z Phase 2 [15]
TIOSPIRONE DME5QDP N. A. N. A. Discontinued in Phase 3 [16]
Sunepitron DM6M8ZX N. A. N. A. Discontinued in Phase 3 [17]
MAZAPERTINE DMRHYAU N. A. N. A. Discontinued in Phase 2 [18]
SOU-001 DMPAEK5 Urinary incontinence MF50.2 Discontinued in Phase 2 [19]
SNAP-5089 DMROJEN Heart arrhythmia BC65 Terminated [20]
WB-4101 DMQU8B1 N. A. N. A. Terminated [21]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Targeting Dopamine D2 receptor (D2R)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Dopamine DMPGUCF Acromegaly 5A60.0 Approved [22]
Haloperidol DM96SE0 Delirium Approved [23]
Perphenazine DMA4MRX Schizophrenia 6A20 Approved [24]
Perazine DM2AOTZ Psychotic disorder 6A20-6A25 Approved [25]
Domperidone DMBDPY0 Gastrointestinal disease DE2Z Approved [26]
Levodopa DMN3E57 Parkinson disease 8A00.0 Approved [27]
Quetiapine DM1N62C Anorexia nervosa cachexia 6B80 Approved [28]
Pimozide DMW83TP Schizophrenia 6A20 Approved [29]
Chlorpromazine DMBGZI3 Acute intermittent hepatic porphyria 5C58.11 Approved [30]
Iloperidone DM6AUFY Schizophrenia 6A20 Approved [31]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Dopamine DMPGUCF Acromegaly 5A60.0 Approved [32]
Ergotidine DM78IME Osteoarthritis FA00-FA05 Approved [33]
Norepinephrine DMOUC09 Alopecia ED70 Approved [32]
SEROTONIN DMOFCRY Discovery agent N.A. Investigative [32]
Drug(s) Metabolized By Cytochrome P450 2D6 (CYP2D6)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [34]
Progesterone DMUY35B Amenorrhea GA20.0 Approved [35]
Tamoxifen DMLB0EZ Breast cancer 2C60-2C65 Approved [36]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [37]
Imatinib DM7RJXL Acute lymphoblastic leukaemia 2A85 Approved [38]
Quinine DMSWYF5 Malaria 1F40-1F45 Approved [39]
Propofol DMB4OLE Anaesthesia 9A78.6 Approved [40]
Dopamine DMPGUCF Acromegaly 5A60.0 Approved [41]
Nicotine DMWX5CO Lung cancer 2C25.0 Approved [42]
Propranolol DM79NTF Angina pectoris BA40 Approved [43]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Norepinephrine DMOUC09 Alopecia ED70 Approved [44]
Dopamine DMPGUCF Acromegaly 5A60.0 Approved [44]
Ergotidine DM78IME Osteoarthritis FA00-FA05 Approved [45]
Haloperidol DM96SE0 Delirium Approved [45]
Leflunomide DMR8ONJ Arthritis FA20 Approved [46]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [47]
Dextroamphetamine DMMIHVP Attention deficit hyperactivity disorder 6A05.Z Approved [45]
Dexamethasone DMMWZET Acute adrenal insufficiency Approved [48]
Cocaine DMSOX7I Anaesthesia 9A78.6 Approved [49]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [50]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By D(2) dopamine receptor (DRD2)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Droperidol DM0DXA8 Nausea MD90 Approved [51]
Thioridazine DM35M8J Schizophrenia 6A20 Approved [51]
Zuclopenthixol DMKYD5N Schizophrenia 6A20 Approved [51]
Meglitinides DM1OFHN Type-2 diabetes 5A11 Approved [52]
Sulpiride DMF54ZG Schizophrenia 6A20 Approved [53]
Risperidone DMN6DXL Bipolar I disorder Approved [54]
Olanzapine DMPFN6Y Bipolar depression Approved [55]
Bromocriptine DMVE3TK Acromegaly 5A60.0 Approved [56]
Fluphenazine DMIT8LX Psychotic disorder 6A20-6A25 Approved [57]
Chlorpromazine DMBGZI3 Acute intermittent hepatic porphyria 5C58.11 Approved [58]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By PRKCA-binding protein (PICK1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [59]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [60]
Arsenic DMTL2Y1 N. A. N. A. Approved [61]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [62]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [63]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [64]
⏷ Show the Full List of 6 Drug(s)
Drug(s) Affected By Zeta-sarcoglycan (SGCZ)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [65]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [64]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [65]
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [65]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [47]
Vorinostat DMWMPD4 Adult acute monocytic leukemia Approved [66]
Chlorothiazide DMLHESP Chronic heart failure BD1Z Approved [67]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [68]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [65]
Trichostatin A DM9C8NX Solid tumour/cancer 2A00-2F9Z Investigative [69]
⏷ Show the Full List of 7 Drug(s)
Drug(s) Affected By Catalase (CAT)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [70]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [71]
Haloperidol DM96SE0 Delirium Approved [51]
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [72]
Selenium DM25CGV N. A. N. A. Approved [73]
Methimazole DM25FL8 Hyperthyroidism 5A02 Approved [74]
Citalopram DM2G9AE Acute coronary syndrome BA41 Approved [75]
Methotrexate DM2TEOL Anterior urethra cancer Approved [76]
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [77]
Quercetin DM3NC4M Obesity 5B81 Approved [78]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Superoxide dismutase (SOD1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [79]
Haloperidol DM96SE0 Delirium Approved [51]
Beta-carotene DM0RXBT Vitamin deficiency 5B55-5B71 Approved [80]
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [81]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [70]
Nitric Oxide DM1RBYG Hypertension BA00-BA04 Approved [82]
SPI-1005 DM6XFHS Reperfusion injury ND56.Z Approved [83]
Methotrexate DM2TEOL Anterior urethra cancer Approved [84]
Epinephrine DM3KJBC Acute asthma CA23 Approved [85]
Quercetin DM3NC4M Obesity 5B81 Approved [86]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Metallothionein-2 (MT2A)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [87]
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [88]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [89]
Deoxycholic acid DM3GYAL Subcutaneous fat disorder EF02 Approved [90]
Quercetin DM3NC4M Obesity 5B81 Approved [91]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [92]
Acetic Acid, Glacial DM4SJ5Y infection in the ear canal AA0Y Approved [93]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [94]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [95]
Cidofovir DMA13GD Cytomegalovirus infection 1D82 Approved [96]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Acetic Acid, Glacial DM4SJ5Y infection in the ear canal AA0Y Approved [93]
Panobinostat DM58WKG Chronic graft versus host disease Approved [66]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [97]
Leflunomide DMR8ONJ Arthritis FA20 Approved [46]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [98]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [69]
Motexafin gadolinium DMEJKRF Brain cancer 2A00 Approved [93]
Folic Acid DMEMBJC Colorectal carcinoma Approved [99]
Amiodarone DMUTEX3 Tachyarrhythmias BC71 Approved [100]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [101]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Angiopoietin-2 (ANGPT2)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [102]
Methotrexate DM2TEOL Anterior urethra cancer Approved [103]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [104]
Panobinostat DM58WKG Chronic graft versus host disease Approved [66]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [105]
Thalidomide DM70BU5 Adult T-cell leukemia/lymphoma Approved [106]
Propranolol DM79NTF Angina pectoris BA40 Approved [107]
Testosterone DM7HUNW Hot flushes GA30 Approved [108]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [108]
Atorvastatin DMF28YC Acute coronary syndrome BA41 Approved [109]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [110]
Gefitinib DM15F0X Colon adenocarcinoma Approved [111]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [112]
Nitric Oxide DM1RBYG Hypertension BA00-BA04 Approved [113]
Etretinate DM2CZFA Keratosis ED56 Approved [114]
Sulindac DM2QHZU Acute myelogenous leukaemia 2A41 Approved [115]
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [116]
Lapatinib DM3BH1Y Breast cancer 2C60-2C65 Approved [117]
Quercetin DM3NC4M Obesity 5B81 Approved [118]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [119]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [120]
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [121]
Quercetin DM3NC4M Obesity 5B81 Approved [122]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [123]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [124]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [125]
Testosterone DM7HUNW Hot flushes GA30 Approved [108]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [108]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [98]
Demecolcine DMCZQGK Solid tumour/cancer 2A00-2F9Z Approved [126]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [127]
Polyethylene glycol DM4I1JP Constipation DD91.1 Approved [127]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [127]
Panobinostat DM58WKG Chronic graft versus host disease Approved [66]
Thalidomide DM70BU5 Adult T-cell leukemia/lymphoma Approved [127]
Nilotinib DM7HXWT Chronic myelogenous leukaemia 2A20.0 Approved [127]
Ramelteon DM7IW9J Insomnia 7A00-7A0Z Approved [127]
Disulfiram DMCL2OK Alcohol dependence 6C40.2 Approved [128]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [47]
Dabigatran DMDI6R4 Stroke 8B20 Approved [127]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [47]
DTI-015 DMXZRW0 Brain cancer 2A00 Approved [129]
Urethane DM7NSI0 N. A. N. A. Phase 4 [130]
(+)-JQ1 DM1CZSJ Testicular cancer 2C80 Phase 1 [131]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [64]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [65]
Trichostatin A DM9C8NX Solid tumour/cancer 2A00-2F9Z Investigative [132]
acetaldehyde DMJFKG4 Discovery agent N.A. Investigative [133]
⏷ Show the Full List of 8 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [89]
Quercetin DM3NC4M Obesity 5B81 Approved [134]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [135]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [136]
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [137]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [138]
Leflunomide DMR8ONJ Arthritis FA20 Approved [46]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [139]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [140]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [141]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [120]
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [110]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [142]
Methotrexate DM2TEOL Anterior urethra cancer Approved [143]
Quercetin DM3NC4M Obesity 5B81 Approved [78]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [123]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [144]
Chlorpromazine DMBGZI3 Acute intermittent hepatic porphyria 5C58.11 Approved [145]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [136]
Testosterone DM7HUNW Hot flushes GA30 Approved [108]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [146]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [142]
Colchicine DM2POTE Acute gout flare FA25.0 Approved [147]
Methotrexate DM2TEOL Anterior urethra cancer Approved [143]
Quercetin DM3NC4M Obesity 5B81 Approved [78]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [123]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [148]
Testosterone DM7HUNW Hot flushes GA30 Approved [108]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [108]
Leflunomide DMR8ONJ Arthritis FA20 Approved [46]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Benzbromarone DMC3YUA Gout FA25 Approved [149]
Verapamil DMA7PEW Angina pectoris BA40 Approved [149]
Quercetin DM3NC4M Obesity 5B81 Approved [78]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [150]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [151]
Zidovudine DM4KI7O Human immunodeficiency virus infection 1C62 Approved [152]
Rifampicin DM5DSFZ Non-insulin dependent diabetes 5A11 Approved [153]
Adenosine triphosphate DM79F6G Malnutrition 5B50-5B71 Approved [154]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [139]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [47]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [155]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [156]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [156]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [157]
Imatinib DM7RJXL Acute lymphoblastic leukaemia 2A85 Approved [158]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [141]
Folic Acid DMEMBJC Colorectal carcinoma Approved [159]
Alitretinoin DMME8LH Kaposi sarcoma 2B57 Approved [156]
Bexarotene DMOBIKY Cutaneous T-cell lymphoma 2B01 Approved [160]
Malathion DMXZ84M Pediculus capitis infestation 1G00.0 Approved [161]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Nitric Oxide DM1RBYG Hypertension BA00-BA04 Approved [162]
Quercetin DM3NC4M Obesity 5B81 Approved [163]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [92]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [148]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [164]
Isoniazid DM5JVS3 Latent tuberculosis infection Approved [165]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [166]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [139]
Tofacitinib DMBS370 Rheumatoid arthritis FA20 Approved [167]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [47]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fluoxetine DM3PD2C Bipolar depression Approved [168]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [169]
Panobinostat DM58WKG Chronic graft versus host disease Approved [66]
Haloperidol DM96SE0 Delirium Approved [170]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [171]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [140]
Ifosfamide DMCT3I8 Adult central nervous system germ cell tumor Approved [96]
Benzatropine DMF7EXL Parkinsonian disorder Approved [170]
Sodium lauryl sulfate DMLJ634 Constipation DD91.1 Approved [172]
Dexamethasone DMMWZET Acute adrenal insufficiency Approved [173]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Etoposide DMNH3PG Acute myelogenous leukaemia 2A41 Approved [174]
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [175]
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [81]
Ciprofloxacin XR DM2NLS9 Acute gonococcal cervicitis Approved [176]
Methotrexate DM2TEOL Anterior urethra cancer Approved [143]
Lapatinib DM3BH1Y Breast cancer 2C60-2C65 Approved [177]
Quercetin DM3NC4M Obesity 5B81 Approved [78]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [123]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [178]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [179]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [180]
Quercetin DM3NC4M Obesity 5B81 Approved [78]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [148]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [136]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [98]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [47]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [141]
Ethanol DMDRQZU Chronic pain MG30 Approved [181]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [101]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [60]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [88]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [142]
Selenium DM25CGV N. A. N. A. Approved [182]
Methotrexate DM2TEOL Anterior urethra cancer Approved [183]
Quercetin DM3NC4M Obesity 5B81 Approved [78]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [123]
Methylprednisolone DM4BDON Acute adrenal insufficiency Approved [184]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [125]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [185]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [171]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Galanin peptides (GAL)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Verapamil DMA7PEW Angina pectoris BA40 Approved [186]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [142]
Sulindac DM2QHZU Acute myelogenous leukaemia 2A41 Approved [186]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [187]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [188]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [95]
Testosterone DM7HUNW Hot flushes GA30 Approved [108]
Methazolamide DM7J2TA Glaucoma/ocular hypertension 9C61 Approved [186]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [108]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [171]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Gemcitabine DMSE3I7 Anterior urethra cancer Approved [189]
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [120]
Methotrexate DM2TEOL Anterior urethra cancer Approved [143]
Quercetin DM3NC4M Obesity 5B81 Approved [78]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [123]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [178]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [190]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [95]
Testosterone DM7HUNW Hot flushes GA30 Approved [108]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [108]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Eicosapentaenoic acid/docosa-hexaenoic acid DMMUCG4 Hypertriglyceridemia 5C80.1 Approved [191]
Etoposide DMNH3PG Acute myelogenous leukaemia 2A41 Approved [192]
Gamolenic acid DMQN30Z Allergy 4A80-4A85 Approved [193]
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [194]
Flupentixol DM0DJ9O Schizophrenia 6A20 Approved [195]
Sertraline DM0FB1J Coronary heart disease BA80.Z Approved [196]
Ibandronate DM0QZBN Hypercalcaemia 5B91.0 Approved [197]
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [198]
Fexofenadine DM17ONX Allergic rhinitis CA08.0 Approved [199]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [200]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [201]
Enzalutamide DMGL19D Prostate cancer 2C82.0 Approved [202]
Arsenic DMTL2Y1 N. A. N. A. Approved [203]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [63]
Dihydrotestosterone DM3S8XC Prostate hyperplasia GA90 Phase 4 [202]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [64]
SB-203347 DM3AWMF Discovery agent N.A. Investigative [204]
Beta-D-Glucose DM5IHYP Discovery agent N.A. Investigative [205]
fMet-Leu-Phe DMQ391A N. A. N. A. Investigative [205]
⏷ Show the Full List of 9 Drug(s)
Drug(s) Affected By Thrombopoietin (THPO)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [206]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [140]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [101]
Gemcitabine DMSE3I7 Anterior urethra cancer Approved [207]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [62]
Testosterone undecanoate DMZO10Y Hypogonadism 5A61.0 Approved [208]
Triclosan DMZUR4N Malaria 1F40-1F45 Approved [209]
Methylprednisolone DM4BDON Acute adrenal insufficiency Approved [51]
Urethane DM7NSI0 N. A. N. A. Phase 4 [130]
SNDX-275 DMH7W9X Breast cancer 2C60-2C65 Phase 3 [210]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [211]
Pantothenic acid DM091H2 Vitamin deficiency 5B55-5B71 Approved [212]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [180]
Selenium DM25CGV N. A. N. A. Approved [213]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [124]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [214]
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [215]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [138]
Leflunomide DMR8ONJ Arthritis FA20 Approved [46]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [139]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Levonorgestrel DM1DP7T Atypical endometrial hyperplasia Approved [216]
Methotrexate DM2TEOL Anterior urethra cancer Approved [143]
Quercetin DM3NC4M Obesity 5B81 Approved [217]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [123]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [218]
Remdesivir DMBFZ6L Coronavirus Disease 2019 (COVID-19) 1D6Y Approved [219]
Chlorpromazine DMBGZI3 Acute intermittent hepatic porphyria 5C58.11 Approved [145]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [220]
Thalidomide DM70BU5 Adult T-cell leukemia/lymphoma Approved [221]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [138]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [222]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [148]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [47]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [59]
Decitabine DMQL8XJ Acute myelogenous leukaemia 2A41 Approved [223]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [223]
Triclosan DMZUR4N Malaria 1F40-1F45 Approved [209]
Urethane DM7NSI0 N. A. N. A. Phase 4 [130]
(+)-JQ1 DM1CZSJ Testicular cancer 2C80 Phase 1 [224]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [64]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [148]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [140]
Folic Acid DMEMBJC Colorectal carcinoma Approved [225]
Dasatinib DMJV2EK Blast phase chronic myelogenous leukemia, BCR-ABL1 positive Approved [226]
Estriol DMOEM2I Hormone deficiency 5A61.1 Approved [227]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [101]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [227]
Progesterone DMUY35B Amenorrhea GA20.0 Approved [228]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [63]
DTI-015 DMXZRW0 Brain cancer 2A00 Approved [129]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Mevalonate kinase (MVK)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Selenium DM25CGV N. A. N. A. Approved [213]
Clavulanate DM2FGRT Bacteremia 1A73 Approved [229]
Fluoxetine DM3PD2C Bipolar depression Approved [168]
obeticholic acid DM3Q1SM Primary biliary cholangitis DB96.1 Approved [230]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [150]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [148]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [188]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [139]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [231]
Dexamethasone DMMWZET Acute adrenal insufficiency Approved [173]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [88]
Quercetin DM3NC4M Obesity 5B81 Approved [78]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [123]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [104]
Chlorpromazine DMBGZI3 Acute intermittent hepatic porphyria 5C58.11 Approved [145]
Testosterone DM7HUNW Hot flushes GA30 Approved [108]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [108]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [232]
Demecolcine DMCZQGK Solid tumour/cancer 2A00-2F9Z Approved [126]
Niclosamide DMJAGXQ Cestodes infection 1F70-1F76 Approved [233]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [78]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [123]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [218]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [190]
Clodronate DM9Y6X7 Hypercalcaemia 5B91.0 Approved [96]
Cidofovir DMA13GD Cytomegalovirus infection 1D82 Approved [96]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [139]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [47]
Demecolcine DMCZQGK Solid tumour/cancer 2A00-2F9Z Approved [126]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [234]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By PCNA-associated factor (PCLAF)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [146]
Methotrexate DM2TEOL Anterior urethra cancer Approved [143]
Rifampicin DM5DSFZ Non-insulin dependent diabetes 5A11 Approved [235]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [95]
Testosterone DM7HUNW Hot flushes GA30 Approved [108]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [108]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [139]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [47]
Palbociclib DMD7L94 Breast cancer 2C60-2C65 Approved [236]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [141]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [237]
Methotrexate DM2TEOL Anterior urethra cancer Approved [143]
Quercetin DM3NC4M Obesity 5B81 Approved [78]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [123]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [148]
Testosterone DM7HUNW Hot flushes GA30 Approved [108]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [108]
Leflunomide DMR8ONJ Arthritis FA20 Approved [46]
Clodronate DM9Y6X7 Hypercalcaemia 5B91.0 Approved [96]
Cidofovir DMA13GD Cytomegalovirus infection 1D82 Approved [96]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [78]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [135]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [105]
Testosterone DM7HUNW Hot flushes GA30 Approved [108]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [108]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [238]
Palbociclib DMD7L94 Breast cancer 2C60-2C65 Approved [236]
Ethanol DMDRQZU Chronic pain MG30 Approved [239]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [234]
Azathioprine DMMZSXQ Lupus nephritis 4A40.0Y Approved [240]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Borealin (CDCA8)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Methotrexate DM2TEOL Anterior urethra cancer Approved [143]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [135]
Testosterone DM7HUNW Hot flushes GA30 Approved [108]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [108]
Leflunomide DMR8ONJ Arthritis FA20 Approved [46]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [232]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [47]
Palbociclib DMD7L94 Breast cancer 2C60-2C65 Approved [236]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [234]
Niclosamide DMJAGXQ Cestodes infection 1F70-1F76 Approved [233]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [78]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [104]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [188]
Panobinostat DM58WKG Chronic graft versus host disease Approved [66]
Rifampicin DM5DSFZ Non-insulin dependent diabetes 5A11 Approved [153]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [139]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [140]
Demecolcine DMCZQGK Solid tumour/cancer 2A00-2F9Z Approved [126]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [234]
Azathioprine DMMZSXQ Lupus nephritis 4A40.0Y Approved [240]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Protein MCM10 homolog (MCM10)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [120]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [142]
Colchicine DM2POTE Acute gout flare FA25.0 Approved [147]
Quercetin DM3NC4M Obesity 5B81 Approved [78]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [218]
Testosterone DM7HUNW Hot flushes GA30 Approved [108]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [108]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [232]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [238]
Palbociclib DMD7L94 Breast cancer 2C60-2C65 Approved [236]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [148]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [47]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [241]
Arsenic DMTL2Y1 N. A. N. A. Approved [61]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [242]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [63]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [64]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [243]
Sulforaphane DMQY3L0 Skin disease EA00-EM0Z Investigative [244]
⏷ Show the Full List of 9 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Methotrexate DM2TEOL Anterior urethra cancer Approved [143]
Quercetin DM3NC4M Obesity 5B81 Approved [78]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [123]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [148]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [105]
Liothyronine DM6IR3P Congenital hypothyroidism Approved [245]
Testosterone DM7HUNW Hot flushes GA30 Approved [108]
Riboflavin DM8YMWE Acne vulgaris ED80 Approved [246]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [108]
Leflunomide DMR8ONJ Arthritis FA20 Approved [46]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By CD177 antigen (CD177)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [105]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [247]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [64]
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [218]
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [248]
Testosterone DM7HUNW Hot flushes GA30 Approved [108]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [108]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [232]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [140]
Palbociclib DMD7L94 Breast cancer 2C60-2C65 Approved [236]
Dasatinib DMJV2EK Blast phase chronic myelogenous leukemia, BCR-ABL1 positive Approved [226]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [249]
Arsenic DMTL2Y1 N. A. N. A. Approved [61]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [201]
Methotrexate DM2TEOL Anterior urethra cancer Approved [143]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [148]
Testosterone DM7HUNW Hot flushes GA30 Approved [108]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [108]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [78]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [250]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [141]
Dasatinib DMJV2EK Blast phase chronic myelogenous leukemia, BCR-ABL1 positive Approved [226]
Azathioprine DMMZSXQ Lupus nephritis 4A40.0Y Approved [240]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Methotrexate DM2TEOL Anterior urethra cancer Approved [184]
Aripiprazole DM3NUMH Bipolar I disorder Approved [251]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [148]
Methylprednisolone DM4BDON Acute adrenal insufficiency Approved [184]
Testosterone DM7HUNW Hot flushes GA30 Approved [108]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [108]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [139]
Rosiglitazone DMILWZR Chronic kidney disease GB61 Approved [150]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [59]
Azathioprine DMMZSXQ Lupus nephritis 4A40.0Y Approved [184]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Beta-carotene DM0RXBT Vitamin deficiency 5B55-5B71 Approved [80]
Quercetin DM3NC4M Obesity 5B81 Approved [78]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [123]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [148]
Testosterone DM7HUNW Hot flushes GA30 Approved [108]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [108]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [139]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [250]
Palbociclib DMD7L94 Breast cancer 2C60-2C65 Approved [236]
Azathioprine DMMZSXQ Lupus nephritis 4A40.0Y Approved [240]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Methotrexate DM2TEOL Anterior urethra cancer Approved [143]
Quercetin DM3NC4M Obesity 5B81 Approved [78]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [123]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [148]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [252]
Testosterone DM7HUNW Hot flushes GA30 Approved [108]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [108]
Leflunomide DMR8ONJ Arthritis FA20 Approved [46]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [139]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [140]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [253]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [89]
Colchicine DM2POTE Acute gout flare FA25.0 Approved [147]
Sulindac DM2QHZU Acute myelogenous leukaemia 2A41 Approved [115]
Quercetin DM3NC4M Obesity 5B81 Approved [254]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [255]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [156]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [156]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [256]
Aspirin DM672AH Acute coronary syndrome BA41 Approved [257]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [201]
Methotrexate DM2TEOL Anterior urethra cancer Approved [143]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [148]
Testosterone DM7HUNW Hot flushes GA30 Approved [108]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [108]
Leflunomide DMR8ONJ Arthritis FA20 Approved [46]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [232]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [47]
Palbociclib DMD7L94 Breast cancer 2C60-2C65 Approved [236]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [141]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [78]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [148]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [258]
Testosterone DM7HUNW Hot flushes GA30 Approved [108]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [108]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [139]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [47]
Demecolcine DMCZQGK Solid tumour/cancer 2A00-2F9Z Approved [126]
Niclosamide DMJAGXQ Cestodes infection 1F70-1F76 Approved [259]
Dasatinib DMJV2EK Blast phase chronic myelogenous leukemia, BCR-ABL1 positive Approved [226]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Methotrexate DM2TEOL Anterior urethra cancer Approved [183]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [135]
Panobinostat DM58WKG Chronic graft versus host disease Approved [66]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [47]
Rosiglitazone DMILWZR Chronic kidney disease GB61 Approved [260]
Vorinostat DMWMPD4 Adult acute monocytic leukemia Approved [66]
Permethrin DMZ0Q1G Pediculus capitis infestation 1G00.0 Approved [161]
SNDX-275 DMH7W9X Breast cancer 2C60-2C65 Phase 3 [66]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [64]
PMID27336223-Compound-5 DM6E50A N. A. N. A. Patented [260]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [148]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [139]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [261]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [141]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [234]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [101]
Menadione DMSJDTY Vitamin K deficiency 5B59 Approved [142]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [62]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [63]
SNDX-275 DMH7W9X Breast cancer 2C60-2C65 Phase 3 [66]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Lymphocyte antigen 96 (LY96)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [262]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [263]
Methotrexate DM2TEOL Anterior urethra cancer Approved [76]
Quercetin DM3NC4M Obesity 5B81 Approved [78]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [150]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [190]
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [215]
Testosterone DM7HUNW Hot flushes GA30 Approved [108]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [108]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [139]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [135]
Acetic Acid, Glacial DM4SJ5Y infection in the ear canal AA0Y Approved [93]
Butorphanol DM5KYPJ Pain MG30-MG3Z Approved [264]
Vinblastine DM5TVS3 Advanced cancer 2A00-2F9Z Approved [265]
Aspirin DM672AH Acute coronary syndrome BA41 Approved [266]
Thalidomide DM70BU5 Adult T-cell leukemia/lymphoma Approved [267]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [138]
Testosterone DM7HUNW Hot flushes GA30 Approved [268]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [238]
Ursodeoxycholic acid DMCUT21 Cholelithiasis DC11 Approved [269]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Selenium DM25CGV N. A. N. A. Approved [270]
Trametinib DM2JGQ3 Melanoma 2C30 Approved [271]
Quercetin DM3NC4M Obesity 5B81 Approved [134]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [148]
Remdesivir DMBFZ6L Coronavirus Disease 2019 (COVID-19) 1D6Y Approved [219]
Crizotinib DM4F29C Non-small-cell lung cancer 2C25.Y Approved [272]
Panobinostat DM58WKG Chronic graft versus host disease Approved [66]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [273]
Aspirin DM672AH Acute coronary syndrome BA41 Approved [274]
Testosterone DM7HUNW Hot flushes GA30 Approved [268]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Emtricitabine DMBMUWZ Hepatitis virus infection 1E50-1E51 Approved [275]
Tubocurarine DMBZIVP Anaesthesia 9A78.6 Approved [276]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [47]
Ethanol DMDRQZU Chronic pain MG30 Approved [277]
Trifluoperazine DMKBYWI Anxiety Approved [278]
Dopamine DMPGUCF Acromegaly 5A60.0 Approved [279]
Sorafenib DMS8IFC Adenocarcinoma 2D40 Approved [280]
Arsenic DMTL2Y1 N. A. N. A. Approved [61]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [63]
Nicotine DMWX5CO Lung cancer 2C25.0 Approved [276]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [281]
Sertraline DM0FB1J Coronary heart disease BA80.Z Approved [282]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [283]
Sulindac DM2QHZU Acute myelogenous leukaemia 2A41 Approved [284]
Quercetin DM3NC4M Obesity 5B81 Approved [285]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [284]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [135]
Pyrazinamide DM4IF32 Meningeal tuberculosis Approved [286]
Glucosamine DM4ZLFD Osteoarthritis FA00-FA05 Approved [287]
Rifampicin DM5DSFZ Non-insulin dependent diabetes 5A11 Approved [284]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Prolactin (PRL)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Verapamil DMA7PEW Angina pectoris BA40 Approved [288]
Ranitidine DM0GUSX Gastric ulcer DA60 Approved [289]
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [290]
Citalopram DM2G9AE Acute coronary syndrome BA41 Approved [291]
Methotrexate DM2TEOL Anterior urethra cancer Approved [76]
Thioridazine DM35M8J Schizophrenia 6A20 Approved [292]
Naloxone DM3FXMA Narcotic depression 6A7Z Approved [293]
Aripiprazole DM3NUMH Bipolar I disorder Approved [294]
Fluoxetine DM3PD2C Bipolar depression Approved [295]
Penicillamine DM40EF6 Cystinuria 5C60.2 Approved [296]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Tumor necrosis factor (TNF)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Indomethacin DMSC4A7 Bursitis Approved [297]
Amphotericin B DMTAJQE Acne vulgaris ED80 Approved [298]
Fructose DM43AN2 Vomiting MD90 Approved [51]
Ketoprofen DMRKXPT Bursitis Approved [51]
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [299]
Sertraline DM0FB1J Coronary heart disease BA80.Z Approved [300]
Baclofen DM0QV1J Multiple sclerosis 8A40 Approved [301]
Gefitinib DM15F0X Colon adenocarcinoma Approved [302]
Ganciclovir DM1MBYQ Cytomegalovirus infection 1D82 Approved [303]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [102]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [78]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [148]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [188]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [252]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [47]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [101]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [304]
Nabiximols DMHKJ5I Cancer related pain MG30 Phase 3 [305]
(+)-JQ1 DM1CZSJ Testicular cancer 2C80 Phase 1 [306]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [139]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [180]
Selenium DM25CGV N. A. N. A. Approved [213]
Methotrexate DM2TEOL Anterior urethra cancer Approved [76]
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [307]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [123]
Penicillamine DM40EF6 Cystinuria 5C60.2 Approved [308]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [309]
Isoniazid DM5JVS3 Latent tuberculosis infection Approved [310]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [105]
Aluminium DM6ECN9 Hyperhidrosis EE00 Approved [311]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Transcription factor Jun (JUN)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Mitoxantrone DMM39BF Acute myelogenous leukaemia 2A41 Approved [312]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [313]
Fructose DM43AN2 Vomiting MD90 Approved [51]
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [314]
Mechlorethamine DM0CVXA Chronic myelogenous leukaemia 2A20.0 Approved [315]
Sertraline DM0FB1J Coronary heart disease BA80.Z Approved [282]
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [81]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [222]
Colchicine DM2POTE Acute gout flare FA25.0 Approved [316]
Methotrexate DM2TEOL Anterior urethra cancer Approved [317]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Insulin receptor (INSR)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [318]
Methotrexate DM2TEOL Anterior urethra cancer Approved [76]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [187]
Testosterone DM7HUNW Hot flushes GA30 Approved [319]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [139]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [69]
Sulfasalazine DMICA9H Irritable bowel syndrome DD91.0 Approved [320]
Rosiglitazone DMILWZR Chronic kidney disease GB61 Approved [321]
Phenytoin DMNOKBV Epilepsy 8A60-8A68 Approved [322]
Diclofenac DMPIHLS Chronic renal failure GB61.Z Approved [323]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Tyrosine 3-monooxygenase (TH)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Zonisamide DM0DTF7 Alcohol dependence 6C40.2 Approved [324]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [325]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [326]
Lovastatin DM9OZWQ Arteriosclerosis BD40 Approved [327]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [171]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [238]
Mifepristone DMGZQEF Cushing disease 5A70 Approved [328]
Alitretinoin DMME8LH Kaposi sarcoma 2B57 Approved [329]
Decitabine DMQL8XJ Acute myelogenous leukaemia 2A41 Approved [330]
Piperazine DMTY9LU Ascariasis 1F62 Approved [331]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Synaptophysin (SYP)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [180]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [329]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [171]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [47]
Ethanol DMDRQZU Chronic pain MG30 Approved [332]
Alitretinoin DMME8LH Kaposi sarcoma 2B57 Approved [329]
Abacavir DMMN36E Human immunodeficiency virus infection 1C62 Approved [333]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [241]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [62]
Urethane DM7NSI0 N. A. N. A. Phase 4 [130]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Poly polymerase 1 (PARP1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [88]
Gefitinib DM15F0X Colon adenocarcinoma Approved [334]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [335]
Nitric Oxide DM1RBYG Hypertension BA00-BA04 Approved [113]
Citalopram DM2G9AE Acute coronary syndrome BA41 Approved [336]
Ciprofloxacin XR DM2NLS9 Acute gonococcal cervicitis Approved [337]
Imipramine DM2NUH3 Depression 6A70-6A7Z Approved [336]
Colchicine DM2POTE Acute gout flare FA25.0 Approved [338]
Sulindac DM2QHZU Acute myelogenous leukaemia 2A41 Approved [339]
Methotrexate DM2TEOL Anterior urethra cancer Approved [340]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Sevoflurane DMC9O43 Anaesthesia 9A78.6 Approved [341]
Docetaxel DMDI269 Advanced cancer 2A00-2F9Z Approved [342]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [343]
Gemcitabine DMSE3I7 Anterior urethra cancer Approved [344]
Etoposide DMNH3PG Acute myelogenous leukaemia 2A41 Approved [51]
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [88]
Verapamil DMA7PEW Angina pectoris BA40 Approved [345]
Mechlorethamine DM0CVXA Chronic myelogenous leukaemia 2A20.0 Approved [346]
Sertraline DM0FB1J Coronary heart disease BA80.Z Approved [300]
Beta-carotene DM0RXBT Vitamin deficiency 5B55-5B71 Approved [347]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [348]
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [349]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [350]
Colchicine DM2POTE Acute gout flare FA25.0 Approved [351]
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [352]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [148]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [353]
Leflunomide DMR8ONJ Arthritis FA20 Approved [46]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [139]
Testosterone enanthate DMB6871 N. A. N. A. Approved [354]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [348]
Indinavir DM0T3YH Human immunodeficiency virus infection 1C62 Approved [284]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [355]
Etretinate DM2CZFA Keratosis ED56 Approved [356]
Colchicine DM2POTE Acute gout flare FA25.0 Approved [357]
Dactinomycin DM2YGNW Adult kidney Wilms tumor Approved [358]
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [359]
Naloxone DM3FXMA Narcotic depression 6A7Z Approved [360]
Quercetin DM3NC4M Obesity 5B81 Approved [78]
Furazolidone DM3P6V7 Diarrhea ME05.1 Approved [361]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Aspirin DM672AH Acute coronary syndrome BA41 Approved [362]
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [363]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [222]
Selenium DM25CGV N. A. N. A. Approved [213]
Methotrexate DM2TEOL Anterior urethra cancer Approved [364]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [365]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [366]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [366]
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [367]
Ergotidine DM78IME Osteoarthritis FA00-FA05 Approved [368]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [369]
Quercetin DM3NC4M Obesity 5B81 Approved [370]
obeticholic acid DM3Q1SM Primary biliary cholangitis DB96.1 Approved [230]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [148]
Panobinostat DM58WKG Chronic graft versus host disease Approved [66]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [371]
Leflunomide DMR8ONJ Arthritis FA20 Approved [46]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [47]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [141]
Capsaicin DMGMF6V Back pain ME84.Z Approved [372]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Sertraline DM0FB1J Coronary heart disease BA80.Z Approved [282]
Bepridil DM0RKS4 Chronic/stable angina BA40.1 Approved [373]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [180]
Selenium DM25CGV N. A. N. A. Approved [213]
Sulindac DM2QHZU Acute myelogenous leukaemia 2A41 Approved [115]
Pyrazinamide DM4IF32 Meningeal tuberculosis Approved [286]
Glucosamine DM4ZLFD Osteoarthritis FA00-FA05 Approved [287]
Nefazodone DM4ZS8M Major depressive disorder 6A70.3 Approved [374]
Rifampicin DM5DSFZ Non-insulin dependent diabetes 5A11 Approved [375]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [376]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Sulindac DM2QHZU Acute myelogenous leukaemia 2A41 Approved [284]
Quercetin DM3NC4M Obesity 5B81 Approved [134]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [284]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [104]
Pyrazinamide DM4IF32 Meningeal tuberculosis Approved [286]
Glucosamine DM4ZLFD Osteoarthritis FA00-FA05 Approved [377]
Nefazodone DM4ZS8M Major depressive disorder 6A70.3 Approved [374]
Rifampicin DM5DSFZ Non-insulin dependent diabetes 5A11 Approved [284]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [378]
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [379]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [135]
Cyclophosphamide DM4O2Z7 Advanced cancer 2A00-2F9Z Approved [380]
Aspirin DM672AH Acute coronary syndrome BA41 Approved [115]
Perphenazine DMA4MRX Schizophrenia 6A20 Approved [381]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [47]
Melphalan DMOLNHF Hematologic disease 3C0Z Approved [382]
Decitabine DMQL8XJ Acute myelogenous leukaemia 2A41 Approved [223]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [241]
Cocaine DMSOX7I Anaesthesia 9A78.6 Approved [383]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [62]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Dexamethasone DMMWZET Acute adrenal insufficiency Approved [384]
Aspirin DM672AH Acute coronary syndrome BA41 Approved [257]
Sertraline DM0FB1J Coronary heart disease BA80.Z Approved [282]
Gefitinib DM15F0X Colon adenocarcinoma Approved [385]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [180]
Sulindac DM2QHZU Acute myelogenous leukaemia 2A41 Approved [386]
Methotrexate DM2TEOL Anterior urethra cancer Approved [84]
Dactinomycin DM2YGNW Adult kidney Wilms tumor Approved [387]
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [388]
Quercetin DM3NC4M Obesity 5B81 Approved [122]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By D(1A) dopamine receptor (DRD1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Gabapentin DM6T924 Complex partial seizure 8A68.0 Approved [51]
Haloperidol DM96SE0 Delirium Approved [389]
Flupentixol DM0DJ9O Schizophrenia 6A20 Approved [390]
Pergolide mesylate DM5GKOV N. A. N. A. Approved [391]
Chlorpromazine DMBGZI3 Acute intermittent hepatic porphyria 5C58.11 Approved [389]
Acocantherin DM7JT24 Atrial fibrillation BC81.3 Approved [392]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [47]
Dopamine DMPGUCF Acromegaly 5A60.0 Approved [393]
Clozapine DMFC71L Schizophrenia 6A20 Approved [394]
Bardoxolone methyl DMODA2X Mixed connective tissue disease 4A43.3 Phase 3 [395]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fructose DM43AN2 Vomiting MD90 Approved [396]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [178]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [397]
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [215]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [398]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [47]
Demecolcine DMCZQGK Solid tumour/cancer 2A00-2F9Z Approved [126]
Pioglitazone DMKJ485 Amyotrophic lateral sclerosis 8B60.0 Approved [399]
Mirtazapine DML53ZJ Depression 6A70-6A7Z Approved [400]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [60]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fructose DM43AN2 Vomiting MD90 Approved [51]
Aprepitant DM053KT Depression 6A70-6A7Z Approved [401]
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [262]
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [402]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [350]
Colchicine DM2POTE Acute gout flare FA25.0 Approved [403]
Sulindac DM2QHZU Acute myelogenous leukaemia 2A41 Approved [404]
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [405]
Deoxycholic acid DM3GYAL Subcutaneous fat disorder EF02 Approved [406]
Quercetin DM3NC4M Obesity 5B81 Approved [78]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [407]
Progesterone DMUY35B Amenorrhea GA20.0 Approved [408]
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [363]
Sertraline DM0FB1J Coronary heart disease BA80.Z Approved [300]
Beta-carotene DM0RXBT Vitamin deficiency 5B55-5B71 Approved [409]
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [410]
Secobarbital DM14RF5 Epilepsy 8A60-8A68 Approved [411]
Gefitinib DM15F0X Colon adenocarcinoma Approved [412]
Fexofenadine DM17ONX Allergic rhinitis CA08.0 Approved [413]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [414]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [65]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [329]
Alitretinoin DMME8LH Kaposi sarcoma 2B57 Approved [329]
Scopolamine DMOM8AL Addictive disorder 6C50-6C5Z Approved [415]
Triclosan DMZUR4N Malaria 1F40-1F45 Approved [209]
Nicotine DMWX5CO Lung cancer 2C25.0 Approved [51]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [64]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [416]
2-AMINO-1-METHYL-6-PHENYLIMIDAZO[4,5-B]PYRIDINE DMNQL17 Discovery agent N.A. Investigative [417]
Elaidoylamide DMP8VDT Discovery agent N.A. Investigative [418]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Ethanol DMDRQZU Chronic pain MG30 Approved [419]
Progesterone DMUY35B Amenorrhea GA20.0 Approved [408]
Carvedilol DMHTEAO Chronic heart failure BD1Z Approved [420]
Paclitaxel DMLB81S Breast carcinoma Approved [421]
Etoposide DMNH3PG Acute myelogenous leukaemia 2A41 Approved [422]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [407]
Urokinase DM0GOUD Myocardial infarction BA41-BA43 Approved [51]
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [262]
Sertraline DM0FB1J Coronary heart disease BA80.Z Approved [300]
Beta-carotene DM0RXBT Vitamin deficiency 5B55-5B71 Approved [409]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Paroxetine DM5PVQE Anxiety disorder 6B00-6B0Z Approved [423]
Fluoxetine DM3PD2C Bipolar depression Approved [424]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [142]
Ribavirin DMEYLH9 Hepatitis C virus infection 1E51.1 Approved [425]
Colchicine DM2POTE Acute gout flare FA25.0 Approved [426]
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [427]
Quercetin DM3NC4M Obesity 5B81 Approved [78]
Aripiprazole DM3NUMH Bipolar I disorder Approved [428]
Gabapentin DM6T924 Complex partial seizure 8A68.0 Approved [426]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [98]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By D(3) dopamine receptor (DRD3)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Haloperidol DM96SE0 Delirium Approved [429]
Clozapine DMFC71L Schizophrenia 6A20 Approved [430]
Risperidone DMN6DXL Bipolar I disorder Approved [431]
Folic Acid DMEMBJC Colorectal carcinoma Approved [432]
Cocaine DMSOX7I Anaesthesia 9A78.6 Approved [433]
Droperidol DM0DXA8 Nausea MD90 Approved [51]
Thioridazine DM35M8J Schizophrenia 6A20 Approved [51]
Fluphenazine DMIT8LX Psychotic disorder 6A20-6A25 Approved [51]
Chlorpromazine DMBGZI3 Acute intermittent hepatic porphyria 5C58.11 Approved [51]
Trifluoperazine DMKBYWI Anxiety Approved [51]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [434]
Quercetin DM3NC4M Obesity 5B81 Approved [78]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [135]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [105]
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [215]
Testosterone DM7HUNW Hot flushes GA30 Approved [435]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [398]
Leflunomide DMR8ONJ Arthritis FA20 Approved [46]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [139]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [140]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [253]
Triacetin DM0AEPG Onychomycosis EE12.1 Approved [436]
Sertraline DM0FB1J Coronary heart disease BA80.Z Approved [282]
Bepridil DM0RKS4 Chronic/stable angina BA40.1 Approved [373]
Indinavir DM0T3YH Human immunodeficiency virus infection 1C62 Approved [284]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [89]
Colchicine DM2POTE Acute gout flare FA25.0 Approved [357]
Sulindac DM2QHZU Acute myelogenous leukaemia 2A41 Approved [437]
Methotrexate DM2TEOL Anterior urethra cancer Approved [143]
Quercetin DM3NC4M Obesity 5B81 Approved [78]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Nicotine DMWX5CO Lung cancer 2C25.0 Approved [438]
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [439]
Sertraline DM0FB1J Coronary heart disease BA80.Z Approved [440]
Gefitinib DM15F0X Colon adenocarcinoma Approved [441]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [442]
Ribavirin DMEYLH9 Hepatitis C virus infection 1E51.1 Approved [443]
Colchicine DM2POTE Acute gout flare FA25.0 Approved [426]
Quercetin DM3NC4M Obesity 5B81 Approved [444]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [445]
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [379]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Caspase-3 (CASP3)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Sevoflurane DMC9O43 Anaesthesia 9A78.6 Approved [446]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [447]
Lovastatin DM9OZWQ Arteriosclerosis BD40 Approved [448]
Cidofovir DMA13GD Cytomegalovirus infection 1D82 Approved [449]
Docetaxel DMDI269 Advanced cancer 2A00-2F9Z Approved [450]
Etoposide DMNH3PG Acute myelogenous leukaemia 2A41 Approved [451]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [452]
Mannitol DMSCDY9 Bronchiectasis CA24 Approved [453]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [454]
Aprepitant DM053KT Depression 6A70-6A7Z Approved [401]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Methotrexate DM2TEOL Anterior urethra cancer Approved [183]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [104]
Panobinostat DM58WKG Chronic graft versus host disease Approved [66]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [47]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [304]
Vorinostat DMWMPD4 Adult acute monocytic leukemia Approved [66]
Triclosan DMZUR4N Malaria 1F40-1F45 Approved [209]
SNDX-275 DMH7W9X Breast cancer 2C60-2C65 Phase 3 [66]
(+)-JQ1 DM1CZSJ Testicular cancer 2C80 Phase 1 [455]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [64]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Tuberin (TSC2)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [180]
Selenium DM25CGV N. A. N. A. Approved [213]
Methotrexate DM2TEOL Anterior urethra cancer Approved [76]
Quercetin DM3NC4M Obesity 5B81 Approved [456]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [47]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [141]
Rosiglitazone DMILWZR Chronic kidney disease GB61 Approved [457]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [458]
Azacitidine DMTA5OE Acute myelogenous leukaemia 2A41 Approved [459]
Arsenic DMTL2Y1 N. A. N. A. Approved [61]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Selenium DM25CGV N. A. N. A. Approved [213]
Quercetin DM3NC4M Obesity 5B81 Approved [460]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [461]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [462]
Tacrolimus DMZ7XNQ Graft-versus-host disease 4B24 Approved [461]
Urethane DM7NSI0 N. A. N. A. Phase 4 [130]
Resveratrol DM3RWXL Giant cell arteritis 4A44.2 Phase 3 [463]
Epigallocatechin gallate DMCGWBJ Hepatic fibrosis DB93.0 Phase 3 [460]
Tocopherol DMBIJZ6 N. A. N. A. Phase 2 [213]
Adaphostin DM16QSG Chronic myelogenous leukaemia 2A20.0 Phase 1 [464]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [348]
Gefitinib DM15F0X Colon adenocarcinoma Approved [465]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [466]
Selenium DM25CGV N. A. N. A. Approved [213]
Sulindac DM2QHZU Acute myelogenous leukaemia 2A41 Approved [467]
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [352]
Quercetin DM3NC4M Obesity 5B81 Approved [122]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [468]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [148]
Glucosamine DM4ZLFD Osteoarthritis FA00-FA05 Approved [287]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [262]
Nitric Oxide DM1RBYG Hypertension BA00-BA04 Approved [113]
Selenium DM25CGV N. A. N. A. Approved [469]
Quercetin DM3NC4M Obesity 5B81 Approved [122]
obeticholic acid DM3Q1SM Primary biliary cholangitis DB96.1 Approved [230]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [135]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [470]
Aspirin DM672AH Acute coronary syndrome BA41 Approved [471]
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [367]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [139]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [472]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [142]
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [352]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [473]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [188]
Chlorpromazine DMBGZI3 Acute intermittent hepatic porphyria 5C58.11 Approved [145]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [139]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [140]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [141]
Diethylstilbestrol DMN3UXQ Gonorrheal vaginitis GA02 Approved [474]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [262]
Beta-carotene DM0RXBT Vitamin deficiency 5B55-5B71 Approved [347]
Selenium DM25CGV N. A. N. A. Approved [213]
Sulindac DM2QHZU Acute myelogenous leukaemia 2A41 Approved [475]
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [388]
Deoxycholic acid DM3GYAL Subcutaneous fat disorder EF02 Approved [406]
Quercetin DM3NC4M Obesity 5B81 Approved [78]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [476]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [178]
Glucosamine DM4ZLFD Osteoarthritis FA00-FA05 Approved [477]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Apoptosis regulator BAX (BAX)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Sevoflurane DMC9O43 Anaesthesia 9A78.6 Approved [341]
Aprepitant DM053KT Depression 6A70-6A7Z Approved [401]
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [88]
Verapamil DMA7PEW Angina pectoris BA40 Approved [345]
Beta-carotene DM0RXBT Vitamin deficiency 5B55-5B71 Approved [80]
Leuprorelin acetate DM15HAT Prostate cancer 2C82.0 Approved [478]
Talazoparib DM1KS78 Breast cancer 2C60-2C65 Approved [479]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [180]
Meloxicam DM2AR7L Arthritis FA20 Approved [480]
Ciprofloxacin XR DM2NLS9 Acute gonococcal cervicitis Approved [337]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Bcl-2-like protein 1 (BCL2L1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [481]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [482]
Nitric Oxide DM1RBYG Hypertension BA00-BA04 Approved [113]
Selenium DM25CGV N. A. N. A. Approved [213]
Sulindac DM2QHZU Acute myelogenous leukaemia 2A41 Approved [483]
Methotrexate DM2TEOL Anterior urethra cancer Approved [484]
Dactinomycin DM2YGNW Adult kidney Wilms tumor Approved [485]
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [486]
Quercetin DM3NC4M Obesity 5B81 Approved [122]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [92]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Beclin-1 (BECN1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Calcipotriol DM03CP7 Psoriasis EA90 Approved [487]
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [88]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [442]
Methotrexate DM2TEOL Anterior urethra cancer Approved [484]
Quercetin DM3NC4M Obesity 5B81 Approved [488]
Fluoxetine DM3PD2C Bipolar depression Approved [489]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [490]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [491]
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [492]
Imatinib DM7RJXL Acute lymphoblastic leukaemia 2A85 Approved [493]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Mechlorethamine DM0CVXA Chronic myelogenous leukaemia 2A20.0 Approved [494]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [180]
Sulindac DM2QHZU Acute myelogenous leukaemia 2A41 Approved [495]
Methotrexate DM2TEOL Anterior urethra cancer Approved [484]
Quercetin DM3NC4M Obesity 5B81 Approved [496]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [135]
Levamisole DM5EN79 Parasitic infection 1D0Y-1G2Z Approved [497]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [498]
Aspirin DM672AH Acute coronary syndrome BA41 Approved [499]
Promethazine DM6I5GR Hyperemesis gravidarum Approved [500]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Inactive caspase-12 (CASP12)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [501]
Ethanol DMDRQZU Chronic pain MG30 Approved [502]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [503]
Paclitaxel DMLB81S Breast carcinoma Approved [504]
Resveratrol DM3RWXL Giant cell arteritis 4A44.2 Phase 3 [505]
Thymoquinone DMVDTR2 Polycystic ovarian syndrome 5A80.1 Phase 2/3 [506]
Tetrandrine DMAOJBX Sarcoma 2A60-2C35 Phase 1 [507]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [64]
THAPSIGARGIN DMDMQIE N. A. N. A. Preclinical [502]
3,7,3',4'-TETRAHYDROXYFLAVONE DMES906 Discovery agent N.A. Investigative [508]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [142]
Nitric Oxide DM1RBYG Hypertension BA00-BA04 Approved [113]
Sulindac DM2QHZU Acute myelogenous leukaemia 2A41 Approved [115]
Methotrexate DM2TEOL Anterior urethra cancer Approved [509]
Dactinomycin DM2YGNW Adult kidney Wilms tumor Approved [510]
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [121]
Penicillamine DM40EF6 Cystinuria 5C60.2 Approved [511]
Nefazodone DM4ZS8M Major depressive disorder 6A70.3 Approved [512]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [513]
Aspirin DM672AH Acute coronary syndrome BA41 Approved [274]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Tribbles homolog 3 (TRIB3)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [253]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [150]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [187]
Cyclophosphamide DM4O2Z7 Advanced cancer 2A00-2F9Z Approved [514]
Acetic Acid, Glacial DM4SJ5Y infection in the ear canal AA0Y Approved [93]
Isoniazid DM5JVS3 Latent tuberculosis infection Approved [310]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [514]
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [215]
Thalidomide DM70BU5 Adult T-cell leukemia/lymphoma Approved [515]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [138]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [78]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [135]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [47]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [234]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [59]
Diethylstilbestrol DMN3UXQ Gonorrheal vaginitis GA02 Approved [516]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [101]
Azacitidine DMTA5OE Acute myelogenous leukaemia 2A41 Approved [517]
Amphotericin B DMTAJQE Acne vulgaris ED80 Approved [518]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [62]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [281]
Sertraline DM0FB1J Coronary heart disease BA80.Z Approved [282]
Indinavir DM0T3YH Human immunodeficiency virus infection 1C62 Approved [284]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [142]
Sulindac DM2QHZU Acute myelogenous leukaemia 2A41 Approved [284]
Quercetin DM3NC4M Obesity 5B81 Approved [519]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [284]
Pyrazinamide DM4IF32 Meningeal tuberculosis Approved [286]
Glucosamine DM4ZLFD Osteoarthritis FA00-FA05 Approved [287]
Rifampicin DM5DSFZ Non-insulin dependent diabetes 5A11 Approved [375]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Methotrexate DM2TEOL Anterior urethra cancer Approved [76]
Quercetin DM3NC4M Obesity 5B81 Approved [78]
obeticholic acid DM3Q1SM Primary biliary cholangitis DB96.1 Approved [230]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [171]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [520]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [101]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [50]
Urethane DM7NSI0 N. A. N. A. Phase 4 [130]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [521]
methyl p-hydroxybenzoate DMO58UW Discovery agent N.A. Investigative [522]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Alvimopan DMHR8KW Gastrointestinal disease DE2Z Approved [523]
Fentanyl DM8WAHT Analgesia MB40.8 Approved [524]
Morphine DMRMS0L Advanced cancer 2A00-2F9Z Approved [525]
Methotrexate DM2TEOL Anterior urethra cancer Approved [183]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [526]
Butorphanol DM5KYPJ Pain MG30-MG3Z Approved [527]
Oliceridine DM6MDCF Acute pain MG31 Approved [524]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [528]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [47]
Decitabine DMQL8XJ Acute myelogenous leukaemia 2A41 Approved [529]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [139]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [47]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [59]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [62]
Perazine DM2AOTZ Psychotic disorder 6A20-6A25 Approved [530]
Almogran DM7I64Z Migraine 8A80 Approved [531]
Ranitidine DM0GUSX Gastric ulcer DA60 Approved [532]
Methimazole DM25FL8 Hyperthyroidism 5A02 Approved [533]
Sulindac DM2QHZU Acute myelogenous leukaemia 2A41 Approved [534]
Docetaxel DMDI269 Advanced cancer 2A00-2F9Z Approved [535]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [65]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [148]
Panobinostat DM58WKG Chronic graft versus host disease Approved [66]
Rifampicin DM5DSFZ Non-insulin dependent diabetes 5A11 Approved [235]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [94]
Leflunomide DMR8ONJ Arthritis FA20 Approved [46]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [140]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [141]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [59]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [101]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Selenium DM25CGV N. A. N. A. Approved [213]
Quercetin DM3NC4M Obesity 5B81 Approved [78]
Testosterone enanthate DMB6871 N. A. N. A. Approved [354]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [66]
Demecolcine DMCZQGK Solid tumour/cancer 2A00-2F9Z Approved [126]
Ethanol DMDRQZU Chronic pain MG30 Approved [239]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [60]
Arsenic DMTL2Y1 N. A. N. A. Approved [61]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [304]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [242]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Trazodone DMK1GBJ Depression 6A70-6A7Z Approved [536]
Nefazodone DM4ZS8M Major depressive disorder 6A70.3 Approved [536]
Fluoxetine DM3PD2C Bipolar depression Approved [537]
Olanzapine DMPFN6Y Bipolar depression Approved [538]
Perospirone DMVHJLX Psychotic disorder 6A20-6A25 Approved [538]
Etoperidone DMR7U8F N. A. N. A. Phase 4 [536]
phorbol 12-myristate 13-acetate DMJWD62 Acute myeloid leukaemia 2A60 Phase 2 [539]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [64]
DU 125530 DM63UA9 Mood disorder 6A60-6E23 Discontinued in Phase 2 [540]
THAPSIGARGIN DMDMQIE N. A. N. A. Preclinical [539]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Dopamine DMPGUCF Acromegaly 5A60.0 Approved [541]
Amphetamine DMSZQAK Attention deficit hyperactivity disorder 6A05.Z Approved [542]
Bupropion DM5PCS7 Depression 6A70-6A7Z Approved [543]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [544]
Testosterone DM7HUNW Hot flushes GA30 Approved [108]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [108]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [47]
Dextroamphetamine DMMIHVP Attention deficit hyperactivity disorder 6A05.Z Approved [545]
Vorinostat DMWMPD4 Adult acute monocytic leukemia Approved [210]
Permethrin DMZ0Q1G Pediculus capitis infestation 1G00.0 Approved [546]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [135]
Panobinostat DM58WKG Chronic graft versus host disease Approved [66]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [47]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [59]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [64]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [65]
Trichostatin A DM9C8NX Solid tumour/cancer 2A00-2F9Z Investigative [69]
⏷ Show the Full List of 7 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [47]
Folic Acid DMEMBJC Colorectal carcinoma Approved [432]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [64]
Drug Name Drug ID Indication ICD 11 Highest Status REF
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [190]
Leflunomide DMR8ONJ Arthritis FA20 Approved [46]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [139]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [140]
Paclitaxel DMLB81S Breast carcinoma Approved [547]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [101]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [50]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [242]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [548]
Vorinostat DMWMPD4 Adult acute monocytic leukemia Approved [210]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Cubilin (CUBN)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [47]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [234]
SNDX-275 DMH7W9X Breast cancer 2C60-2C65 Phase 3 [210]
(+)-JQ1 DM1CZSJ Testicular cancer 2C80 Phase 1 [549]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [64]
PMID28460551-Compound-2 DM4DOUB N. A. N. A. Patented [550]
3R14S-OCHRATOXIN A DM2KEW6 Discovery agent N.A. Investigative [551]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [65]
⏷ Show the Full List of 8 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [104]
Panobinostat DM58WKG Chronic graft versus host disease Approved [66]
Testosterone DM7HUNW Hot flushes GA30 Approved [268]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [139]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [140]
Ifosfamide DMCT3I8 Adult central nervous system germ cell tumor Approved [96]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [552]
Progesterone DMUY35B Amenorrhea GA20.0 Approved [553]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [64]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [554]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [65]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [104]
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [215]
Testosterone DM7HUNW Hot flushes GA30 Approved [108]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [108]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [47]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [59]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [555]
Arsenic DMTL2Y1 N. A. N. A. Approved [61]
Docetaxel DMDI269 Advanced cancer 2A00-2F9Z Approved [555]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [180]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [148]
Aspirin DM672AH Acute coronary syndrome BA41 Approved [556]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [140]
Hesperidin DMI5DW1 Vascular purpura 3B60 Approved [557]
Diclofenac DMPIHLS Chronic renal failure GB61.Z Approved [323]
Azacitidine DMTA5OE Acute myelogenous leukaemia 2A41 Approved [558]
Arsenic DMTL2Y1 N. A. N. A. Approved [61]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [304]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [242]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Selenium DM25CGV N. A. N. A. Approved [213]
Quercetin DM3NC4M Obesity 5B81 Approved [217]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [157]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [238]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [141]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [59]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [101]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [62]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [63]
Urethane DM7NSI0 N. A. N. A. Phase 4 [130]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [62]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [242]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [559]
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [148]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [171]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [47]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [141]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [63]
PMID28870136-Compound-52 DMFDERP N. A. N. A. Patented [217]
COUMARIN DM0N8ZM Discovery agent N.A. Investigative [217]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [65]
Formaldehyde DM7Q6M0 Discovery agent N.A. Investigative [126]
Hexadecanoic acid DMWUXDZ Discovery agent N.A. Investigative [560]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [148]
Panobinostat DM58WKG Chronic graft versus host disease Approved [66]
Testosterone DM7HUNW Hot flushes GA30 Approved [268]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [139]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [561]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [562]
SNDX-275 DMH7W9X Breast cancer 2C60-2C65 Phase 3 [66]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [563]
THAPSIGARGIN DMDMQIE N. A. N. A. Preclinical [564]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [565]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Clozapine DMFC71L Schizophrenia 6A20 Approved [566]
Olanzapine DMPFN6Y Bipolar depression Approved [566]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [64]
LYSERGIC ACID DIETHYLAMIDE DMACMLO Addictive disorder 6C50-6C5Z Withdrawn from market [567]
SB 258585 DM2QJKZ Discovery agent N.A. Investigative [568]
Formaldehyde DM7Q6M0 Discovery agent N.A. Investigative [126]
⏷ Show the Full List of 6 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Capivasertib DM9SKW8 Breast cancer 2C60-2C65 Approved [569]
Nicotine DMWX5CO Lung cancer 2C25.0 Approved [570]
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [481]
Beta-carotene DM0RXBT Vitamin deficiency 5B55-5B71 Approved [347]
Gefitinib DM15F0X Colon adenocarcinoma Approved [571]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [572]
Imiquimod DM1TMA3 Alopecia areata ED70.2 Approved [573]
Selenium DM25CGV N. A. N. A. Approved [213]
Methimazole DM25FL8 Hyperthyroidism 5A02 Approved [574]
Ribavirin DMEYLH9 Hepatitis C virus infection 1E51.1 Approved [443]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Nitric Oxide DM1RBYG Hypertension BA00-BA04 Approved [575]
Selenium DM25CGV N. A. N. A. Approved [213]
Methotrexate DM2TEOL Anterior urethra cancer Approved [183]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [178]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [140]
Amiodarone DMUTEX3 Tachyarrhythmias BC71 Approved [100]
Bortezomib DMNO38U Leukemia Approved [231]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [101]
Decitabine DMQL8XJ Acute myelogenous leukaemia 2A41 Approved [576]
Arsenic DMTL2Y1 N. A. N. A. Approved [577]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [65]
Quercetin DM3NC4M Obesity 5B81 Approved [78]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [104]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [188]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [94]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [98]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [47]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [141]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [59]
Decitabine DMQL8XJ Acute myelogenous leukaemia 2A41 Approved [223]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Beta-arrestin-2 (ARRB2)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [135]
Testosterone DM7HUNW Hot flushes GA30 Approved [268]
Fentanyl DM8WAHT Analgesia MB40.8 Approved [578]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [47]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [141]
Isoproterenol DMK7MEY Atrioventricular block Approved [579]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [60]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [62]
Morphine DMRMS0L Advanced cancer 2A00-2F9Z Approved [580]
Resveratrol DM3RWXL Giant cell arteritis 4A44.2 Phase 3 [581]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By D(4) dopamine receptor (DRD4)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Clozapine DMFC71L Schizophrenia 6A20 Approved [582]
Haloperidol DM96SE0 Delirium Approved [389]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [47]
Niclosamide DMJAGXQ Cestodes infection 1F70-1F76 Approved [259]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [59]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [241]
Cocaine DMSOX7I Anaesthesia 9A78.6 Approved [583]
Droperidol DM0DXA8 Nausea MD90 Approved [51]
Thioridazine DM35M8J Schizophrenia 6A20 Approved [51]
Fluphenazine DMIT8LX Psychotic disorder 6A20-6A25 Approved [51]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [135]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [94]
Testosterone DM7HUNW Hot flushes GA30 Approved [108]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [108]
Haloperidol DM96SE0 Delirium Approved [170]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [98]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [47]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [241]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [584]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [63]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Cadherin-13 (CDH13)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [104]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [47]
Folic Acid DMEMBJC Colorectal carcinoma Approved [159]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [59]
Decitabine DMQL8XJ Acute myelogenous leukaemia 2A41 Approved [585]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [50]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [63]
Triclosan DMZUR4N Malaria 1F40-1F45 Approved [209]
Daunorubicin DMQUSBT Acute monocytic leukemia Approved [586]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [587]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Amiodarone DMUTEX3 Tachyarrhythmias BC71 Approved [100]
Arsenic DMTL2Y1 N. A. N. A. Approved [61]
Permethrin DMZ0Q1G Pediculus capitis infestation 1G00.0 Approved [161]
Carbamazepine DMZOLBI Epilepsy 8A60-8A68 Approved [238]
Triclosan DMZUR4N Malaria 1F40-1F45 Approved [209]
SNDX-275 DMH7W9X Breast cancer 2C60-2C65 Phase 3 [210]
(+)-JQ1 DM1CZSJ Testicular cancer 2C80 Phase 1 [588]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [64]
⏷ Show the Full List of 8 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [142]
Ciprofloxacin XR DM2NLS9 Acute gonococcal cervicitis Approved [589]
Quercetin DM3NC4M Obesity 5B81 Approved [590]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [591]
Panobinostat DM58WKG Chronic graft versus host disease Approved [66]
Chlorpromazine DMBGZI3 Acute intermittent hepatic porphyria 5C58.11 Approved [592]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [593]
Testosterone DM7HUNW Hot flushes GA30 Approved [594]
Lamotrigine DM8SXYG Bipolar disorder 6A60 Approved [595]
Ibuprofen DM8VCBE Dysmenorrhea GA34.3 Approved [596]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [104]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [105]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [597]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [140]
Amphotericin B DMTAJQE Acne vulgaris ED80 Approved [518]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [62]
Vorinostat DMWMPD4 Adult acute monocytic leukemia Approved [66]
Carbamazepine DMZOLBI Epilepsy 8A60-8A68 Approved [238]
SNDX-275 DMH7W9X Breast cancer 2C60-2C65 Phase 3 [66]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [64]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [242]
Malathion DMXZ84M Pediculus capitis infestation 1G00.0 Approved [161]
Phenobarbital DMXZOCG Cluster headache 8A81.0 Approved [598]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [64]
Formaldehyde DM7Q6M0 Discovery agent N.A. Investigative [126]
Drug(s) Affected By Proenkephalin-B (PDYN)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [180]
Panobinostat DM58WKG Chronic graft versus host disease Approved [66]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [140]
Heroin diacetylmorphine DMDBWHY Neurological disorder 6B60 Approved [599]
Ethanol DMDRQZU Chronic pain MG30 Approved [600]
Amiodarone DMUTEX3 Tachyarrhythmias BC71 Approved [100]
Decitabine DMQL8XJ Acute myelogenous leukaemia 2A41 Approved [223]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [223]
Cocaine DMSOX7I Anaesthesia 9A78.6 Approved [601]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [50]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Astrotactin-2 (ASTN2)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [142]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [135]
Panobinostat DM58WKG Chronic graft versus host disease Approved [66]
Aspirin DM672AH Acute coronary syndrome BA41 Approved [115]
Clodronate DM9Y6X7 Hypercalcaemia 5B91.0 Approved [96]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [98]
Testosterone enanthate DMB6871 N. A. N. A. Approved [354]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [47]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [101]
Decitabine DMQL8XJ Acute myelogenous leukaemia 2A41 Approved [223]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [148]
Rosiglitazone DMILWZR Chronic kidney disease GB61 Approved [260]
Amphotericin B DMTAJQE Acne vulgaris ED80 Approved [518]
ANW-32821 DMMJOZD N. A. N. A. Phase 2 [602]
(+)-JQ1 DM1CZSJ Testicular cancer 2C80 Phase 1 [549]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [603]
PMID27336223-Compound-5 DM6E50A N. A. N. A. Patented [260]
⏷ Show the Full List of 7 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [140]
Flunitrazepam DMGR5Z3 Insomnia 7A00-7A0Z Approved [604]
Flumazenil DMPCG2L Benzodiazepine overdose PC91 Approved [605]
Decitabine DMQL8XJ Acute myelogenous leukaemia 2A41 Approved [606]
Diazepam DM08E9O Alcohol withdrawal Approved [607]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [521]
TBPS DMFC3XP Discovery agent N.A. Investigative [608]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [65]
Trichostatin A DM9C8NX Solid tumour/cancer 2A00-2F9Z Investigative [69]
Manganese DMKT129 N. A. N. A. Investigative [609]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [78]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [135]
Testosterone enanthate DMB6871 N. A. N. A. Approved [354]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [250]
Decitabine DMQL8XJ Acute myelogenous leukaemia 2A41 Approved [610]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [241]
Arsenic DMTL2Y1 N. A. N. A. Approved [61]
Hydralazine DMU8JGH Chronic heart failure BD1Z Approved [611]
Menadione DMSJDTY Vitamin K deficiency 5B59 Approved [612]
Aspirin DM672AH Acute coronary syndrome BA41 Approved [613]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Rofecoxib DM3P5DA Osteoarthritis FA00-FA05 Approved [614]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [250]
Flupentixol DM0DJ9O Schizophrenia 6A20 Approved [195]
Quercetin DM3NC4M Obesity 5B81 Approved [615]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [92]
Penicillamine DM40EF6 Cystinuria 5C60.2 Approved [511]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [156]
Bupivacaine DM4PRFC Anaesthesia 9A78.6 Approved [616]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [156]
Panobinostat DM58WKG Chronic graft versus host disease Approved [66]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Cytochrome P450 2E1 (CYP2E1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fomepizole DM6VOWQ Athylene glycol or methanol poisoning NE61 Approved [617]
Ademetionine DMYQDBO Hepatic fibrosis DB93.0 Approved [618]
Theophylline DMRJFN9 Bronchitis CA20 Approved [51]
Rifampicin DM5DSFZ Non-insulin dependent diabetes 5A11 Approved [619]
Ethanol DMDRQZU Chronic pain MG30 Approved [620]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [62]
Phenobarbital DMXZOCG Cluster headache 8A81.0 Approved [621]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [47]
Didanosine DMI2QPE Human immunodeficiency virus infection 1C62 Approved [51]
Thioridazine DM35M8J Schizophrenia 6A20 Approved [622]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [623]
Rifampicin DM5DSFZ Non-insulin dependent diabetes 5A11 Approved [153]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [166]
Ibuprofen DM8VCBE Dysmenorrhea GA34.3 Approved [96]
Clodronate DM9Y6X7 Hypercalcaemia 5B91.0 Approved [96]
Cidofovir DMA13GD Cytomegalovirus infection 1D82 Approved [96]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [96]
Ifosfamide DMCT3I8 Adult central nervous system germ cell tumor Approved [96]
Fenofibrate DMFKXDY Coronary atherosclerosis Approved [96]
Adefovir Dipivoxil DMMAWY1 Hepatitis B virus infection 1E51.0 Approved [96]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [65]
Mivebresib DMCPF90 Acute myeloid leukaemia 2A60 Phase 1 [624]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [64]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [65]
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [350]
Selenium DM25CGV N. A. N. A. Approved [182]
Methotrexate DM2TEOL Anterior urethra cancer Approved [184]
Lapatinib DM3BH1Y Breast cancer 2C60-2C65 Approved [625]
Epinephrine DM3KJBC Acute asthma CA23 Approved [85]
Quercetin DM3NC4M Obesity 5B81 Approved [626]
Rofecoxib DM3P5DA Osteoarthritis FA00-FA05 Approved [627]
obeticholic acid DM3Q1SM Primary biliary cholangitis DB96.1 Approved [230]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [628]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [218]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [104]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [138]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [139]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [140]
Arsenic DMTL2Y1 N. A. N. A. Approved [61]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [62]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [63]
Carbamazepine DMZOLBI Epilepsy 8A60-8A68 Approved [238]
Triclosan DMZUR4N Malaria 1F40-1F45 Approved [209]
(+)-JQ1 DM1CZSJ Testicular cancer 2C80 Phase 1 [549]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Estrogen receptor (ESR1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [629]
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [630]
Gefitinib DM15F0X Colon adenocarcinoma Approved [631]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [632]
Lapatinib DM3BH1Y Breast cancer 2C60-2C65 Approved [633]
Liraglutide DM3FXPS Non-insulin dependent diabetes 5A11 Approved [634]
Quercetin DM3NC4M Obesity 5B81 Approved [635]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [636]
Procaine DM4LSNE Anaesthesia 9A78.6 Approved [632]
Estrone DM5T6US Acne vulgaris ED80 Approved [637]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Haloperidol DM96SE0 Delirium Approved [638]
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [198]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [639]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [104]
Bupivacaine DM4PRFC Anaesthesia 9A78.6 Approved [640]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [641]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [138]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [398]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [171]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [47]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Cytochrome P450 1A2 (CYP1A2)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Zolmitriptan DM1IB4Q Migraine 8A80 Approved [642]
Rofecoxib DM3P5DA Osteoarthritis FA00-FA05 Approved [642]
Etoricoxib DM6A4NW Rheumatoid arthritis FA20 Approved [642]
Capsaicin DMGMF6V Back pain ME84.Z Approved [643]
Hesperetin DMKER83 High blood cholesterol level 5C80.00 Approved [644]
Stiripentol DMMSDOY Dravet syndrome 8A61.11 Approved [645]
Nifedipine DMSVOZT Angina pectoris BA40 Approved [646]
Zileuton DMVRIC2 Allergic asthma CA23.0 Approved [647]
Nicotine DMWX5CO Lung cancer 2C25.0 Approved [648]
Clonidine DM6RZ9Q Attention deficit hyperactivity disorder 6A05.Z Approved [51]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Busulfan DMXYJ9C Chronic myelogenous leukaemia 2A20.0 Approved [649]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [241]
Etoposide DMNH3PG Acute myelogenous leukaemia 2A41 Approved [650]
Chlorambucil DMRKE63 Chronic lymphocytic leukaemia 2A82.0 Approved [650]
Fluorouracil DMUM7HZ Adenocarcinoma 2D40 Approved [651]
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [623]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [180]
Selenium DM25CGV N. A. N. A. Approved [213]
Etretinate DM2CZFA Keratosis ED56 Approved [356]
Imipramine DM2NUH3 Depression 6A70-6A7Z Approved [652]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [237]
Quercetin DM3NC4M Obesity 5B81 Approved [78]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [148]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [139]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [140]
Pioglitazone DMKJ485 Amyotrophic lateral sclerosis 8B60.0 Approved [399]
Azathioprine DMMZSXQ Lupus nephritis 4A40.0Y Approved [240]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [101]
Menadione DMSJDTY Vitamin K deficiency 5B59 Approved [237]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [562]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [238]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [548]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [64]
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [135]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [653]
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [215]
Ergotidine DM78IME Osteoarthritis FA00-FA05 Approved [654]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [398]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [140]
Demecolcine DMCZQGK Solid tumour/cancer 2A00-2F9Z Approved [126]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [234]
Niclosamide DMJAGXQ Cestodes infection 1F70-1F76 Approved [259]
Irinotecan DMP6SC2 Adenocarcinoma 2D40 Approved [655]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Acyloxyacyl hydrolase (AOAH)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [148]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [140]
Arsenic DMTL2Y1 N. A. N. A. Approved [61]
Vorinostat DMWMPD4 Adult acute monocytic leukemia Approved [66]
(+)-JQ1 DM1CZSJ Testicular cancer 2C80 Phase 1 [224]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [64]
Trichostatin A DM9C8NX Solid tumour/cancer 2A00-2F9Z Investigative [69]
⏷ Show the Full List of 7 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Testosterone enanthate DMB6871 N. A. N. A. Approved [354]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [140]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [63]
Vorinostat DMWMPD4 Adult acute monocytic leukemia Approved [210]
Triclosan DMZUR4N Malaria 1F40-1F45 Approved [209]
EXISULIND DMBY56U Colorectal cancer 2B91.Z Phase 3 [656]
CP-461 DMEYMTX Inflammatory bowel disease DD72 Phase 2 [656]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [64]
Geldanamycin DMS7TC5 Kidney cancer 2C90.0 Discontinued in Phase 2 [190]
(5-(1-benzyl-1H-indazol-3-yl)furan-2-yl)methanol DM15P2G Discovery agent N.A. Investigative [656]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Alpha-synuclein (SNCA)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [104]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [105]
Testosterone enanthate DMB6871 N. A. N. A. Approved [354]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [561]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [141]
Niclosamide DMJAGXQ Cestodes infection 1F70-1F76 Approved [259]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [59]
Bortezomib DMNO38U Leukemia Approved [657]
Decitabine DMQL8XJ Acute myelogenous leukaemia 2A41 Approved [658]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [223]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Epinephrine DM3KJBC Acute asthma CA23 Approved [659]
Dobutamine DMD1B8Z Heart failure BD10-BD13 Approved [659]
Dopamine DMPGUCF Acromegaly 5A60.0 Approved [659]
Modafinil DMYILBE Malignant glioma 2A00.0 Approved [660]
Levodopa DMN3E57 Parkinson disease 8A00.0 Approved [659]
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [198]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [180]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [104]
Tolcapone DM8MNVO Parkinson disease 8A00.0 Approved [661]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [47]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Cytochrome P450 3A4 (CYP3A4)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Eplerenone DMF0NQR Heart failure BD10-BD13 Approved [662]
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [663]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [664]
Voriconazole DMAOL2S Aspergillosis 1F20 Approved [665]
Proguanil DMBL79I Malaria 1F40-1F45 Approved [666]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [666]
Loratadine DMF3AN7 Allergy 4A80-4A85 Approved [667]
Nelfinavir mesylate DMFX6G8 N. A. N. A. Approved [668]
Capsaicin DMGMF6V Back pain ME84.Z Approved [669]
Axitinib DMGVH6N Renal cell carcinoma 2C90 Approved [670]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [671]
obeticholic acid DM3Q1SM Primary biliary cholangitis DB96.1 Approved [230]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [105]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [139]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [140]
Diclofenac DMPIHLS Chronic renal failure GB61.Z Approved [323]
Arsenic DMTL2Y1 N. A. N. A. Approved [61]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [62]
Fluorouracil DMUM7HZ Adenocarcinoma 2D40 Approved [672]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [673]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Busulfan DMXYJ9C Chronic myelogenous leukaemia 2A20.0 Approved [649]
Azathioprine DMMZSXQ Lupus nephritis 4A40.0Y Approved [674]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [675]
Ethanol DMDRQZU Chronic pain MG30 Approved [676]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [156]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [156]
Methyldopa DM5I621 Hypertension BA00-BA04 Approved [677]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [105]
Testosterone DM7HUNW Hot flushes GA30 Approved [108]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [108]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [78]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [135]
Panobinostat DM58WKG Chronic graft versus host disease Approved [66]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [190]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [98]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [69]
Folic Acid DMEMBJC Colorectal carcinoma Approved [678]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [234]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [59]
Pioglitazone DMKJ485 Amyotrophic lateral sclerosis 8B60.0 Approved [399]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [135]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [353]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [140]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [141]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [234]
Dasatinib DMJV2EK Blast phase chronic myelogenous leukemia, BCR-ABL1 positive Approved [226]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [101]
Azacitidine DMTA5OE Acute myelogenous leukaemia 2A41 Approved [558]
Genistein DM0JETC Menopause symptom GA30.0 Phase 2/3 [679]
Afimoxifene DMFORDT Breast cancer 2C60-2C65 Phase 2 [680]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [78]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [135]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [125]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [98]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [47]
Demecolcine DMCZQGK Solid tumour/cancer 2A00-2F9Z Approved [126]
Diethylstilbestrol DMN3UXQ Gonorrheal vaginitis GA02 Approved [681]
Melphalan DMOLNHF Hematologic disease 3C0Z Approved [682]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [101]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [249]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [142]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [135]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [353]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [139]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [250]
Ethanol DMDRQZU Chronic pain MG30 Approved [683]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [59]
ARZOXIFENE DMOKCVI Breast cancer 2C60-2C65 Approved [684]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [101]
Amphotericin B DMTAJQE Acne vulgaris ED80 Approved [518]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [98]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [140]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [59]
Menadione DMSJDTY Vitamin K deficiency 5B59 Approved [142]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [63]
Urethane DM7NSI0 N. A. N. A. Phase 4 [130]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [603]
PMID28460551-Compound-2 DM4DOUB N. A. N. A. Patented [550]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [65]
⏷ Show the Full List of 9 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Methotrexate DM2TEOL Anterior urethra cancer Approved [685]
Quercetin DM3NC4M Obesity 5B81 Approved [78]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [148]
Methylprednisolone DM4BDON Acute adrenal insufficiency Approved [184]
Rifampicin DM5DSFZ Non-insulin dependent diabetes 5A11 Approved [235]
Leflunomide DMR8ONJ Arthritis FA20 Approved [46]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [47]
Adenosine DMM2NSK Paroxysmal supraventricular tachycardia BC81.Z Approved [686]
Azathioprine DMMZSXQ Lupus nephritis 4A40.0Y Approved [184]
Prednisolone DMQ8FR2 Acute adrenal insufficiency Approved [184]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [262]
Methotrexate DM2TEOL Anterior urethra cancer Approved [687]
Quercetin DM3NC4M Obesity 5B81 Approved [78]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [123]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [218]
Panobinostat DM58WKG Chronic graft versus host disease Approved [66]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [445]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [688]
Testosterone DM7HUNW Hot flushes GA30 Approved [268]
Leflunomide DMR8ONJ Arthritis FA20 Approved [46]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [120]
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [65]
Methotrexate DM2TEOL Anterior urethra cancer Approved [484]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [123]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [104]
Cyclophosphamide DM4O2Z7 Advanced cancer 2A00-2F9Z Approved [689]
Panobinostat DM58WKG Chronic graft versus host disease Approved [66]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [94]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [139]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [47]
⏷ Show the Full List of 10 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Adrenergic receptor alpha-1B (ADRA1B) TTBRKXS ADA1B_HUMAN Antagonist [4]
Dopamine D2 receptor (D2R) TTEX248 DRD2_HUMAN Agonist [3]

Drug Transporter (DTP)
DTP Name DTP ID UniProt ID MOA REF
Vesicular amine transporter 2 (SLC18A2) DTT7VPB VMAT2_HUMAN Substrate [5]

Drug-Metabolizing Enzyme (DME)
DME Name DME ID UniProt ID MOA REF
Cytochrome P450 2D6 (CYP2D6) Main DME DECB0K3 CP2D6_HUMAN Substrate [6]

Drug Off-Target (DOT)
DOT Name DOT ID UniProt ID Interaction REF
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1 (PLCB1) OT9HYT7A PLCB1_HUMAN Gene/Protein Processing [7]
2-oxoglutarate dehydrogenase-like, mitochondrial (OGDHL) OT1AZK6R OGDHL_HUMAN Gene/Protein Processing [8]
3',5'-cyclic-AMP phosphodiesterase 4B (PDE4B) OTOA8WU2 PDE4B_HUMAN Drug Response [9]
3',5'-cyclic-AMP phosphodiesterase 4D (PDE4D) OT1RWFV0 PDE4D_HUMAN Drug Response [9]
5-hydroxytryptamine receptor 1A (HTR1A) OT38K9MK 5HT1A_HUMAN Drug Response [10]
5-hydroxytryptamine receptor 6 (HTR6) OT8GTDDY 5HT6R_HUMAN Drug Response [11]
Abnormal spindle-like microcephaly-associated protein (ASPM) OTKXQMNA ASPM_HUMAN Gene/Protein Processing [8]
Actin, alpha cardiac muscle 1 (ACTC1) OTJU04B1 ACTC_HUMAN Gene/Protein Processing [8]
Activator of apoptosis harakiri (HRK) OTR4GWJ0 HRK_HUMAN Gene/Protein Processing [8]
Acyloxyacyl hydrolase (AOAH) OTOYBXKW AOAH_HUMAN Drug Response [9]

References

1 Methamphetamine FDA Label
2 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4803).
3 Pharmacotherapy for obesity. Drugs. 2005;65(10):1391-418.
4 Mirtazapine treatment after conditioning with methamphetamine alters subsequent expression of place preference. Drug Alcohol Depend. 2009 Jan 1;99(1-3):231-9.
5 Synthesis and Discovery of Arylpiperidinylquinazolines: New Inhibitors of the Vesicular Monoamine Transporter. J Med Chem. 2018 Oct 25;61(20):9121-9131.
6 Cytochrome P450 2D6.1 and cytochrome P450 2D6.10 differ in catalytic activity for multiple substrates. Pharmacogenetics. 2001 Aug;11(6):477-87.
7 Inhibition of PLC1 signaling pathway regulates methamphetamine self-administration and neurotoxicity in rats. Food Chem Toxicol. 2021 Mar;149:111970. doi: 10.1016/j.fct.2021.111970. Epub 2021 Jan 7.
8 Methamphetamine alters the normal progression by inducing cell cycle arrest in astrocytes. PLoS One. 2014 Oct 7;9(10):e109603.
9 Genome-wide association for methamphetamine dependence: convergent results from 2 samples. Arch Gen Psychiatry. 2008 Mar;65(3):345-55. doi: 10.1001/archpsyc.65.3.345.
10 Serotonin 1A receptor gene is associated with Japanese methamphetamine-induced psychosis patients. Neuropharmacology. 2010 Feb;58(2):452-6. doi: 10.1016/j.neuropharm.2009.09.006. Epub 2009 Sep 10.
11 Serotonin 6 receptor gene is associated with methamphetamine-induced psychosis in a Japanese population. Drug Alcohol Depend. 2011 Jan 1;113(1):1-7. doi: 10.1016/j.drugalcdep.2010.06.021. Epub 2010 Aug 11.
12 Interaction of neuroleptics and antidepressants with rat brain alpha 2-receptors: a possible relationship between alpha 2-receptor antagonism and antidepressant action. Biol Psychiatry. 1984 Sep;19(9):1283-91.
13 Activation of alpha1-adrenoceptors inhibits growth hormone secretion in humans. Exp Clin Endocrinol Diabetes. 2009 Oct;117(9):460-2.
14 Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
15 A structure-activity relationship study of benzylic modifications of 4-[1-(1-naphthyl)ethyl]-1H-imidazoles on alpha 1- and alpha 2-adrenergic recep... J Med Chem. 1994 Jul 22;37(15):2328-33.
16 3-Benzisothiazolylpiperazine derivatives as potential atypical antipsychotic agents. J Med Chem. 1996 Jan 5;39(1):143-8.
17 An integrated in silico 3D model-driven discovery of a novel, potent, and selective amidosulfonamide 5-HT1A agonist (PRX-00023) for the treatment o... J Med Chem. 2006 Jun 1;49(11):3116-35.
18 A new arylpiperazine antipsychotic with high D2/D3/5-HT1A/alpha 1A-adrenergic affinity and a low potential for extrapyramidal effects. J Med Chem. 1994 Apr 15;37(8):1060-2.
19 Drug repositioning: identifying and developing new uses for existing drugs. Nat Rev Drug Discov. 2004 Aug;3(8):673-83.
20 Alpha- and beta-adrenoceptors: from the gene to the clinic. 2. Structure-activity relationships and therapeutic applications. J Med Chem. 1995 Sep 15;38(19):3681-716.
21 Alpha- and beta-adrenoceptors: from the gene to the clinic. 1. Molecular biology and adrenoceptor subclassification. J Med Chem. 1995 Sep 1;38(18):3415-44.
22 The Detection of Dopamine Gene Receptors (DRD1-DRD5) Expression on Human Peripheral Blood Lymphocytes by Real Time PCR. Iran J Allergy Asthma Immunol. 2004 Dec;3(4):169-74.
23 Dopaminergic synapses in the matrix of the ventrolateral striatum after chronic haloperidol treatment. Synapse. 2002 Aug;45(2):78-85.
24 CYP2D6 and DRD2 genes differentially impact pharmacodynamic sensitivity and time course of prolactin response to perphenazine. Pharmacogenet Genomics. 2007 Nov;17(11):989-93.
25 Synthesis and in vitro binding of N-phenyl piperazine analogs as potential dopamine D3 receptor ligands. Bioorg Med Chem. 2005 Jan 3;13(1):77-87.
26 Screening of domperidone in wastewater by high performance liquid chromatography and solid phase extraction methods. Talanta. 2006 Jan 15;68(3):928-31.
27 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3639).
28 Receptor reserve-dependent properties of antipsychotics at human dopamine D2 receptors. Eur J Pharmacol. 2009 Apr 1;607(1-3):35-40.
29 [The benzamides tiapride, sulpiride, and amisulpride in treatment for Tourette's syndrome]. Nervenarzt. 2007 Mar;78(3):264, 266-8, 270-1.
30 Modulatory role of dopamine D2 receptors and fundamental role of L-type Ca2+ channels in the induction of long-term potentiation in the basolateral... Eur J Pharmacol. 2009 Mar 15;606(1-3):90-3.
31 Hughes B: 2009 FDA drug approvals. Nat Rev Drug Discov. 2010 Feb;9(2):89-92.
32 SLC18: Vesicular neurotransmitter transporters for monoamines and acetylcholine. Mol Aspects Med. 2013 Apr-Jun;34(2-3):360-72.
33 The vesicular monoamine transporter 2: an underexplored pharmacological target. Neurochem Int. 2014 Jul;73:89-97.
34 Inhibitory effects of anticancer drugs on dextromethorphan-O-demethylase activity in human liver microsomes. Cancer Chemother Pharmacol. 1993;32(6):491-5.
35 Effect of genetic polymorphism on the metabolism of endogenous neuroactive substances, progesterone and p-tyramine, catalyzed by CYP2D6. Brain Res Mol Brain Res. 2004 Oct 22;129(1-2):117-23.
36 CYP2D6 polymorphisms and tamoxifen metabolism: clinical relevance. Curr Oncol Rep. 2010 Jan;12(1):7-15.
37 Metabolic interactions between acetaminophen (paracetamol) and two flavonoids, luteolin and quercetin, through in-vitro inhibition studies. J Pharm Pharmacol. 2017 Dec;69(12):1762-1772.
38 Substrates, inducers, inhibitors and structure-activity relationships of human Cytochrome P450 2C9 and implications in drug development. Curr Med Chem. 2009;16(27):3480-675.
39 Inhibition of cytochrome P450 2D6: structure-activity studies using a series of quinidine and quinine analogues. Chem Res Toxicol. 2003 Apr;16(4):450-9.
40 Effects of propofol on human hepatic microsomal cytochrome P450 activities. Xenobiotica. 1998 Sep;28(9):845-53.
41 Pharmacogenetics of schizophrenia. Am J Med Genet. 2000 Spring;97(1):98-106.
42 Roles of CYP2A6 and CYP2B6 in nicotine C-oxidation by human liver microsomes. Arch Toxicol. 1999 Mar;73(2):65-70.
43 Structure-activity relationship for human cytochrome P450 substrates and inhibitors. Drug Metab Rev. 2002 Feb-May;34(1-2):69-82.
44 The effect of rare human sequence variants on the function of vesicular monoamine transporter 2. Pharmacogenetics. 2004 Sep;14(9):587-94. doi: 10.1097/00008571-200409000-00003.
45 Synaptic vesicular monoamine transporter expression: distribution and pharmacologic profile. Brain Res Mol Brain Res. 1994 Mar;22(1-4):219-26. doi: 10.1016/0169-328x(94)90050-7.
46 Endoplasmic reticulum stress and MAPK signaling pathway activation underlie leflunomide-induced toxicity in HepG2 Cells. Toxicology. 2017 Dec 1;392:11-21.
47 Integrative omics data analyses of repeated dose toxicity of valproic acid in vitro reveal new mechanisms of steatosis induction. Toxicology. 2018 Jan 15;393:160-170.
48 Gene expression profile of human lymphoid CEM cells sensitive and resistant to glucocorticoid-evoked apoptosis. Genomics. 2003 Jun;81(6):543-55.
49 Loss of striatal vesicular monoamine transporter protein (VMAT2) in human cocaine users. Am J Psychiatry. 2003 Jan;160(1):47-55. doi: 10.1176/appi.ajp.160.1.47.
50 Blood transcript immune signatures distinguish a subset of people with elevated serum ALT from others given acetaminophen. Clin Pharmacol Ther. 2016 Apr;99(4):432-41.
51 ADReCS-Target: target profiles for aiding drug safety research and application. Nucleic Acids Res. 2018 Jan 4;46(D1):D911-D917. doi: 10.1093/nar/gkx899.
52 Dose-finding study of paliperidone ER based on striatal and extrastriatal dopamine D2 receptor occupancy in patients with schizophrenia. Psychopharmacology (Berl). 2008 Apr;197(2):229-35. doi: 10.1007/s00213-007-1029-z. Epub 2007 Dec 6.
53 Positron emission tomography measurement of dopamine D? receptor occupancy in the pituitary and cerebral cortex: relation to antipsychotic-induced hyperprolactinemia. J Clin Psychiatry. 2010 Sep;71(9):1131-7. doi: 10.4088/JCP.08m04307yel. Epub 2010 Feb 23.
54 Variants of the dopamine D2 receptor gene and risperidone-induced hyperprolactinemia in children and adolescents. Pharmacogenet Genomics. 2009 May;19(5):373-82. doi: 10.1097/FPC.0b013e328329a60f.
55 Dopamine receptor D2 gene is associated with weight gain in schizophrenic patients under long-term atypical antipsychotic treatment. Pharmacogenet Genomics. 2010 Jun;20(6):359-66. doi: 10.1097/FPC.0b013e3283397d06.
56 Imaging gene-substance interactions: the effect of the DRD2 TaqIA polymorphism and the dopamine agonist bromocriptine on the brain activation during the anticipation of reward. Neurosci Lett. 2006 Sep 25;405(3):196-201. doi: 10.1016/j.neulet.2006.07.030. Epub 2006 Aug 8.
57 Discovery of antiandrogen activity of nonsteroidal scaffolds of marketed drugs. Proc Natl Acad Sci U S A. 2007 Jul 17;104(29):11927-32. doi: 10.1073/pnas.0609752104. Epub 2007 Jul 2.
58 Response to chlorpromazine treatment may be associated with polymorphisms of the DRD2 gene in Chinese schizophrenic patients. Neurosci Lett. 2005 Mar 7;376(1):1-4. doi: 10.1016/j.neulet.2004.11.014. Epub 2004 Dec 2.
59 Temozolomide induces activation of Wnt/-catenin signaling in glioma cells via PI3K/Akt pathway: implications in glioma therapy. Cell Biol Toxicol. 2020 Jun;36(3):273-278. doi: 10.1007/s10565-019-09502-7. Epub 2019 Nov 22.
60 Low doses of cisplatin induce gene alterations, cell cycle arrest, and apoptosis in human promyelocytic leukemia cells. Biomark Insights. 2016 Aug 24;11:113-21.
61 Prenatal arsenic exposure and the epigenome: identifying sites of 5-methylcytosine alterations that predict functional changes in gene expression in newborn cord blood and subsequent birth outcomes. Toxicol Sci. 2015 Jan;143(1):97-106. doi: 10.1093/toxsci/kfu210. Epub 2014 Oct 10.
62 Multiple microRNAs function as self-protective modules in acetaminophen-induced hepatotoxicity in humans. Arch Toxicol. 2018 Feb;92(2):845-858.
63 Bringing in vitro analysis closer to in vivo: studying doxorubicin toxicity and associated mechanisms in 3D human microtissues with PBPK-based dose modelling. Toxicol Lett. 2018 Sep 15;294:184-192.
64 Air pollution and DNA methylation alterations in lung cancer: A systematic and comparative study. Oncotarget. 2017 Jan 3;8(1):1369-1391. doi: 10.18632/oncotarget.13622.
65 DNA methylome-wide alterations associated with estrogen receptor-dependent effects of bisphenols in breast cancer. Clin Epigenetics. 2019 Oct 10;11(1):138. doi: 10.1186/s13148-019-0725-y.
66 A transcriptome-based classifier to identify developmental toxicants by stem cell testing: design, validation and optimization for histone deacetylase inhibitors. Arch Toxicol. 2015 Sep;89(9):1599-618.
67 Genome-wide association analyses suggest NELL1 influences adverse metabolic response to HCTZ in African Americans. Pharmacogenomics J. 2014 Feb;14(1):35-40. doi: 10.1038/tpj.2013.3. Epub 2013 Feb 12.
68 Effect of aflatoxin B(1), benzo[a]pyrene, and methapyrilene on transcriptomic and epigenetic alterations in human liver HepaRG cells. Food Chem Toxicol. 2018 Nov;121:214-223. doi: 10.1016/j.fct.2018.08.034. Epub 2018 Aug 26.
69 From transient transcriptome responses to disturbed neurodevelopment: role of histone acetylation and methylation as epigenetic switch between reversible and irreversible drug effects. Arch Toxicol. 2014 Jul;88(7):1451-68.
70 Gypenosides protect retinal pigment epithelium cells from oxidative stress. Food Chem Toxicol. 2018 Feb;112:76-85.
71 Role of antioxidant systems in human androgen-independent prostate cancer cells. Prostate. 2000 May 1;43(2):144-9. doi: 10.1002/(sici)1097-0045(20000501)43:2<144::aid-pros9>3.0.co;2-h.
72 Cytotoxic Effects of Cannabinoids on Human HT-29 Colorectal Adenocarcinoma Cells: Different Mechanisms of THC, CBD, and CB83. Int J Mol Sci. 2020 Aug 1;21(15):5533. doi: 10.3390/ijms21155533.
73 Selenium deficiency alters epithelial cell morphology and responses to influenza. Free Radic Biol Med. 2007 Jun 15;42(12):1826-37.
74 Hepatocellular peroxisomes in human alcoholic and drug-induced hepatitis: a quantitative study. Hepatology. 1991 Nov;14(5):811-7.
75 Antioxidant enzyme and malondialdehyde values in social phobia before and after citalopram treatment. Eur Arch Psychiatry Clin Neurosci. 2004 Aug;254(4):231-5.
76 The contribution of methotrexate exposure and host factors on transcriptional variance in human liver. Toxicol Sci. 2007 Jun;97(2):582-94.
77 The effect of statins on lipids peroxidation and activities of antioxidants enzymes in patients with dyslipidemia. Przegl Lek. 2006;63(9):738-42.
78 Comparison of phenotypic and transcriptomic effects of false-positive genotoxins, true genotoxins and non-genotoxins using HepG2 cells. Mutagenesis. 2011 Sep;26(5):593-604.
79 Poly(ADP-ribose) polymerase 1 contributes to oxidative stress through downregulation of sirtuin 3 during cisplatin nephrotoxicity. Anat Cell Biol. 2016 Sep;49(3):165-176. doi: 10.5115/acb.2016.49.3.165. Epub 2016 Sep 29.
80 Beta-carotene and apocarotenals promote retinoid signaling in BEAS-2B human bronchioepithelial cells. Arch Biochem Biophys. 2006 Nov 1;455(1):48-60.
81 Gene expression profiles with activation of the estrogen receptor alpha-selective estrogen receptor modulator complex in breast cancer cells expressing wild-type estrogen receptor. Cancer Res. 2002 Aug 1;62(15):4419-26.
82 Inactivation of cytochrome c oxidase by mutant SOD1s in mouse motoneuronal NSC-34 cells is independent from copper availability but is because of nitric oxide. J Neurochem. 2010 Jan;112(1):183-92. doi: 10.1111/j.1471-4159.2009.06441.x. Epub 2009 Oct 20.
83 Impairment of mitochondrial anti-oxidant defence in SOD1-related motor neuron injury and amelioration by ebselen. Brain. 2006 Jul;129(Pt 7):1693-709. doi: 10.1093/brain/awl118. Epub 2006 May 15.
84 Development of an alternative zebrafish model for drug-induced intestinal toxicity. J Appl Toxicol. 2018 Feb;38(2):259-273. doi: 10.1002/jat.3520. Epub 2017 Oct 13.
85 Epinephrine upregulates superoxide dismutase in human coronary artery endothelial cells. Free Radic Biol Med. 2001 Jan 15;30(2):148-53.
86 Molecular pathways in the chemosensitization of cisplatin by quercetin in human head and neck cancer. Cancer Biol Ther. 2005 Sep;4(9):949-55.
87 Expression pattern of cisplatin-induced metallothionein isoforms in squamous cell carcinoma. Anticancer Res. 2003 Jan-Feb;23(1A):299-303.
88 Cannabidiol enhances cytotoxicity of anti-cancer drugs in human head and neck squamous cell carcinoma. Sci Rep. 2020 Nov 26;10(1):20622. doi: 10.1038/s41598-020-77674-y.
89 Gene expression after treatment with hydrogen peroxide, menadione, or t-butyl hydroperoxide in breast cancer cells. Cancer Res. 2002 Nov 1;62(21):6246-54.
90 Identification of novel activators of the metal responsive transcription factor (MTF-1) using a gene expression biomarker in a microarray compendium. Metallomics. 2020 Sep 23;12(9):1400-1415. doi: 10.1039/d0mt00071j.
91 Expression of antioxidant proteins in human intestinal Caco-2 cells treated with dietary flavonoids. Cancer Lett. 1999 Nov 15;146(2):161-7.
92 Increased sensitivity for troglitazone-induced cytotoxicity using a human in vitro co-culture model. Toxicol In Vitro. 2009 Oct;23(7):1387-95.
93 Motexafin gadolinium and zinc induce oxidative stress responses and apoptosis in B-cell lymphoma lines. Cancer Res. 2005 Dec 15;65(24):11676-88.
94 Chronic occupational exposure to arsenic induces carcinogenic gene signaling networks and neoplastic transformation in human lung epithelial cells. Toxicol Appl Pharmacol. 2012 Jun 1;261(2):204-16.
95 JunD is involved in the antiproliferative effect of Delta9-tetrahydrocannabinol on human breast cancer cells. Oncogene. 2008 Aug 28;27(37):5033-44.
96 Transcriptomics hit the target: monitoring of ligand-activated and stress response pathways for chemical testing. Toxicol In Vitro. 2015 Dec 25;30(1 Pt A):7-18.
97 Synergistic antiproliferative effect of arsenic trioxide combined with bortezomib in HL60 cell line and primary blasts from patients affected by myeloproliferative disorders. Cancer Genet Cytogenet. 2010 Jun;199(2):110-20. doi: 10.1016/j.cancergencyto.2010.02.010.
98 Integrating multiple omics to unravel mechanisms of Cyclosporin A induced hepatotoxicity in vitro. Toxicol In Vitro. 2015 Apr;29(3):489-501.
99 Effects of folate deficiency on gene expression in the apoptosis and cancer pathways in colon cancer cells. Carcinogenesis. 2006 May;27(5):916-24. doi: 10.1093/carcin/bgi312. Epub 2005 Dec 16.
100 Identification by automated screening of a small molecule that selectively eliminates neural stem cells derived from hESCs but not dopamine neurons. PLoS One. 2009 Sep 23;4(9):e7155.
101 Physiological and toxicological transcriptome changes in HepG2 cells exposed to copper. Physiol Genomics. 2009 Aug 7;38(3):386-401.
102 Oxidative Stress Alters miRNA and Gene Expression Profiles in Villous First Trimester Trophoblasts. Biomed Res Int. 2015;2015:257090. doi: 10.1155/2015/257090. Epub 2015 Aug 3.
103 Effects of methotrexate on vascular endothelial growth factor, angiopoietin 1, and angiopoietin 2 in nasal polyps. Am J Rhinol Allergy. 2011 Jul-Aug;25(4):e129-32. doi: 10.2500/ajra.2011.25.3618.
104 Development of a neural teratogenicity test based on human embryonic stem cells: response to retinoic acid exposure. Toxicol Sci. 2011 Dec;124(2):370-7.
105 Essential role of cell cycle regulatory genes p21 and p27 expression in inhibition of breast cancer cells by arsenic trioxide. Med Oncol. 2011 Dec;28(4):1225-54.
106 Thalidomide downregulates angiogenic genes in bone marrow endothelial cells of patients with active multiple myeloma. J Clin Oncol. 2005 Aug 10;23(23):5334-46. doi: 10.1200/JCO.2005.03.723. Epub 2005 Jun 6.
107 Propranolol inhibits proliferation and induces apoptosis of hemangioma-derived endothelial cells via Akt pathway by down-regulating Ang-2 expression. Chem Biol Interact. 2020 Jan 25;316:108925. doi: 10.1016/j.cbi.2019.108925. Epub 2019 Dec 12.
108 Effects of 1alpha,25 dihydroxyvitamin D3 and testosterone on miRNA and mRNA expression in LNCaP cells. Mol Cancer. 2011 May 18;10:58.
109 Atorvastatin affects several angiogenic mediators in human endothelial cells. Endothelium. 2005 Sep-Dec;12(5-6):233-41.
110 mTOR inhibition reverses acquired endocrine therapy resistance of breast cancer cells at the cell proliferation and gene-expression levels. Cancer Sci. 2008 Oct;99(10):1992-2003. doi: 10.1111/j.1349-7006.2008.00955.x.
111 Leptomycin B reduces primary and acquired resistance of gefitinib in lung cancer cells. Toxicol Appl Pharmacol. 2017 Nov 15;335:16-27. doi: 10.1016/j.taap.2017.09.017. Epub 2017 Sep 21.
112 Assessment of the cytotoxic, genotoxic, and apoptotic potential of flurbiprofen in HeLa and HepG2 cell lines. J Biochem Mol Toxicol. 2021 Jun;35(6):1-11. doi: 10.1002/jbt.22770. Epub 2021 Mar 11.
113 Apoptotic signaling pathways induced by nitric oxide in human lymphoblastoid cells expressing wild-type or mutant p53. Cancer Res. 2004 May 1;64(9):3022-9. doi: 10.1158/0008-5472.can-03-1880.
114 Bexarotene activates the p53/p73 pathway in human cutaneous T-cell lymphoma. Br J Dermatol. 2009 Mar;160(3):519-26. doi: 10.1111/j.1365-2133.2008.08931.x. Epub 2008 Nov 25.
115 Expression profile analysis of colon cancer cells in response to sulindac or aspirin. Biochem Biophys Res Commun. 2002 Mar 29;292(2):498-512.
116 Apoptotic induction by simvastatin in human lung cancer A549 cells via Akt signaling dependent down-regulation of survivin. Invest New Drugs. 2011 Oct;29(5):945-52. doi: 10.1007/s10637-010-9450-2. Epub 2010 May 13.
117 Combining lapatinib (GW572016), a small molecule inhibitor of ErbB1 and ErbB2 tyrosine kinases, with therapeutic anti-ErbB2 antibodies enhances apoptosis of ErbB2-overexpressing breast cancer cells. Oncogene. 2005 Sep 15;24(41):6213-21. doi: 10.1038/sj.onc.1208774.
118 Quercetin inhibit human SW480 colon cancer growth in association with inhibition of cyclin D1 and survivin expression through Wnt/beta-catenin signaling pathway. Cancer Invest. 2009 Jul;27(6):604-12. doi: 10.1080/07357900802337191.
119 Troglitazone sensitizes tumor cells to TRAIL-induced apoptosis via down-regulation of FLIP and Survivin. Apoptosis. 2006 Sep;11(9):1503-12. doi: 10.1007/s10495-006-8896-3.
120 Cannabidiol-induced transcriptomic changes and cellular senescence in human Sertoli cells. Toxicol Sci. 2023 Feb 17;191(2):227-238. doi: 10.1093/toxsci/kfac131.
121 Simvastatin inactivates beta1-integrin and extracellular signal-related kinase signaling and inhibits cell proliferation in head and neck squamous cell carcinoma cells. Cancer Sci. 2007 Jun;98(6):890-9.
122 Quercetin potentiates apoptosis by inhibiting nuclear factor-kappaB signaling in H460 lung cancer cells. Biol Pharm Bull. 2013;36(6):944-51. doi: 10.1248/bpb.b12-01004.
123 Effects of ciglitazone and troglitazone on the proliferation of human stomach cancer cells. World J Gastroenterol. 2009 Jan 21;15(3):310-20.
124 Retinoic acid-induced downmodulation of telomerase activity in human cancer cells. Exp Mol Pathol. 2005 Oct;79(2):108-17.
125 Global effects of inorganic arsenic on gene expression profile in human macrophages. Mol Immunol. 2009 Feb;46(4):649-56.
126 Characterization of formaldehyde's genotoxic mode of action by gene expression analysis in TK6 cells. Arch Toxicol. 2013 Nov;87(11):1999-2012.
127 Exposure-based assessment of chemical teratogenicity using morphogenetic aggregates of human embryonic stem cells. Reprod Toxicol. 2020 Jan;91:74-91. doi: 10.1016/j.reprotox.2019.10.004. Epub 2019 Nov 8.
128 The enzymatic activity of human aldehyde dehydrogenases 1A2 and 2 (ALDH1A2 and ALDH2) is detected by Aldefluor, inhibited by diethylaminobenzaldehyde and has significant effects on cell proliferation and drug resistance. Chem Biol Interact. 2012 Jan 5;195(1):52-60.
129 Gene expression profile induced by BCNU in human glioma cell lines with differential MGMT expression. J Neurooncol. 2005 Jul;73(3):189-98.
130 Ethyl carbamate induces cell death through its effects on multiple metabolic pathways. Chem Biol Interact. 2017 Nov 1;277:21-32.
131 Loss of TRIM33 causes resistance to BET bromodomain inhibitors through MYC- and TGF-beta-dependent mechanisms. Proc Natl Acad Sci U S A. 2016 Aug 2;113(31):E4558-66.
132 A trichostatin A expression signature identified by TempO-Seq targeted whole transcriptome profiling. PLoS One. 2017 May 25;12(5):e0178302. doi: 10.1371/journal.pone.0178302. eCollection 2017.
133 Transcriptome profile analysis of saturated aliphatic aldehydes reveals carbon number-specific molecules involved in pulmonary toxicity. Chem Res Toxicol. 2014 Aug 18;27(8):1362-70.
134 Quercetin induced cell apoptosis and altered gene expression in AGS human gastric cancer cells. Environ Toxicol. 2018 Nov;33(11):1168-1181. doi: 10.1002/tox.22623. Epub 2018 Aug 27.
135 Phenotypic characterization of retinoic acid differentiated SH-SY5Y cells by transcriptional profiling. PLoS One. 2013 May 28;8(5):e63862.
136 Classification of heavy-metal toxicity by human DNA microarray analysis. Environ Sci Technol. 2007 May 15;41(10):3769-74.
137 How benzene and its metabolites affect human marrow derived mesenchymal stem cells. Toxicol Lett. 2012 Oct 17;214(2):145-53. doi: 10.1016/j.toxlet.2012.08.015. Epub 2012 Aug 30.
138 THC exposure of human iPSC neurons impacts genes associated with neuropsychiatric disorders. Transl Psychiatry. 2018 Apr 25;8(1):89. doi: 10.1038/s41398-018-0137-3.
139 Comparison of HepG2 and HepaRG by whole-genome gene expression analysis for the purpose of chemical hazard identification. Toxicol Sci. 2010 May;115(1):66-79.
140 Human embryonic stem cell-derived test systems for developmental neurotoxicity: a transcriptomics approach. Arch Toxicol. 2013 Jan;87(1):123-43.
141 Quantitative proteomics reveals a broad-spectrum antiviral property of ivermectin, benefiting for COVID-19 treatment. J Cell Physiol. 2021 Apr;236(4):2959-2975. doi: 10.1002/jcp.30055. Epub 2020 Sep 22.
142 Global gene expression analysis reveals differences in cellular responses to hydroxyl- and superoxide anion radical-induced oxidative stress in caco-2 cells. Toxicol Sci. 2010 Apr;114(2):193-203. doi: 10.1093/toxsci/kfp309. Epub 2009 Dec 31.
143 Methotrexate modulates folate phenotype and inflammatory profile in EA.hy 926 cells. Eur J Pharmacol. 2014 Jun 5;732:60-7.
144 CyclinB2 and BIRC5 genes as surrogate biomarkers for neurite outgrowth in SH-SY5Y subclonal cells. Neuropharmacology. 2006 Jun;50(8):1041-7. doi: 10.1016/j.neuropharm.2006.02.004. Epub 2006 Mar 30.
145 Effects of chlorpromazine with and without UV irradiation on gene expression of HepG2 cells. Mutat Res. 2005 Aug 4;575(1-2):47-60. doi: 10.1016/j.mrfmmm.2005.03.002. Epub 2005 Apr 26.
146 Comparative gene expression profiling reveals partially overlapping but distinct genomic actions of different antiestrogens in human breast cancer cells. J Cell Biochem. 2006 Aug 1;98(5):1163-84.
147 Utilization of CDKN1A/p21 gene for class discrimination of DNA damage-induced clastogenicity. Toxicology. 2014 Jan 6;315:8-16. doi: 10.1016/j.tox.2013.10.009. Epub 2013 Nov 6.
148 Transcriptional and Metabolic Dissection of ATRA-Induced Granulocytic Differentiation in NB4 Acute Promyelocytic Leukemia Cells. Cells. 2020 Nov 5;9(11):2423. doi: 10.3390/cells9112423.
149 Multidrug resistance protein-6 (MRP6) in human dermal fibroblasts. Comparison between cells from normal subjects and from Pseudoxanthoma elasticum patients. Matrix Biol. 2003 Nov;22(6):491-500. doi: 10.1016/j.matbio.2003.09.001.
150 Transcriptomic analysis of untreated and drug-treated differentiated HepaRG cells over a 2-week period. Toxicol In Vitro. 2015 Dec 25;30(1 Pt A):27-35.
151 Expression of the human ABCC6 gene is induced by retinoids through the retinoid X receptor. Biochem Biophys Res Commun. 2006 Dec 1;350(4):1082-7. doi: 10.1016/j.bbrc.2006.10.007. Epub 2006 Oct 10.
152 Differential gene expression in human hepatocyte cell lines exposed to the antiretroviral agent zidovudine. Arch Toxicol. 2014 Mar;88(3):609-23. doi: 10.1007/s00204-013-1169-3. Epub 2013 Nov 30.
153 Rifampin Regulation of Drug Transporters Gene Expression and the Association of MicroRNAs in Human Hepatocytes. Front Pharmacol. 2016 Apr 26;7:111.
154 Loss of ATP-dependent transport activity in pseudoxanthoma elasticum-associated mutants of human ABCC6 (MRP6). J Biol Chem. 2002 May 10;277(19):16860-7.
155 Activation of PPAR and inhibition of cell proliferation reduces key proteins associated with the basal subtype of bladder cancer in As3+-transformed UROtsa cells. PLoS One. 2020 Aug 21;15(8):e0237976. doi: 10.1371/journal.pone.0237976. eCollection 2020.
156 Retinoic acid and its 4-oxo metabolites are functionally active in human skin cells in vitro. J Invest Dermatol. 2005 Jul;125(1):143-53.
157 Proteomics-based identification of differentially abundant proteins from human keratinocytes exposed to arsenic trioxide. J Proteomics Bioinform. 2014 Jul;7(7):166-178.
158 Oral lichenoid eruption secondary to imatinib (Glivec). J Dermatolog Treat. 2004 Jul;15(4):253-5. doi: 10.1080/09546630410015556.
159 Impact of extracellular folate levels on global gene expression. Mol Pharmacol. 2001 Dec;60(6):1288-95. doi: 10.1124/mol.60.6.1288.
160 Retinoic acid receptor- and retinoid X receptor-selective retinoids activate signaling pathways that converge on AP-1 and inhibit squamous differentiation in human bronchial epithelial cells. Cell Growth Differ. 1996 Aug;7(8):997-1004.
161 Exposure to Insecticides Modifies Gene Expression and DNA Methylation in Hematopoietic Tissues In Vitro. Int J Mol Sci. 2023 Mar 26;24(7):6259. doi: 10.3390/ijms24076259.
162 Regulatory role of nitric oxide on monocyte-derived dendritic cell functions. J Interferon Cytokine Res. 2003 Aug;23(8):423-31. doi: 10.1089/107999003322277838.
163 Plant polyphenols differentially modulate inflammatory responses of human keratinocytes by interfering with activation of transcription factors NFB and AhR and EGFR-ERK pathway. Toxicol Appl Pharmacol. 2011 Sep 1;255(2):138-49.
164 13-cis retinoic acid inhibits development and progression of chronic allograft nephropathy. Am J Pathol. 2005 Jul;167(1):285-98. doi: 10.1016/S0002-9440(10)62973-2.
165 Characterization of drug-specific signaling between primary human hepatocytes and immune cells. Toxicol Sci. 2017 Jul 1;158(1):76-89.
166 Gene expression profile induced by arsenic trioxide in chronic lymphocytic leukemia cells reveals a central role for heme oxygenase-1 in apoptosis and regulation of matrix metalloproteinase-9. Oncotarget. 2016 Dec 13;7(50):83359-83377.
167 Regulation of inflammatory responses in tumor necrosis factor-activated and rheumatoid arthritis synovial macrophages by JAK inhibitors. Arthritis Rheum. 2012 Dec;64(12):3856-66. doi: 10.1002/art.37691.
168 Screening autism-associated environmental factors in differentiating human neural progenitors with fractional factorial design-based transcriptomics. Sci Rep. 2023 Jun 29;13(1):10519. doi: 10.1038/s41598-023-37488-0.
169 Effects of troglitazone on cellular differentiation, insulin signaling, and glucose metabolism in cultured human skeletal muscle cells. Biochem Biophys Res Commun. 2001 Jan 26;280(3):664-74. doi: 10.1006/bbrc.2000.4216.
170 Cannabidiol Displays Proteomic Similarities to Antipsychotics in Cuprizone-Exposed Human Oligodendrocytic Cell Line MO3.13. Front Mol Neurosci. 2021 May 28;14:673144. doi: 10.3389/fnmol.2021.673144. eCollection 2021.
171 Integrative "-Omics" analysis in primary human hepatocytes unravels persistent mechanisms of cyclosporine A-induced cholestasis. Chem Res Toxicol. 2016 Dec 19;29(12):2164-2174.
172 CXCL14 downregulation in human keratinocytes is a potential biomarker for a novel in vitro skin sensitization test. Toxicol Appl Pharmacol. 2020 Jan 1;386:114828. doi: 10.1016/j.taap.2019.114828. Epub 2019 Nov 14.
173 Identification of mechanisms of action of bisphenol a-induced human preadipocyte differentiation by transcriptional profiling. Obesity (Silver Spring). 2014 Nov;22(11):2333-43.
174 Incidence of mutation and deletion in topoisomerase II alpha mRNA of etoposide and mAMSA-resistant cell lines. Jpn J Cancer Res. 2001 Oct;92(10):1133-7. doi: 10.1111/j.1349-7006.2001.tb01069.x.
175 HU-331 and Oxidized Cannabidiol Act as Inhibitors of Human Topoisomerase II and . Chem Res Toxicol. 2018 Feb 19;31(2):137-144. doi: 10.1021/acs.chemrestox.7b00302. Epub 2018 Jan 8.
176 Interactions between the etoposide derivative F14512 and human type II topoisomerases: implications for the C4 spermine moiety in promoting enzyme-mediated DNA cleavage. Biochemistry. 2011 Apr 19;50(15):3240-9. doi: 10.1021/bi200094z. Epub 2011 Mar 28.
177 The involvement of hepatic cytochrome P450s in the cytotoxicity of lapatinib. Toxicol Sci. 2023 Dec 21;197(1):69-78. doi: 10.1093/toxsci/kfad099.
178 Differential modulation of PI3-kinase/Akt pathway during all-trans retinoic acid- and Am80-induced HL-60 cell differentiation revealed by DNA microarray analysis. Biochem Pharmacol. 2004 Dec 1;68(11):2177-86.
179 Arsenic trioxide exposure to ovarian carcinoma cells leads to decreased level of topoisomerase II and cytotoxicity. Int J Gynecol Cancer. 2006 Jul-Aug;16(4):1552-6. doi: 10.1111/j.1525-1438.2006.00626.x.
180 Microarray analysis of H2O2-, HNE-, or tBH-treated ARPE-19 cells. Free Radic Biol Med. 2002 Nov 15;33(10):1419-32.
181 NFATc4 mediates ethanol-triggered hepatocyte senescence. Toxicol Lett. 2021 Oct 10;350:10-21. doi: 10.1016/j.toxlet.2021.06.018. Epub 2021 Jun 27.
182 Changes in gene expression profiles in response to selenium supplementation among individuals with arsenic-induced pre-malignant skin lesions. Toxicol Lett. 2007 Mar 8;169(2):162-76. doi: 10.1016/j.toxlet.2007.01.006. Epub 2007 Jan 19.
183 Global molecular effects of tocilizumab therapy in rheumatoid arthritis synovium. Arthritis Rheumatol. 2014 Jan;66(1):15-23.
184 Antirheumatic drug response signatures in human chondrocytes: potential molecular targets to stimulate cartilage regeneration. Arthritis Res Ther. 2009;11(1):R15.
185 Progesterone and calcitriol attenuate inflammatory cytokines CXCL1 and CXCL2 in ovarian and endometrial cancer cells. J Cell Biochem. 2012 Oct;113(10):3143-52. doi: 10.1002/jcb.24191.
186 Discovery of molecular mechanisms of neuroprotection using cell-based bioassays and oligonucleotide arrays. Physiol Genomics. 2002 Oct 29;11(2):45-52. doi: 10.1152/physiolgenomics.00064.2002.
187 Retinoic acid receptor alpha amplifications and retinoic acid sensitivity in breast cancers. Clin Breast Cancer. 2013 Oct;13(5):401-8.
188 Temporal changes in gene expression in the skin of patients treated with isotretinoin provide insight into its mechanism of action. Dermatoendocrinol. 2009 May;1(3):177-87.
189 14-3-3 regulation of and interaction with YAP1 in acquired gemcitabine resistance via promoting ribonucleotide reductase expression. Oncotarget. 2016 Apr 5;7(14):17726-36. doi: 10.18632/oncotarget.7394.
190 Identification of transcriptome signatures and biomarkers specific for potential developmental toxicants inhibiting human neural crest cell migration. Arch Toxicol. 2016 Jan;90(1):159-80.
191 Docosahexaenoic acid regulates gene expression in HUVEC cells treated with polycyclic aromatic hydrocarbons. Toxicol Lett. 2015 Jul 16;236(2):75-81.
192 Etoposide induces necrosis through p53-mediated antiapoptosis in human kidney proximal tubule cells. Toxicol Sci. 2015 Nov;148(1):204-19.
193 Conjugated linoleic acid, unlike other unsaturated fatty acids, strongly induces glutathione synthesis without any lipoperoxidation. Br J Nutr. 2006 Nov;96(5):811-9.
194 COX-2 and PPAR-gama confer cannabidiol-induced apoptosis of human lung cancer cells. Mol Cancer Ther. 2013 Jan;12(1):69-82.
195 Mitochondrial involvement in schizophrenia and other functional psychoses. Neurochem Res. 1996 Sep;21(9):995-1004.
196 Immunomodulatory effect of selective serotonin reuptake inhibitors (SSRIs) on human T lymphocyte function and gene expression. Eur Neuropsychopharmacol. 2007 Dec;17(12):774-80.
197 Stimulation of cyclooxygenase-2 expression by bone-derived transforming growth factor-beta enhances bone metastases in breast cancer. Cancer Res. 2006 Feb 15;66(4):2067-73.
198 Arsenite and cadmium promote the development of mammary tumors. Carcinogenesis. 2020 Jul 14;41(7):1005-1014. doi: 10.1093/carcin/bgz176.
199 An in vitro coculture system of human peripheral blood mononuclear cells with hepatocellular carcinoma-derived cells for predicting drug-induced liver injury. Arch Toxicol. 2021 Jan;95(1):149-168. doi: 10.1007/s00204-020-02882-4. Epub 2020 Aug 20.
200 A2E selectively induces cox-2 in ARPE-19 and human neural cells. Curr Eye Res. 2006 Mar;31(3):259-63.
201 Minimal peroxide exposure of neuronal cells induces multifaceted adaptive responses. PLoS One. 2010 Dec 17;5(12):e14352. doi: 10.1371/journal.pone.0014352.
202 LSD1 activates a lethal prostate cancer gene network independently of its demethylase function. Proc Natl Acad Sci U S A. 2018 May 1;115(18):E4179-E4188.
203 Drinking-water arsenic exposure modulates gene expression in human lymphocytes from a U.S. population. Environ Health Perspect. 2008 Apr;116(4):524-31. doi: 10.1289/ehp.10861.
204 Characteristics of arachidonic acid generation in human basophils: relationship between the effects of inhibitors of secretory phospholipase A2 activity and leukotriene C4 release. J Pharmacol Exp Ther. 1998 Mar;284(3):847-57.
205 Groups IV, V, and X phospholipases A2s in human neutrophils: role in eicosanoid production and gram-negative bacterial phospholipid hydrolysis. J Biol Chem. 2002 Feb 15;277(7):5061-73. doi: 10.1074/jbc.M109083200. Epub 2001 Dec 6.
206 1,25(OH)2-vitamin D3 inhibits proliferation and decreases production of monocyte chemoattractant protein-1, thrombopoietin, VEGF, and angiogenin by human annulus cells in vitro. Spine (Phila Pa 1976). 2008 Apr 1;33(7):755-65. doi: 10.1097/BRS.0b013e3181695d59.
207 Metronomic gemcitabine suppresses tumour growth, improves perfusion, and reduces hypoxia in human pancreatic ductal adenocarcinoma. Br J Cancer. 2010 Jun 29;103(1):52-60.
208 Levonorgestrel enhances spermatogenesis suppression by testosterone with greater alteration in testicular gene expression in men. Biol Reprod. 2009 Mar;80(3):484-92.
209 Transcriptome and DNA methylome dynamics during triclosan-induced cardiomyocyte differentiation toxicity. Stem Cells Int. 2018 Oct 29;2018:8608327.
210 Definition of transcriptome-based indices for quantitative characterization of chemically disturbed stem cell development: introduction of the STOP-Toxukn and STOP-Toxukk tests. Arch Toxicol. 2017 Feb;91(2):839-864.
211 Targeting multiple cannabinoid anti-tumour pathways with a resorcinol derivative leads to inhibition of advanced stages of breast cancer. Br J Pharmacol. 2014 Oct;171(19):4464-77. doi: 10.1111/bph.12803. Epub 2014 Sep 5.
212 Calcium pantothenate modulates gene expression in proliferating human dermal fibroblasts. Exp Dermatol. 2009 Nov;18(11):969-78. doi: 10.1111/j.1600-0625.2009.00884.x. Epub 2009 Apr 8.
213 Selenium and vitamin E: cell type- and intervention-specific tissue effects in prostate cancer. J Natl Cancer Inst. 2009 Mar 4;101(5):306-20.
214 Study of As(2)O(3) regulating proliferation and apoptosis of Tca8113 cells by inhibiting the expression of Id-1. Artif Cells Nanomed Biotechnol. 2019 Dec;47(1):1932-1937. doi: 10.1080/21691401.2019.1613419.
215 Keratinocyte-derived IL-36gama plays a role in hydroquinone-induced chemical leukoderma through inhibition of melanogenesis in human epidermal melanocytes. Arch Toxicol. 2019 Aug;93(8):2307-2320.
216 Effect of menstrual cycle and hormonal treatment on ki-67 and bcl-2 expression and adenomyosis. Gynecol Endocrinol. 2005 Mar;20(3):127-31. doi: 10.1080/09513590400021086.
217 Quantitative phosphoproteomics reveal cellular responses from caffeine, coumarin and quercetin in treated HepG2 cells. Toxicol Appl Pharmacol. 2022 Aug 15;449:116110. doi: 10.1016/j.taap.2022.116110. Epub 2022 Jun 7.
218 Effect of retinoic acid on gene expression in human conjunctival epithelium: secretory phospholipase A2 mediates retinoic acid induction of MUC16. Invest Ophthalmol Vis Sci. 2005 Nov;46(11):4050-61.
219 An in vitro study on anti-carcinogenic effect of remdesivir in human ovarian cancer cells via generation of reactive oxygen species. Hum Exp Toxicol. 2022 Jan-Dec;41:9603271221089257. doi: 10.1177/09603271221089257.
220 Mitophagy inhibits proliferation by decreasing cyclooxygenase-2 (COX-2) in arsenic trioxide-treated HepG2 cells. Environ Toxicol Pharmacol. 2016 Jul;45:212-21.
221 Thalidomide suppresses angiogenesis and immune evasion via lncRNA FGD5-AS1/miR-454-3p/ZEB1 axis-mediated VEGFA expression and PD-1/PD-L1 checkpoint in NSCLC. Chem Biol Interact. 2021 Nov 1;349:109652. doi: 10.1016/j.cbi.2021.109652. Epub 2021 Sep 11.
222 Oxidative stress modulates theophylline effects on steroid responsiveness. Biochem Biophys Res Commun. 2008 Dec 19;377(3):797-802.
223 Acute hypersensitivity of pluripotent testicular cancer-derived embryonal carcinoma to low-dose 5-aza deoxycytidine is associated with global DNA Damage-associated p53 activation, anti-pluripotency and DNA demethylation. PLoS One. 2012;7(12):e53003. doi: 10.1371/journal.pone.0053003. Epub 2012 Dec 27.
224 Bromodomain-containing protein 4 (BRD4) regulates RNA polymerase II serine 2 phosphorylation in human CD4+ T cells. J Biol Chem. 2012 Dec 14;287(51):43137-55.
225 Neuronal and cardiac toxicity of pharmacological compounds identified through transcriptomic analysis of human pluripotent stem cell-derived embryoid bodies. Toxicol Appl Pharmacol. 2021 Dec 15;433:115792. doi: 10.1016/j.taap.2021.115792. Epub 2021 Nov 3.
226 Dasatinib reverses cancer-associated fibroblasts (CAFs) from primary lung carcinomas to a phenotype comparable to that of normal fibroblasts. Mol Cancer. 2010 Jun 27;9:168.
227 The effect of estrogen compounds on human embryoid bodies. Reprod Sci. 2013 Jun;20(6):661-9. doi: 10.1177/1933719112462630. Epub 2012 Nov 26.
228 Effects of progesterone treatment on expression of genes involved in uterine quiescence. Reprod Sci. 2011 Aug;18(8):781-97.
229 Molecular mechanisms of hepatotoxic cholestasis by clavulanic acid: Role of NRF2 and FXR pathways. Food Chem Toxicol. 2021 Dec;158:112664. doi: 10.1016/j.fct.2021.112664. Epub 2021 Nov 9.
230 Pharmacotoxicology of clinically-relevant concentrations of obeticholic acid in an organotypic human hepatocyte system. Toxicol In Vitro. 2017 Mar;39:93-103.
231 The proapoptotic effect of zoledronic acid is independent of either the bone microenvironment or the intrinsic resistance to bortezomib of myeloma cells and is enhanced by the combination with arsenic trioxide. Exp Hematol. 2011 Jan;39(1):55-65.
232 Inter-laboratory comparison of human renal proximal tubule (HK-2) transcriptome alterations due to Cyclosporine A exposure and medium exhaustion. Toxicol In Vitro. 2009 Apr;23(3):486-99.
233 Computational discovery of niclosamide ethanolamine, a repurposed drug candidate that reduces growth of hepatocellular carcinoma cells initro and in mice by inhibiting cell division cycle 37 signaling. Gastroenterology. 2017 Jun;152(8):2022-2036.
234 Interleukin-19 as a translational indicator of renal injury. Arch Toxicol. 2015 Jan;89(1):101-6.
235 Integrated analysis of rifampicin-induced microRNA and gene expression changes in human hepatocytes. Drug Metab Pharmacokinet. 2014;29(4):333-40.
236 Cdk4/6 inhibition induces epithelial-mesenchymal transition and enhances invasiveness in pancreatic cancer cells. Mol Cancer Ther. 2012 Oct;11(10):2138-48. doi: 10.1158/1535-7163.MCT-12-0562. Epub 2012 Aug 6.
237 Time series analysis of oxidative stress response patterns in HepG2: a toxicogenomics approach. Toxicology. 2013 Apr 5;306:24-34.
238 Gene Expression Regulation and Pathway Analysis After Valproic Acid and Carbamazepine Exposure in a Human Embryonic Stem Cell-Based Neurodevelopmental Toxicity Assay. Toxicol Sci. 2015 Aug;146(2):311-20. doi: 10.1093/toxsci/kfv094. Epub 2015 May 15.
239 Effects of acute ethanol treatment on NCCIT cells and NCCIT cell-derived embryoid bodies (EBs). Toxicol In Vitro. 2010 Sep;24(6):1696-704. doi: 10.1016/j.tiv.2010.05.017. Epub 2010 May 26.
240 A transcriptomics-based in vitro assay for predicting chemical genotoxicity in vivo. Carcinogenesis. 2012 Jul;33(7):1421-9.
241 Activation of AIFM2 enhances apoptosis of human lung cancer cells undergoing toxicological stress. Toxicol Lett. 2016 Sep 6;258:227-236.
242 17-Estradiol Activates HSF1 via MAPK Signaling in ER-Positive Breast Cancer Cells. Cancers (Basel). 2019 Oct 11;11(10):1533. doi: 10.3390/cancers11101533.
243 Bisphenol A induces DSB-ATM-p53 signaling leading to cell cycle arrest, senescence, autophagy, stress response, and estrogen release in human fetal lung fibroblasts. Arch Toxicol. 2018 Apr;92(4):1453-1469.
244 Transcriptome and DNA methylation changes modulated by sulforaphane induce cell cycle arrest, apoptosis, DNA damage, and suppression of proliferation in human liver cancer cells. Food Chem Toxicol. 2020 Feb;136:111047. doi: 10.1016/j.fct.2019.111047. Epub 2019 Dec 12.
245 Monitoring of deiodinase deficiency based on transcriptomic responses in SH-SY5Y cells. Arch Toxicol. 2013 Jun;87(6):1103-13. doi: 10.1007/s00204-013-1018-4. Epub 2013 Feb 10.
246 Riboflavin depletion impairs cell proliferation in adult human duodenum: identification of potential effectors. Dig Dis Sci. 2011 Apr;56(4):1007-19. doi: 10.1007/s10620-010-1374-3. Epub 2010 Sep 17.
247 Effects of lithium and valproic acid on gene expression and phenotypic markers in an NT2 neurosphere model of neural development. PLoS One. 2013;8(3):e58822.
248 In vitro effects of aldehydes present in tobacco smoke on gene expression in human lung alveolar epithelial cells. Toxicol In Vitro. 2013 Apr;27(3):1072-81.
249 The thioxotriazole copper(II) complex A0 induces endoplasmic reticulum stress and paraptotic death in human cancer cells. J Biol Chem. 2009 Sep 4;284(36):24306-19.
250 Stem cell transcriptome responses and corresponding biomarkers that indicate the transition from adaptive responses to cytotoxicity. Chem Res Toxicol. 2017 Apr 17;30(4):905-922.
251 Small Molecule Antipsychotic Aripiprazole Potentiates Ozone-Induced Inflammation in Airway Epithelium. Chem Res Toxicol. 2019 Oct 21;32(10):1997-2005. doi: 10.1021/acs.chemrestox.9b00149. Epub 2019 Sep 11.
252 Epigenetic activation of O-linked -N-acetylglucosamine transferase overrides the differentiation blockage in acute leukemia. EBioMedicine. 2020 Apr;54:102678. doi: 10.1016/j.ebiom.2020.102678. Epub 2020 Apr 6.
253 Inhibiting Heat Shock Proteins Can Potentiate the Cytotoxic Effect of Cannabidiol in Human Glioma Cells. Anticancer Res. 2015 Nov;35(11):5827-37.
254 Integrated assessment by multiple gene expression analysis of quercetin bioactivity on anticancer-related mechanisms in colon cancer cells in vitro. Eur J Nutr. 2005 Mar;44(3):143-56. doi: 10.1007/s00394-004-0503-1. Epub 2004 Apr 30.
255 Expression of NAG-1, a transforming growth factor-beta superfamily member, by troglitazone requires the early growth response gene EGR-1. J Biol Chem. 2004 Feb 20;279(8):6883-92. doi: 10.1074/jbc.M305295200. Epub 2003 Dec 8.
256 Growth differentiation factor 15 production is necessary for normal erythroid differentiation and is increased in refractory anaemia with ring-sideroblasts. Br J Haematol. 2009 Jan;144(2):251-62. doi: 10.1111/j.1365-2141.2008.07441.x. Epub 2008 Nov 19.
257 DNA array analysis of the effects of aspirin on colon cancer cells: involvement of Rac1. Carcinogenesis. 2004 Jul;25(7):1293-8.
258 Arsenic-induced sumoylation of Mus81 is involved in regulating genomic stability. Cell Cycle. 2017 Apr 18;16(8):802-811. doi: 10.1080/15384101.2017.1302628. Epub 2017 Mar 20.
259 Mitochondrial Uncoupling Induces Epigenome Remodeling and Promotes Differentiation in Neuroblastoma. Cancer Res. 2023 Jan 18;83(2):181-194. doi: 10.1158/0008-5472.CAN-22-1029.
260 PPARgamma controls CD1d expression by turning on retinoic acid synthesis in developing human dendritic cells. J Exp Med. 2006 Oct 2;203(10):2351-62.
261 Design principles of concentration-dependent transcriptome deviations in drug-exposed differentiating stem cells. Chem Res Toxicol. 2014 Mar 17;27(3):408-20.
262 Cannabidiol Modulates the Immunophenotype and Inhibits the Activation of the Inflammasome in Human Gingival Mesenchymal Stem Cells. Front Physiol. 2016 Nov 24;7:559. doi: 10.3389/fphys.2016.00559. eCollection 2016.
263 MS4A3-HSP27 target pathway reveals potential for haematopoietic disorder treatment in alimentary toxic aleukia. Cell Biol Toxicol. 2023 Feb;39(1):201-216. doi: 10.1007/s10565-021-09639-4. Epub 2021 Sep 28.
264 Non-canonical Opioid Signaling Inhibits Itch Transmission in the Spinal Cord of Mice. Cell Rep. 2018 Apr 17;23(3):866-877. doi: 10.1016/j.celrep.2018.03.087.
265 Protein kinase Cdelta-dependent induction of manganese superoxide dismutase gene expression by microtubule-active anticancer drugs. J Biol Chem. 1998 Dec 18;273(51):34639-45. doi: 10.1074/jbc.273.51.34639.
266 Aspirin induces apoptosis through release of cytochrome c from mitochondria. Neoplasia. 2000 Nov-Dec;2(6):505-13. doi: 10.1038/sj.neo.7900120.
267 Early Transcriptomic Changes upon Thalidomide Exposure Influence the Later Neuronal Development in Human Embryonic Stem Cell-Derived Spheres. Int J Mol Sci. 2020 Aug 3;21(15):5564. doi: 10.3390/ijms21155564.
268 The exosome-like vesicles derived from androgen exposed-prostate stromal cells promote epithelial cells proliferation and epithelial-mesenchymal transition. Toxicol Appl Pharmacol. 2021 Jan 15;411:115384. doi: 10.1016/j.taap.2020.115384. Epub 2020 Dec 25.
269 Lipid raft-dependent death receptor 5 (DR5) expression and activation are critical for ursodeoxycholic acid-induced apoptosis in gastric cancer cells. Carcinogenesis. 2011 May;32(5):723-31. doi: 10.1093/carcin/bgr038. Epub 2011 Feb 28.
270 Selenium sensitizes MCF-7 breast cancer cells to doxorubicin-induced apoptosis through modulation of phospho-Akt and its downstream substrates. Mol Cancer Ther. 2007 Mar;6(3):1031-8. doi: 10.1158/1535-7163.MCT-06-0643. Epub 2007 Mar 5.
271 Combination small molecule MEK and PI3K inhibition enhances uveal melanoma cell death in a mutant GNAQ- and GNA11-dependent manner. Clin Cancer Res. 2012 Aug 15;18(16):4345-55. doi: 10.1158/1078-0432.CCR-11-3227. Epub 2012 Jun 25.
272 Antitumor action of the MET tyrosine kinase inhibitor crizotinib (PF-02341066) in gastric cancer positive for MET amplification. Mol Cancer Ther. 2012 Jul;11(7):1557-64. doi: 10.1158/1535-7163.MCT-11-0934. Epub 2012 Jun 22.
273 Arsenic trioxide induces different gene expression profiles of genes related to growth and apoptosis in glioma cells dependent on the p53 status. Mol Biol Rep. 2008 Sep;35(3):421-9.
274 Aspirin induces apoptosis in human leukemia cells independently of NF-kappaB and MAPKs through alteration of the Mcl-1/Noxa balance. Apoptosis. 2010 Feb;15(2):219-29. doi: 10.1007/s10495-009-0424-9.
275 Chronic Nucleoside Reverse Transcriptase Inhibitors Disrupt Mitochondrial Homeostasis and Promote Premature Endothelial Senescence. Toxicol Sci. 2019 Dec 1;172(2):445-456. doi: 10.1093/toxsci/kfz203.
276 Nicotinic modulation of gene expression in SH-SY5Y neuroblastoma cells. Brain Res. 2006 Oct 20;1116(1):39-49.
277 Silibinin inhibits ethanol- or acetaldehyde-induced ferroptosis in liver cell lines. Toxicol In Vitro. 2022 Aug;82:105388. doi: 10.1016/j.tiv.2022.105388. Epub 2022 May 18.
278 Rescue of Pink1 Deficiency by Stress-Dependent Activation of Autophagy. Cell Chem Biol. 2017 Apr 20;24(4):471-480.e4. doi: 10.1016/j.chembiol.2017.03.005. Epub 2017 Mar 30.
279 Induction of parkin expression in the presence of oxidative stress. Eur J Neurosci. 2006 Sep;24(5):1366-72. doi: 10.1111/j.1460-9568.2006.04998.x.
280 Sorafenib targets the mitochondrial electron transport chain complexes and ATP synthase to activate the PINK1-Parkin pathway and modulate cellular drug response. J Biol Chem. 2017 Sep 8;292(36):15105-15120. doi: 10.1074/jbc.M117.783175. Epub 2017 Jul 3.
281 Cannabidiol promotes apoptosis via regulation of XIAP/Smac in gastric cancer. Cell Death Dis. 2019 Nov 7;10(11):846. doi: 10.1038/s41419-019-2001-7.
282 Sertraline induces endoplasmic reticulum stress in hepatic cells. Toxicology. 2014 Aug 1;322:78-88. doi: 10.1016/j.tox.2014.05.007. Epub 2014 May 24.
283 Asbestos-induced alveolar epithelial cell apoptosis. The role of endoplasmic reticulum stress response. Am J Respir Cell Mol Biol. 2013 Dec;49(6):892-901. doi: 10.1165/rcmb.2013-0053OC.
284 Drug-induced hepatic steatosis in absence of severe mitochondrial dysfunction in HepaRG cells: proof of multiple mechanism-based toxicity. Cell Biol Toxicol. 2021 Apr;37(2):151-175. doi: 10.1007/s10565-020-09537-1. Epub 2020 Jun 14.
285 Quercetin enhances apoptotic effect of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) in ovarian cancer cells through reactive oxygen species (ROS) mediated CCAAT enhancer-binding protein homologous protein (CHOP)-death receptor 5 pathway. Cancer Sci. 2014 May;105(5):520-7. doi: 10.1111/cas.12395. Epub 2014 Apr 11.
286 Pyrazinamide-induced hepatotoxicity is alleviated by 4-PBA via inhibition of the PERK-eIF2-ATF4-CHOP pathway. Toxicology. 2017 Mar 1;378:65-75. doi: 10.1016/j.tox.2017.01.002. Epub 2017 Jan 4.
287 NGBR is required to ameliorate type 2 diabetes in mice by enhancing insulin sensitivity. J Biol Chem. 2021 Jan-Jun;296:100624. doi: 10.1016/j.jbc.2021.100624. Epub 2021 Apr 2.
288 Verapamil-induced hyperprolactinemia complicated by a pituitary incidentaloma. Ann Pharmacother. 1995 Oct;29(10):999-1001. doi: 10.1177/106002809502901009.
289 [Impotence and gynecomastia secondary to hyperprolactinemia induced by ranitidine]. Therapie. 1994 Jul-Aug;49(4):361-2.
290 Differential effects of estrogen receptor antagonists on pituitary lactotroph proliferation and prolactin release. Mol Cell Endocrinol. 2005 Jul 15;239(1-2):27-36. doi: 10.1016/j.mce.2005.04.008.
291 Cholinergic modulation of the cerebral metabolic response to citalopram in Alzheimer's disease. Brain. 2009 Feb;132(Pt 2):392-401. doi: 10.1093/brain/awn326. Epub 2009 Jan 19.
292 The effect of thioridazine on prolactinoma growth in a schizophrenic man: case report. Gen Hosp Psychiatry. 1985 Oct;7(4):364-6. doi: 10.1016/0163-8343(85)90053-2.
293 Influence of naloxone on muscle sympathetic nerve activity, systemic and calf haemodynamics and ambulatory blood pressure after exercise in mild essential hypertension. J Hypertens. 1995 Apr;13(4):447-61.
294 The efficacy, safety, and tolerability of aripiprazole for the treatment of schizoaffective disorder: results from a pooled analysis of a sub-population of subjects from two randomized, double-blind, placebo-controlled, pivotal trials. J Affect Disord. 2009 May;115(1-2):18-26. doi: 10.1016/j.jad.2008.12.017. Epub 2009 Feb 23.
295 Serum prolactin levels among outpatients with major depressive disorder during the acute phase of treatment with fluoxetine. J Clin Psychiatry. 2006 Jun;67(6):952-7. doi: 10.4088/jcp.v67n0612.
296 Massive breast enlargement in a patient receiving D-penicillamine for systemic sclerosis. J Rheumatol. 1985 Oct;12(5):990-1.
297 Indomethacin and juglone inhibit inflammatory molecules to induce apoptosis in colon cancer cells. J Biochem Mol Toxicol. 2020 Feb;34(2):e22433. doi: 10.1002/jbt.22433. Epub 2020 Jan 9.
298 A cell impedance-based real-time in vitro assay to assess the toxicity of amphotericin B formulations. Toxicol Appl Pharmacol. 2017 Nov 1;334:18-23. doi: 10.1016/j.taap.2017.08.017. Epub 2017 Sep 1.
299 CBD Promotes Oral Ulcer Healing via Inhibiting CMPK2-Mediated Inflammasome. J Dent Res. 2022 Feb;101(2):206-215. doi: 10.1177/00220345211024528. Epub 2021 Jul 16.
300 Sertraline, an antidepressant, induces apoptosis in hepatic cells through the mitogen-activated protein kinase pathway. Toxicol Sci. 2014 Feb;137(2):404-15. doi: 10.1093/toxsci/kft254. Epub 2013 Nov 5.
301 Anti-inflammatory effects of the GABA(B) receptor agonist baclofen in allergic contact dermatitis. Exp Dermatol. 2010 Jul 1;19(7):661-6. doi: 10.1111/j.1600-0625.2010.01076.x. Epub 2010 Feb 25.
302 Frankincense myrrh attenuates hepatocellular carcinoma by regulating tumor blood vessel development through multiple epidermal growth factor receptor-mediated signaling pathways. World J Gastrointest Oncol. 2022 Feb 15;14(2):450-477. doi: 10.4251/wjgo.v14.i2.450.
303 Sulfasalazine unveils a contact-independent HSV-TK/ganciclovir gene therapy bystander effect in malignant gliomas. Int J Oncol. 2007 Jan;30(1):283-90.
304 Predictive toxicology using systemic biology and liver microfluidic "on chip" approaches: application to acetaminophen injury. Toxicol Appl Pharmacol. 2012 Mar 15;259(3):270-80.
305 Clinical response to Nabiximols correlates with the downregulation of immune pathways in multiple sclerosis. Eur J Neurol. 2018 Jul;25(7):934-e70. doi: 10.1111/ene.13623. Epub 2018 Apr 16.
306 BET bromodomain inhibition as a novel strategy for reactivation of HIV-1. J Leukoc Biol. 2012 Dec;92(6):1147-54. doi: 10.1189/jlb.0312165. Epub 2012 Jul 16.
307 Simvastatin protects neurons from cytotoxicity by up-regulating Bcl-2 mRNA and protein. J Neurochem. 2007 Apr;101(1):77-86. doi: 10.1111/j.1471-4159.2006.04375.x. Epub 2007 Jan 4.
308 Chelation and intercalation: complementary properties in a compound for the treatment of Alzheimer's disease. J Struct Biol. 2000 Jun;130(2-3):209-16. doi: 10.1006/jsbi.2000.4285.
309 Increased processing of APLP2 and APP with concomitant formation of APP intracellular domains in BDNF and retinoic acid-differentiated human neuroblastoma cells. J Neurochem. 2005 Nov;95(4):1059-68. doi: 10.1111/j.1471-4159.2005.03440.x. Epub 2005 Sep 7.
310 Comparison of base-line and chemical-induced transcriptomic responses in HepaRG and RPTEC/TERT1 cells using TempO-Seq. Arch Toxicol. 2018 Aug;92(8):2517-2531.
311 Synergistic effects of iron and aluminum on stress-related gene expression in primary human neural cells. J Alzheimers Dis. 2005 Nov;8(2):117-27; discussion 209-15. doi: 10.3233/jad-2005-8204.
312 High-dose mitoxantrone induces programmed cell death or apoptosis in human myeloid leukemia cells. Blood. 1993 Nov 15;82(10):3133-40.
313 Gene expression data from acetaminophen-induced toxicity in human hepatic in vitro systems and clinical liver samples. Data Brief. 2016 Mar 26;7:1052-1057. doi: 10.1016/j.dib.2016.03.069. eCollection 2016 Jun.
314 Inhibition of autophagic flux differently modulates cannabidiol-induced death in 2D and 3D glioblastoma cell cultures. Sci Rep. 2020 Feb 14;10(1):2687. doi: 10.1038/s41598-020-59468-4.
315 Nitrogen mustard prevents transport of Fra-1 into the nucleus to promote c-Fos- and FosB-dependent IL-8 induction in injured mouse epidermis. Toxicol Lett. 2020 Feb 1;319:256-263. doi: 10.1016/j.toxlet.2019.10.006. Epub 2019 Oct 19.
316 Nocodazole-induced p53-dependent c-Jun N-terminal kinase activation reduces apoptosis in human colon carcinoma HCT116 cells. J Biol Chem. 2002 Nov 15;277(46):43648-58. doi: 10.1074/jbc.M203214200. Epub 2002 Sep 6.
317 [Regulation mechanism of autophagy-related protein LC3 by c-Jun in methotrexate resistant human choriocarcinoma JEG-3 cells]. Zhonghua Fu Chan Ke Za Zhi. 2014 Jul;49(7):531-5.
318 Fanconi anemia links reactive oxygen species to insulin resistance and obesity. Antioxid Redox Signal. 2012 Oct 15;17(8):1083-98. doi: 10.1089/ars.2011.4417. Epub 2012 Jun 25.
319 [Testosterone's role in regulating expression of genes of several proliferation factors]. Tsitologiia. 2006;48(10):856-61.
320 Sulfasalazine and BAY 11-7082 interfere with the nuclear factor-kappa B and I kappa B kinase pathway to regulate the release of proinflammatory cytokines from human adipose tissue and skeletal muscle in vitro. Endocrinology. 2005 Mar;146(3):1491-7. doi: 10.1210/en.2004-0809. Epub 2004 Nov 24.
321 Methamphetamine exposure upregulates the amyloid precursor protein and hyperphosphorylated tau expression: The roles of insulin signaling in SH-SY5Y cell line. J Toxicol Sci. 2019;44(7):493-503. doi: 10.2131/jts.44.493.
322 Role of phenytoin in wound healing: microarray analysis of early transcriptional responses in human dermal fibroblasts. Biochem Biophys Res Commun. 2004 Feb 13;314(3):661-6. doi: 10.1016/j.bbrc.2003.12.146.
323 Drug-induced endoplasmic reticulum and oxidative stress responses independently sensitize toward TNF-mediated hepatotoxicity. Toxicol Sci. 2014 Jul;140(1):144-59. doi: 10.1093/toxsci/kfu072. Epub 2014 Apr 20.
324 [The discovery of an antiparkinsonian drug, zonisamide]. Rinsho Shinkeigaku. 2010 Feb;50(2):67-73. doi: 10.5692/clinicalneurol.50.67.
325 A not cytotoxic nickel concentration alters the expression of neuronal differentiation markers in NT2 cells. Neurotoxicology. 2015 Mar;47:47-53. doi: 10.1016/j.neuro.2015.01.001. Epub 2015 Jan 19.
326 Arsenic trioxide inhibits neuroblastoma growth in vivo and promotes apoptotic cell death in vitro. Biochem Biophys Res Commun. 2000 Oct 14;277(1):179-85. doi: 10.1006/bbrc.2000.3651.
327 Lovastatin induces neuronal differentiation and apoptosis of embryonal carcinoma and neuroblastoma cells: enhanced differentiation and apoptosis in combination with dbcAMP. Mol Cell Biochem. 2010 Dec;345(1-2):1-11. doi: 10.1007/s11010-010-0553-z. Epub 2010 Aug 9.
328 Mifepristone induced progesterone withdrawal reveals novel regulatory pathways in human endometrium. Mol Hum Reprod. 2007 Sep;13(9):641-54.
329 Effects of all-trans and 9-cis retinoic acid on differentiating human neural stem cells in vitro. Toxicology. 2023 Mar 15;487:153461. doi: 10.1016/j.tox.2023.153461. Epub 2023 Feb 16.
330 A DNA methyltransferase inhibitor, 5-aza-2'-deoxycytidine, exacerbates neurotoxicity and upregulates Parkinson's disease-related genes in dopaminergic neurons. CNS Neurosci Ther. 2013 Mar;19(3):183-90. doi: 10.1111/cns.12059.
331 Comparing the dopaminergic neurotoxic effects of benzylpiperazine and benzoylpiperazine. Toxicol Mech Methods. 2018 Mar;28(3):177-186. doi: 10.1080/15376516.2017.1376024. Epub 2017 Sep 28.
332 The induction of cytochrome P450 2E1 by ethanol leads to the loss of synaptic proteins via PPARalpha down-regulation. Toxicology. 2017 Jun 15;385:18-27.
333 The antiretroviral nucleoside analogue Abacavir reduces cell growth and promotes differentiation of human medulloblastoma cells. Int J Cancer. 2009 Jul 1;125(1):235-43. doi: 10.1002/ijc.24331.
334 Evidence of securin-mediated resistance to gefitinib-induced apoptosis in human cancer cells. Chem Biol Interact. 2013 Apr 25;203(2):412-22. doi: 10.1016/j.cbi.2013.03.011. Epub 2013 Mar 22.
335 Cigarette smoke and asbestos activate poly-ADP-ribose polymerase in alveolar epithelial cells. J Investig Med. 2001 Jan;49(1):68-76. doi: 10.2310/6650.2001.34092.
336 The antidepressants imipramine, clomipramine, and citalopram induce apoptosis in human acute myeloid leukemia HL-60 cells via caspase-3 activation. J Biochem Mol Toxicol. 1999;13(6):338-47. doi: 10.1002/(sici)1099-0461(1999)13:6<338::aid-jbt8>3.0.co;2-7.
337 Ciprofloxacin mediated cell growth inhibition, S/G2-M cell cycle arrest, and apoptosis in a human transitional cell carcinoma of the bladder cell line. Clin Cancer Res. 2000 Mar;6(3):891-900.
338 Investigation of molecular mechanisms underlying the antiproliferative effects of colchicine against PC3 prostate cancer cells. Toxicol In Vitro. 2021 Jun;73:105138. doi: 10.1016/j.tiv.2021.105138. Epub 2021 Mar 6.
339 Sulindac enhances adenoviral vector expressing mda-7/IL-24-mediated apoptosis in human lung cancer. Mol Cancer Ther. 2005 Feb;4(2):291-304.
340 Methotrexate induces poly(ADP-ribose) polymerase-dependent, caspase 3-independent apoptosis in subsets of proliferating CD4+ T cells. Clin Exp Immunol. 2007 May;148(2):288-95. doi: 10.1111/j.1365-2249.2007.03335.x. Epub 2007 Feb 7.
341 4.8% sevoflurane induces activation of autophagy in human neuroblastoma SH-SY5Y cells by the AMPK/mTOR signaling pathway. Neurotoxicology. 2022 May;90:256-264. doi: 10.1016/j.neuro.2022.04.008. Epub 2022 Apr 23.
342 Enhanced chemotherapeutic efficacy of docetaxel in human lung cancer cell line via GLUT1 inhibitor. J Biochem Mol Toxicol. 2023 Jun;37(6):e23348. doi: 10.1002/jbt.23348. Epub 2023 Mar 31.
343 Breast cancer cells response to the antineoplastic agents cisplatin, carboplatin, and doxorubicin at the mRNA expression levels of distinct apoptosis-related genes, including the new member, BCL2L12. Ann N Y Acad Sci. 2007 Jan;1095:35-44. doi: 10.1196/annals.1397.005.
344 Extracellular signal-regulated kinase activation and Bcl-2 downregulation mediate apoptosis after gemcitabine treatment partly via a p53-independent pathway. Eur J Pharmacol. 2004 Oct 19;502(3):169-83. doi: 10.1016/j.ejphar.2004.09.006.
345 Verapamil potentiates anti-glioblastoma efficacy of temozolomide by modulating apoptotic signaling. Toxicol In Vitro. 2018 Oct;52:306-313. doi: 10.1016/j.tiv.2018.07.001. Epub 2018 Jul 9.
346 Inhibition of caspase-dependent mitochondrial permeability transition protects airway epithelial cells against mustard-induced apoptosis. Apoptosis. 2006 Sep;11(9):1545-59. doi: 10.1007/s10495-006-8764-1.
347 -Carotene Induces Apoptosis in Human Esophageal Squamous Cell Carcinoma Cell Lines via the Cav-1/AKT/NF-B Signaling Pathway. J Biochem Mol Toxicol. 2016 Mar;30(3):148-57. doi: 10.1002/jbt.21773. Epub 2016 Jan 6.
348 Cannabidiol Modulates the Expression of Alzheimer's Disease-Related Genes in Mesenchymal Stem Cells. Int J Mol Sci. 2016 Dec 23;18(1):26. doi: 10.3390/ijms18010026.
349 The estrogen receptor influences microtubule-associated protein tau (MAPT) expression and the selective estrogen receptor inhibitor fulvestrant downregulates MAPT and increases the sensitivity to taxane in breast cancer cells. Breast Cancer Res. 2010;12(3):R43. doi: 10.1186/bcr2598. Epub 2010 Jun 28.
350 Neuroprotective effects of glucomoringin-isothiocyanate against H(2)O(2)-Induced cytotoxicity in neuroblastoma (SH-SY5Y) cells. Neurotoxicology. 2019 Dec;75:89-104. doi: 10.1016/j.neuro.2019.09.008. Epub 2019 Sep 12.
351 Pharmacologic reductions of total tau levels; implications for the role of microtubule dynamics in regulating tau expression. Mol Neurodegener. 2006 Jul 26;1:6. doi: 10.1186/1750-1326-1-6.
352 Differential effects of simvastatin and pravastatin on expression of Alzheimer's disease-related genes in human astrocytes and neuronal cells. J Lipid Res. 2009 Oct;50(10):2095-102. doi: 10.1194/jlr.M900236-JLR200. Epub 2009 May 21.
353 Identification of vitamin D3 target genes in human breast cancer tissue. J Steroid Biochem Mol Biol. 2016 Nov;164:90-97.
354 Transcriptional profiling of testosterone-regulated genes in the skeletal muscle of human immunodeficiency virus-infected men experiencing weight loss. J Clin Endocrinol Metab. 2007 Jul;92(7):2793-802. doi: 10.1210/jc.2006-2722. Epub 2007 Apr 17.
355 K-RAS transformation in prostate epithelial cell overcomes H2O2-induced apoptosis via upregulation of gamma-glutamyltransferase-2. Toxicol In Vitro. 2012 Apr;26(3):429-34. doi: 10.1016/j.tiv.2012.01.013. Epub 2012 Jan 17.
356 Consequences of the natural retinoid/retinoid X receptor ligands action in human breast cancer MDA-MB-231 cell line: Focus on functional proteomics. Toxicol Lett. 2017 Nov 5;281:26-34. doi: 10.1016/j.toxlet.2017.09.001. Epub 2017 Sep 5.
357 High-content imaging-based BAC-GFP toxicity pathway reporters to assess chemical adversity liabilities. Arch Toxicol. 2017 Mar;91(3):1367-1383. doi: 10.1007/s00204-016-1781-0. Epub 2016 Jun 29.
358 Enhanced GRP78 protein expression via the IRE1/ASK1/p38 MAPK pathway during As(2)O(3)-induced endoplasmic reticulum stress in BEAS-2B cells. Toxicology. 2021 Oct;462:152962. doi: 10.1016/j.tox.2021.152962. Epub 2021 Sep 21.
359 [Simvastatin-induced apoptosis of K562 cells is mediated by endoplasmic reticulum stress]. Yao Xue Xue Bao. 2008 Apr;43(4):371-7.
360 Chronic oxycodone induces integrated stress response in rat brain. BMC Neurosci. 2015 Sep 16;16:58. doi: 10.1186/s12868-015-0197-8.
361 Involvement of the activation of Nrf2/HO-1, p38 MAPK signaling pathways and endoplasmic reticulum stress in furazolidone induced cytotoxicity and S phase arrest in human hepatocyte L02 cells: modulation of curcumin. Toxicol Mech Methods. 2017 Mar;27(3):165-172. doi: 10.1080/15376516.2016.1273424. Epub 2017 Jan 8.
362 Association between treatment-emergent suicidal ideation with citalopram and polymorphisms near cyclic adenosine monophosphate response element binding protein in the STAR*D study. Arch Gen Psychiatry. 2007 Jun;64(6):689-97. doi: 10.1001/archpsyc.64.6.689.
363 Cannabidiol upregulates melanogenesis through CB1 dependent pathway by activating p38 MAPK and p42/44 MAPK. Chem Biol Interact. 2017 Aug 1;273:107-114. doi: 10.1016/j.cbi.2017.06.005. Epub 2017 Jun 7.
364 Distinct genetic profile in peripheral blood mononuclear cells of psoriatic arthritis patients treated with methotrexate and TNF-inhibitors. Clin Rheumatol. 2014 Dec;33(12):1815-21. doi: 10.1007/s10067-014-2807-8. Epub 2014 Oct 24.
365 Peroxisome proliferator-activated receptor-gamma ligands suppress fibronectin gene expression in human lung carcinoma cells: involvement of both CRE and Sp1. Am J Physiol Lung Cell Mol Physiol. 2005 Sep;289(3):L419-28. doi: 10.1152/ajplung.00002.2005. Epub 2005 May 20.
366 Nonclassical action of retinoic acid on the activation of the cAMP response element-binding protein in normal human bronchial epithelial cells. Mol Biol Cell. 2006 Feb;17(2):566-75. doi: 10.1091/mbc.e05-06-0519. Epub 2005 Nov 9.
367 p38 MAPK/PP2Ac/TTP pathway on the connection of TNF- and caspases activation on hydroquinone-induced apoptosis. Carcinogenesis. 2013 Apr;34(4):818-27. doi: 10.1093/carcin/bgs409. Epub 2013 Jan 3.
368 Glycyrrhizin attenuates histamine-mediated MUC5AC upregulation, inflammatory cytokine production, and aquaporin 5 downregulation through suppressing the NF-B pathway in human nasal epithelial cells. Chem Biol Interact. 2018 Apr 1;285:21-26. doi: 10.1016/j.cbi.2018.02.010. Epub 2018 Feb 13.
369 Activation of ERK1/2 by protein kinase C-alpha in response to hydrogen peroxide-induced cell death in human gingival fibroblasts. Toxicol In Vitro. 2010 Feb;24(1):319-26. doi: 10.1016/j.tiv.2009.08.007. Epub 2009 Aug 21.
370 Anticarcinogenic action of quercetin by downregulation of phosphatidylinositol 3-kinase (PI3K) and protein kinase C (PKC) via induction of p53 in hepatocellular carcinoma (HepG2) cell line. Mol Biol Rep. 2015 Sep;42(9):1419-29. doi: 10.1007/s11033-015-3921-7. Epub 2015 Aug 27.
371 Genomic and proteomic analysis of the effects of cannabinoids on normal human astrocytes. Brain Res. 2008 Jan 29;1191:1-11.
372 The vanilloid capsaicin induces IL-6 secretion in prostate PC-3 cancer cells. Cytokine. 2011 Jun;54(3):330-7. doi: 10.1016/j.cyto.2011.03.010. Epub 2011 Apr 6.
373 Amiodarone sensitizes human glioma cells but not astrocytes to TRAIL-induced apoptosis via CHOP-mediated DR5 upregulation. Neuro Oncol. 2011 Mar;13(3):267-79. doi: 10.1093/neuonc/noq195. Epub 2011 Feb 3.
374 Robustness testing and optimization of an adverse outcome pathway on cholestatic liver injury. Arch Toxicol. 2020 Apr;94(4):1151-1172. doi: 10.1007/s00204-020-02691-9. Epub 2020 Mar 10.
375 Rifampicin-induced injury in L02 cells is alleviated by 4-PBA via inhibition of the PERK-ATF4-CHOP pathway. Toxicol In Vitro. 2016 Oct;36:186-196. doi: 10.1016/j.tiv.2016.07.017. Epub 2016 Jul 26.
376 Combination of arsenic trioxide and Dasatinib: a new strategy to treat Philadelphia chromosome-positive acute lymphoblastic leukaemia. J Cell Mol Med. 2018 Mar;22(3):1614-1626.
377 Glucosamine-induced endoplasmic reticulum stress attenuates apolipoprotein B100 synthesis via PERK signaling. J Lipid Res. 2009 Sep;50(9):1814-23. doi: 10.1194/jlr.M800343-JLR200. Epub 2009 Apr 21.
378 Arsenic trioxide initiates ER stress responses, perturbs calcium signalling and promotes apoptosis in human lens epithelial cells. Exp Eye Res. 2007 Dec;85(6):825-35. doi: 10.1016/j.exer.2007.08.018. Epub 2007 Aug 29.
379 Hydroquinone-induced endoplasmic reticulum stress affects TK6 cell autophagy and apoptosis via ATF6-mTOR. Environ Toxicol. 2023 Aug;38(8):1874-1890. doi: 10.1002/tox.23814. Epub 2023 May 6.
380 Cardiac toxicity of high-dose cyclophosphamide in patients with multiple myeloma undergoing autologous hematopoietic stem cell transplantation. Int J Hematol. 2007 Jun;85(5):408-14. doi: 10.1532/IJH97.E0620.
381 An unexpected increase of troponin I after perphenazine depot injection. Ann Pharmacother. 2004 Feb;38(2):353-4. doi: 10.1345/aph.1D234. Epub 2003 Dec 23.
382 Cardiac toxicity of high-dose cyclophosphamide and melphalan in patients with multiple myeloma treated with tandem autologous hematopoietic stem cell transplantation. Int J Hematol. 2008 Sep;88(2):227-236. doi: 10.1007/s12185-008-0112-5. Epub 2008 Jun 12.
383 Utility of troponin I in patients with cocaine-associated chest pain. Acad Emerg Med. 2002 Oct;9(10):1007-13. doi: 10.1111/j.1553-2712.2002.tb02134.x.
384 Dexamethasone and the inflammatory response in explants of human omental adipose tissue. Mol Cell Endocrinol. 2010 Feb 5;315(1-2):292-8.
385 Identification of genes linked to gefitinib treatment in prostate cancer cell lines with or without resistance to androgen: a clue to application of gefitinib to hormone-resistant prostate cancer. Oncol Rep. 2006 Jun;15(6):1453-60.
386 The thioredoxin system mediates redox-induced cell death in human colon cancer cells: implications for the mechanism of action of anticancer agents. Cancer Res. 2008 Oct 15;68(20):8269-77. doi: 10.1158/0008-5472.CAN-08-2010.
387 Response rate of fibrosarcoma cells to cytotoxic drugs on the expression level correlates to the therapeutic response rate of fibrosarcomas and is mediated by regulation of apoptotic pathways. BMC Cancer. 2005 Jul 7;5:74. doi: 10.1186/1471-2407-5-74.
388 Suppression of RAGE as a basis of simvastatin-dependent plaque stabilization in type 2 diabetes. Arterioscler Thromb Vasc Biol. 2006 Dec;26(12):2716-23.
389 Profiling 976 ToxCast chemicals across 331 enzymatic and receptor signaling assays. Chem Res Toxicol. 2013 Jun 17;26(6):878-95.
390 Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects. Arch Gen Psychiatry. 1992 Jul;49(7):538-44. doi: 10.1001/archpsyc.1992.01820070032005.
391 Pergolide is an inhibitor of voltage-gated potassium channels, including Kv1.5, and causes pulmonary vasoconstriction. Circulation. 2005 Sep 6;112(10):1494-9. doi: 10.1161/CIRCULATIONAHA.105.556704. Epub 2005 Aug 29.
392 Dopamine-mediated inhibition of renal Na+/K+-ATPase in HK-2 cells is reduced by ouabain. Clin Exp Pharmacol Physiol. 2010 May;37(5-6):613-8. doi: 10.1111/j.1440-1681.2010.05364.x. Epub 2010 Feb 4.
393 Characterizing fucoxanthin as a selective dopamine D(3)/D(4) receptor agonist: Relevance to Parkinson's disease. Chem Biol Interact. 2019 Sep 1;310:108757. doi: 10.1016/j.cbi.2019.108757. Epub 2019 Jul 16.
394 Association study of four dopamine D1 receptor gene polymorphisms and clozapine treatment response. J Psychopharmacol. 2007 Sep;21(7):718-27. doi: 10.1177/0269881106072341. Epub 2006 Nov 8.
395 Characterization of the potent, selective Nrf2 activator, 3-(pyridin-3-ylsulfonyl)-5-(trifluoromethyl)-2H-chromen-2-one, in cellular and in vivo models of pulmonary oxidative stress. J Pharmacol Exp Ther. 2017 Oct;363(1):114-125.
396 Fructose modulates GLUT5 mRNA stability in differentiated Caco-2 cells: role of cAMP-signalling pathway and PABP (polyadenylated-binding protein)-interacting protein (Paip) 2. Biochem J. 2003 Oct 1;375(Pt 1):167-74. doi: 10.1042/BJ20030661.
397 In vitro study of transporters involved in intestinal absorption of inorganic arsenic. Chem Res Toxicol. 2012 Feb 20;25(2):446-53. doi: 10.1021/tx200491f. Epub 2012 Jan 26.
398 Large-scale in silico and microarray-based identification of direct 1,25-dihydroxyvitamin D3 target genes. Mol Endocrinol. 2005 Nov;19(11):2685-95.
399 Peroxisome proliferator activated receptor gamma (PPAR-gama) ligand pioglitazone regulated gene networks in term human primary trophoblast cells. Reprod Toxicol. 2018 Oct;81:99-107.
400 Effects of different antipsychotics and the antidepressant mirtazapine on glucose transporter mRNA levels in human blood cells. J Psychiatr Res. 2006 Jun;40(4):374-9. doi: 10.1016/j.jpsychires.2005.04.016. Epub 2005 Jul 5.
401 Neurokinin-1 receptor (NK1R) inhibition sensitizes APL cells to anti-tumor effect of arsenic trioxide via restriction of NF-B axis: Shedding new light on resistance to Aprepitant. Int J Biochem Cell Biol. 2018 Oct;103:105-114. doi: 10.1016/j.biocel.2018.08.010. Epub 2018 Aug 23.
402 ERE-independent ERalpha target genes differentially expressed in human breast tumors. Mol Cell Endocrinol. 2005 Dec 21;245(1-2):53-9. doi: 10.1016/j.mce.2005.10.003. Epub 2005 Nov 17.
403 Microtubules are required for NF-kappaB nuclear translocation in neuroblastoma IMR-32 cells: modulation by zinc. J Neurochem. 2006 Oct;99(2):402-15. doi: 10.1111/j.1471-4159.2006.04005.x.
404 Protein phosphatase 2A interacts with and directly dephosphorylates RelA. J Biol Chem. 2001 Dec 21;276(51):47828-33. doi: 10.1074/jbc.M106103200. Epub 2001 Oct 8.
405 Activation of nuclear factor-kappa B pathway by simvastatin and RhoA silencing increases doxorubicin cytotoxicity in human colon cancer HT29 cells. Mol Pharmacol. 2008 Aug;74(2):476-84.
406 Prevention of deoxycholate-induced gastric apoptosis by aspirin: roles of NF-kappaB and PKC signaling. J Surg Res. 2008 Mar;145(1):66-73. doi: 10.1016/j.jss.2007.04.039. Epub 2007 Jul 20.
407 Treatment with anticancer agents induces dysregulation of specific Wnt signaling pathways in human ovarian luteinized granulosa cells in vitro. Toxicol Sci. 2013 Nov;136(1):183-92. doi: 10.1093/toxsci/kft175. Epub 2013 Aug 16.
408 Progesterone increases csk homologous kinase in HMC-1560 human mast cells and reduces cell proliferation. J Cell Biochem. 2007 Dec 1;102(5):1271-80. doi: 10.1002/jcb.21357.
409 Growth stimulation of human pulmonary adenocarcinoma cells and small airway epithelial cells by beta-carotene via activation of cAMP, PKA, CREB and ERK1/2. Int J Cancer. 2006 Mar 15;118(6):1370-80. doi: 10.1002/ijc.21537.
410 Estrogen and pure antiestrogen fulvestrant (ICI 182 780) augment cell-matrigel adhesion of MCF-7 breast cancer cells through a novel G protein coupled estrogen receptor (GPR30)-to-calpain signaling axis. Toxicol Appl Pharmacol. 2014 Mar 1;275(2):176-81. doi: 10.1016/j.taap.2014.01.005. Epub 2014 Jan 17.
411 Inhibition of activator protein 1 by barbiturates is mediated by differential effects on mitogen-activated protein kinases and the small G proteins ras and rac-1. J Pharmacol Exp Ther. 2004 Dec;311(3):1232-40. doi: 10.1124/jpet.104.071332. Epub 2004 Jul 19.
412 Growth of hormone-dependent MCF-7 breast cancer cells is promoted by constitutive caveolin-1 whose expression is lost in an EGF-R-mediated manner during development of tamoxifen resistance. Breast Cancer Res Treat. 2010 Feb;119(3):575-91. doi: 10.1007/s10549-009-0355-8. Epub 2009 Mar 15.
413 Effect of histamine H1 receptor antagonists on TARC/CCL17 and MDC/CCL22 production from CD14+ cells induced by antigenic stimulation in vitro. Int Arch Allergy Immunol. 2011;155(1):38-51. doi: 10.1159/000318720. Epub 2010 Nov 25.
414 SIRT3 Mediates the Antioxidant Effect of Hydrogen Sulfide in Endothelial Cells. Antioxid Redox Signal. 2016 Feb 20;24(6):329-43. doi: 10.1089/ars.2015.6331. Epub 2015 Nov 10.
415 Effect of Kangshuai Yizhi Formula I on learning and memory dysfunction induced by scopolamine in mice. Chin J Integr Med. 2010 Jun;16(3):252-7.
416 Environmental pollutant induced cellular injury is reflected in exosomes from placental explants. Placenta. 2020 Jan 1;89:42-49. doi: 10.1016/j.placenta.2019.10.008. Epub 2019 Oct 17.
417 Preferential induction of the AhR gene battery in HepaRG cells after a single or repeated exposure to heterocyclic aromatic amines. Toxicol Appl Pharmacol. 2010 Nov 15;249(1):91-100.
418 Effects of oleamide on choline acetyltransferase and cognitive activities. Biosci Biotechnol Biochem. 2003 Jun;67(6):1284-91.
419 Downregulation of mitogen-activated protein kinases (MAPKs) in chronic ethanol-induced fatty liver. Toxicol Mech Methods. 2020 Jul;30(6):407-416. doi: 10.1080/15376516.2020.1747126. Epub 2020 Apr 1.
420 A unique mechanism of beta-blocker action: carvedilol stimulates beta-arrestin signaling. Proc Natl Acad Sci U S A. 2007 Oct 16;104(42):16657-62. doi: 10.1073/pnas.0707936104. Epub 2007 Oct 9.
421 The stent-eluting drugs sirolimus and paclitaxel suppress healing of the endothelium by induction of autophagy. Am J Pathol. 2009 Nov;175(5):2226-34.
422 Modulation of apoptosis in HaCaT keratinocytes via differential regulation of ERK signaling pathway by flavonoids. J Biol Chem. 2005 Sep 9;280(36):31498-507. doi: 10.1074/jbc.M505537200. Epub 2005 Jul 13.
423 Serotonin transporter mRNA expression in peripheral leukocytes of patients with major depression before and after treatment with paroxetine. Neurosci Lett. 2005 Nov 25;389(1):12-6. doi: 10.1016/j.neulet.2005.06.048.
424 Age-dependent antidepressant pharmacogenomics: polymorphisms of the serotonin transporter and G protein beta3 subunit as predictors of response to fluoxetine and nortriptyline. Int J Neuropsychopharmacol. 2003 Dec;6(4):339-46. doi: 10.1017/S1461145703003663.
425 Serotonin transporter mRNA expression is decreased by lamivudine and ribavirin and increased by interferon in immune cells. Scand J Immunol. 2006 Feb;63(2):106-15. doi: 10.1111/j.1365-3083.2005.01715.x.
426 Establishment of a 13 genes-based molecular prediction score model to discriminate the neurotoxic potential of food relevant-chemicals. Toxicol Lett. 2022 Feb 1;355:1-18. doi: 10.1016/j.toxlet.2021.10.013. Epub 2021 Nov 5.
427 Cholesterol-lowering therapy evokes time-limited changes in serotonergic transmission. Psychiatry Res. 2005 Feb 28;133(2-3):197-203. doi: 10.1016/j.psychres.2004.11.005.
428 Design and synthesis of novel arylpiperazine derivatives containing the imidazole core targeting 5-HT(2A) receptor and 5-HT transporter. J Med Chem. 2011 Sep 22;54(18):6305-18. doi: 10.1021/jm200682b. Epub 2011 Aug 23.
429 The acute EPS of haloperidol may be unrelated to its metabolic transformation to BCPP+. Bioorg Med Chem Lett. 2003 Nov 3;13(21):3779-82. doi: 10.1016/j.bmcl.2003.07.015.
430 Effect of dopamine D3 receptor gene polymorphisms and clozapine treatment response: exploratory analysis of nine polymorphisms and meta-analysis of the Ser9Gly variant. Pharmacogenomics J. 2010 Jun;10(3):200-18. doi: 10.1038/tpj.2009.65. Epub 2009 Dec 22.
431 A common variant in DRD3 gene is associated with risperidone-induced extrapyramidal symptoms. Pharmacogenomics J. 2009 Dec;9(6):404-10. doi: 10.1038/tpj.2009.26. Epub 2009 Jun 9.
432 Folic acid supplementation dysregulates gene expression in lymphoblastoid cells--implications in nutrition. Biochem Biophys Res Commun. 2011 Sep 9;412(4):688-92. doi: 10.1016/j.bbrc.2011.08.027. Epub 2011 Aug 16.
433 Lower level of endogenous dopamine in patients with cocaine dependence: findings from PET imaging of D(2)/D(3) receptors following acute dopamine depletion. Am J Psychiatry. 2009 Oct;166(10):1170-7. doi: 10.1176/appi.ajp.2009.08121801. Epub 2009 Sep 1.
434 Estrogen regulation in human breast cancer cells of new downstream gene targets involved in estrogen metabolism, cell proliferation and cell transformation. J Mol Endocrinol. 2004 Apr;32(2):397-414.
435 Effects of testosterone and metformin on glucose metabolism in endometrium. Fertil Steril. 2010 May 1;93(7):2295-8. doi: 10.1016/j.fertnstert.2009.01.096. Epub 2009 Mar 27.
436 Induction of CCAAT/enhancer-binding protein-homologous protein by cigarette smoke through the superoxide anion-triggered PERK-eIF2 pathway. Toxicology. 2011 Sep 5;287(1-3):105-12. doi: 10.1016/j.tox.2011.06.005. Epub 2011 Jun 15.
437 Utilization of causal reasoning of hepatic gene expression in rats to identify molecular pathways of idiosyncratic drug-induced liver injury. Toxicol Sci. 2014 Jan;137(1):234-48. doi: 10.1093/toxsci/kft232. Epub 2013 Oct 17.
438 eIF4E is a critical regulator of human papillomavirus (HPV)-immortalized cervical epithelial (H8) cell growth induced by nicotine. Toxicology. 2019 May 1;419:1-10. doi: 10.1016/j.tox.2019.02.017. Epub 2019 Mar 2.
439 Transcriptomic Analysis of Stem Cells Treated with Moringin or Cannabidiol: Analogies and Differences in Inflammation Pathways. Int J Mol Sci. 2019 Nov 30;20(23):6039. doi: 10.3390/ijms20236039.
440 Antidepressant drug sertraline modulates AMPK-MTOR signaling-mediated autophagy via targeting mitochondrial VDAC1 protein. Autophagy. 2021 Oct;17(10):2783-2799. doi: 10.1080/15548627.2020.1841953. Epub 2020 Nov 9.
441 EGFR tyrosine kinase inhibitors activate autophagy as a cytoprotective response in human lung cancer cells. PLoS One. 2011;6(6):e18691. doi: 10.1371/journal.pone.0018691. Epub 2011 Jun 2.
442 Repression of Kisspeptin1 weakens hydrogen peroxide-caused injury in HTR8 cells via adjusting PI3K/AKT/mTOR pathway. J Biochem Mol Toxicol. 2020 May;34(5):e22461. doi: 10.1002/jbt.22461. Epub 2020 Feb 11.
443 Ribavirin augments doxorubicin's efficacy in human hepatocellular carcinoma through inhibiting doxorubicin-induced eIF4E activation. J Biochem Mol Toxicol. 2018 Jan;32(1). doi: 10.1002/jbt.22007. Epub 2017 Nov 7.
444 Quercetin inhibits angiogenesis mediated human prostate tumor growth by targeting VEGFR- 2 regulated AKT/mTOR/P70S6K signaling pathways. PLoS One. 2012;7(10):e47516. doi: 10.1371/journal.pone.0047516. Epub 2012 Oct 18.
445 A comprehensive analysis of Wnt/beta-catenin signaling pathway-related genes and crosstalk pathways in the treatment of As2O3 in renal cancer. Ren Fail. 2018 Nov;40(1):331-339.
446 Different apoptosis ratios and gene expressions in two human cell lines after sevoflurane anaesthesia. Acta Anaesthesiol Scand. 2009 Oct;53(9):1192-9. doi: 10.1111/j.1399-6576.2009.02036.x. Epub 2009 Jun 30.
447 [Mechanisms underlying the effect of arsenic trioxide on proliferation inhibition and apoptosis induction in myeloma cell line u266]. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2007 Oct;15(5):982-5.
448 Lovastatin lactone elicits human lung cancer cell apoptosis via a COX-2/PPAR-dependent pathway. Oncotarget. 2016 Mar 1;7(9):10345-62. doi: 10.18632/oncotarget.7213.
449 Induction of apoptosis by cidofovir in human papillomavirus (HPV)-positive cells. Oncol Res. 2000;12(9-10):397-408. doi: 10.3727/096504001108747855.
450 Comparison of burst of reactive oxygen species and activation of caspase-3 in apoptosis of K562 and HL-60 cells induced by docetaxel. Cancer Lett. 2004 Oct 8;214(1):103-13. doi: 10.1016/j.canlet.2004.03.047.
451 Induction of mitochondrial manganese superoxide dismutase confers resistance to apoptosis in acute myeloblastic leukaemia cells exposed to etoposide. Br J Haematol. 2000 Mar;108(3):574-81. doi: 10.1046/j.1365-2141.2000.01852.x.
452 Cisplatin-enhanced sensitivity of glioblastoma multiforme U251 cells to adenovirus-delivered TRAIL in vitro. Tumour Biol. 2010 Dec;31(6):613-22. doi: 10.1007/s13277-010-0077-x. Epub 2010 Jul 11.
453 Insulin-like growth factor I is the key growth factor in serum that protects neuroblastoma cells from hyperosmotic-induced apoptosis. J Cell Physiol. 2000 Jan;182(1):24-32. doi: 10.1002/(SICI)1097-4652(200001)182:1<24::AID-JCP3>3.0.CO;2-6.
454 mRNA expression analysis of a variety of apoptosis-related genes, including the novel gene of the BCL2-family, BCL2L12, in HL-60 leukemia cells after treatment with carboplatin and doxorubicin. Biol Chem. 2004 Nov;385(11):1099-103. doi: 10.1515/BC.2004.143.
455 The Bromodomain Inhibitor JQ1 and the Histone Deacetylase Inhibitor Panobinostat Synergistically Reduce N-Myc Expression and Induce Anticancer Effects. Clin Cancer Res. 2016 May 15;22(10):2534-44. doi: 10.1158/1078-0432.CCR-15-1666. Epub 2016 Jan 5.
456 Inhibition of prostate cancer cell colony formation by the flavonoid quercetin correlates with modulation of specific regulatory genes. Clin Diagn Lab Immunol. 2004 Jan;11(1):63-9. doi: 10.1128/cdli.11.1.63-69.2004.
457 Rosiglitazone, an Agonist of PPARgamma, Inhibits Non-Small Cell Carcinoma Cell Proliferation In Part through Activation of Tumor Sclerosis Complex-2. PPAR Res. 2007;2007:29632. doi: 10.1155/2007/29632.
458 Mechanism of cisplatin proximal tubule toxicity revealed by integrating transcriptomics, proteomics, metabolomics and biokinetics. Toxicol In Vitro. 2015 Dec 25;30(1 Pt A):117-27.
459 Aberrant expression of TSC2 gene in the newly diagnosed acute leukemia. Leuk Res. 2009 Jul;33(7):891-7. doi: 10.1016/j.leukres.2009.01.041. Epub 2009 Feb 27.
460 Impact of quercetin and EGCG on key elements of the Wnt pathway in human colon carcinoma cells. J Agric Food Chem. 2006 Sep 20;54(19):7075-82. doi: 10.1021/jf0612530.
461 GSK3, snail, and adhesion molecule regulation by cyclosporine A in renal tubular cells. Toxicol Sci. 2012 Jun;127(2):425-37. doi: 10.1093/toxsci/kfs108. Epub 2012 Mar 12.
462 Increased galectin-3 facilitates leukemia cell survival from apoptotic stimuli. Biochem Biophys Res Commun. 2011 Aug 26;412(2):334-40. doi: 10.1016/j.bbrc.2011.07.099. Epub 2011 Jul 29.
463 Resveratrol modulates the phosphoinositide 3-kinase pathway through an estrogen receptor alpha-dependent mechanism: relevance in cell proliferation. Int J Cancer. 2004 Mar 20;109(2):167-73. doi: 10.1002/ijc.11720.
464 Induction of apoptosis in human leukemia cells by the tyrosine kinase inhibitor adaphostin proceeds through a RAF-1/MEK/ERK- and AKT-dependent process. Oncogene. 2004 Feb 19;23(7):1364-76. doi: 10.1038/sj.onc.1207248.
465 Effects and mechanisms of betulinic acid on improving EGFR TKI-resistance of lung cancer cells. Environ Toxicol. 2018 Nov;33(11):1153-1159.
466 The protective effects of liraglutide on AD-like neurodegeneration induced by oxidative stress in human neuroblastoma SH-SY5Y cells. Chem Biol Interact. 2019 Sep 1;310:108688. doi: 10.1016/j.cbi.2019.06.001. Epub 2019 Jun 4.
467 Dysregulation of integrin-linked kinase (ILK) signaling in colonic polyposis. Oncogene. 2001 Sep 27;20(43):6250-7. doi: 10.1038/sj.onc.1204791.
468 Suppression of NF-kappaB and GSK-3beta is involved in colon cancer cell growth inhibition by the PPAR agonist troglitazone. Chem Biol Interact. 2010 Oct 6;188(1):75-85. doi: 10.1016/j.cbi.2010.06.001. Epub 2010 Jun 9.
469 Death receptor 5 regulation during selenium-mediated apoptosis in human prostate cancer cells. Cancer Biol Ther. 2002 May-Jun;1(3):287-90. doi: 10.4161/cbt.83.
470 Combination of Poly I:C and arsenic trioxide triggers apoptosis synergistically via activation of TLR3 and mitochondrial pathways in hepatocellular carcinoma cells. Cell Biol Int. 2011 Aug;35(8):803-10. doi: 10.1042/CBI20100739.
471 Role of mitochondria in aspirin-induced apoptosis in human gastric epithelial cells. Am J Physiol Gastrointest Liver Physiol. 2005 Oct;289(4):G731-8. doi: 10.1152/ajpgi.00150.2005. Epub 2005 Jun 23.
472 Cannabidiol Activates Neuronal Precursor Genes in Human Gingival Mesenchymal Stromal Cells. J Cell Biochem. 2017 Jun;118(6):1531-1546. doi: 10.1002/jcb.25815. Epub 2016 Dec 29.
473 Genistein-induced neuronal differentiation is associated with activation of extracellular signal-regulated kinases and upregulation of p21 and N-cadherin. J Cell Biochem. 2005 Dec 1;96(5):1061-70. doi: 10.1002/jcb.20626.
474 Analysis of gene expression induced by diethylstilbestrol (DES) in human primitive Mullerian duct cells using microarray. Cancer Lett. 2005 Apr 8;220(2):197-210.
475 Differential gene expression of sulindac-treated human breast epithelial cells. Int J Oncol. 2005 Dec;27(6):1727-36.
476 Peroxisome proliferator-activated receptor-gamma agonists inhibit respiratory syncytial virus-induced expression of intercellular adhesion molecule-1 in human lung epithelial cells. Immunology. 2007 May;121(1):71-81. doi: 10.1111/j.1365-2567.2006.02539.x.
477 Glucosamine regulation of LPS-mediated inflammation in human bronchial epithelial cells. Eur J Pharmacol. 2010 Jun 10;635(1-3):219-26. doi: 10.1016/j.ejphar.2010.02.044. Epub 2010 Mar 20.
478 Effects of gonadotrophin-releasing hormone agonists on apoptosis of granulosa cells. Ann N Y Acad Sci. 2005 May;1042:531-7. doi: 10.1196/annals.1338.065.
479 BMN 673 (talazoparib): A potent PARP inhibitor for triple negative breast cancer with different genetic profile. J Biochem Mol Toxicol. 2019 May;33(5):e22286. doi: 10.1002/jbt.22286. Epub 2019 Jan 23.
480 Combining kallistatin gene therapy and meloxicam to treat hepatocellular carcinoma in mice. Cancer Sci. 2009 Nov;100(11):2226-33. doi: 10.1111/j.1349-7006.2009.01306.x. Epub 2009 Aug 4.
481 Role of miRNA in the regulation of cannabidiol-mediated apoptosis in neuroblastoma cells. Oncotarget. 2019 Jan 1;10(1):45-59. doi: 10.18632/oncotarget.26534. eCollection 2019 Jan 1.
482 Expression of the retinoic acid-metabolizing enzyme CYP26A1 limits programmed cell death. Mol Pharmacol. 2005 May;67(5):1808-17. doi: 10.1124/mol.104.005769. Epub 2005 Feb 9.
483 Role of BAX in the apoptotic response to anticancer agents. Science. 2000 Nov 3;290(5493):989-92. doi: 10.1126/science.290.5493.989.
484 Functional gene expression profile underlying methotrexate-induced senescence in human colon cancer cells. Tumour Biol. 2011 Oct;32(5):965-76.
485 Mechanisms of thymidine kinase/ganciclovir and cytosine deaminase/ 5-fluorocytosine suicide gene therapy-induced cell death in glioma cells. Oncogene. 2005 Feb 10;24(7):1231-43. doi: 10.1038/sj.onc.1208290.
486 Simvastatin induces apoptosis in human colon cancer cells and in tumor xenografts, and attenuates colitis-associated colon cancer in mice. Int J Cancer. 2008 Aug 15;123(4):951-7. doi: 10.1002/ijc.23593.
487 Calcipotriol induces autophagy in HeLa cells and keratinocytes. J Invest Dermatol. 2011 Apr;131(4):990-3. doi: 10.1038/jid.2010.423. Epub 2011 Jan 13.
488 Multitarget effects of quercetin in leukemia. Cancer Prev Res (Phila). 2014 Dec;7(12):1240-50. doi: 10.1158/1940-6207.CAPR-13-0383. Epub 2014 Oct 7.
489 The antidepressants maprotiline and fluoxetine induce Type II autophagic cell death in drug-resistant Burkitt's lymphoma. Int J Cancer. 2011 Apr 1;128(7):1712-23. doi: 10.1002/ijc.25477. Epub 2010 May 25.
490 Autophagy contributes to 4-Amino-2-Trifluoromethyl-Phenyl Retinate-induced differentiation in human acute promyelocytic leukemia NB4 cells. Toxicol Appl Pharmacol. 2017 Mar 15;319:1-11. doi: 10.1016/j.taap.2017.01.016. Epub 2017 Jan 25.
491 Antitumor effect of arsenic trioxide in human K562 and K562/ADM cells by autophagy. Toxicol Mech Methods. 2012 Sep;22(7):512-9. doi: 10.3109/15376516.2012.686534. Epub 2012 May 22.
492 Inhibition of autophagy enhances Hydroquinone-induced TK6 cell death. Toxicol In Vitro. 2017 Jun;41:123-132. doi: 10.1016/j.tiv.2017.02.024. Epub 2017 Mar 2.
493 Imatinib disturbs lysosomal function and morphology and impairs the activity of mTORC1 in human hepatocyte cell lines. Food Chem Toxicol. 2022 Apr;162:112869. doi: 10.1016/j.fct.2022.112869. Epub 2022 Feb 16.
494 Increased expression of VDAC1 sensitizes carcinoma cells to apoptosis induced by DNA cross-linking agents. Biochem Pharmacol. 2012 May 1;83(9):1172-82. doi: 10.1016/j.bcp.2012.01.017. Epub 2012 Jan 21.
495 Sulindac-derived reactive oxygen species induce apoptosis of human multiple myeloma cells via p38 mitogen activated protein kinase-induced mitochondrial dysfunction. Apoptosis. 2007 Jan;12(1):195-209. doi: 10.1007/s10495-006-0527-5.
496 Inhibition of lung cancer cell growth by quercetin glucuronides via G2/M arrest and induction of apoptosis. Drug Metab Dispos. 2006 Feb;34(2):296-304. doi: 10.1124/dmd.105.005280. Epub 2005 Nov 9.
497 Levamisole induced apoptosis in cultured vascular endothelial cells. Br J Pharmacol. 2000 Dec;131(8):1577-83.
498 Arsenic trioxide (As(2)O(3)) induced apoptosis and its mechanisms in a human esophageal squamous carcinoma cell line. Chin Med J (Engl). 2002 Feb;115(2):280-5.
499 Non-steroidal anti-inflammatory drugs induce apoptosis in gastric cancer cells through up-regulation of bax and bak. Carcinogenesis. 2001 Sep;22(9):1393-7. doi: 10.1093/carcin/22.9.1393.
500 AMPK activation induced by promethazine increases NOXA expression and Beclin-1 phosphorylation and drives autophagy-associated apoptosis in chronic myeloid leukemia. Chem Biol Interact. 2020 Jan 5;315:108888. doi: 10.1016/j.cbi.2019.108888. Epub 2019 Nov 2.
501 Endoplasmic reticulum stress contributes to arsenic trioxide-induced apoptosis in drug-sensitive and -resistant leukemia cells. Leuk Res. 2012 Dec;36(12):1526-35. doi: 10.1016/j.leukres.2012.08.018. Epub 2012 Sep 7.
502 The resveratrol attenuates ethanol-induced hepatocyte apoptosis via inhibiting ER-related caspase-12 activation and PDE activity in vitro. Alcohol Clin Exp Res. 2014 Mar;38(3):683-93. doi: 10.1111/acer.12311. Epub 2013 Nov 13.
503 Silencing of Hsp27 and Hsp72 in glioma cells as a tool for programmed cell death induction upon temozolomide and quercetin treatment. Toxicol Appl Pharmacol. 2013 Dec 15;273(3):580-9. doi: 10.1016/j.taap.2013.10.003. Epub 2013 Oct 12.
504 Combination of all-trans retinoic acid and taxol regressed glioblastoma T98G xenografts in nude mice. Apoptosis. 2007 Nov;12(11):2077-87. doi: 10.1007/s10495-007-0116-2. Epub 2007 Aug 16.
505 Resveratrol induced ER expansion and ER caspase-mediated apoptosis in human nasopharyngeal carcinoma cells. Apoptosis. 2014 Mar;19(3):527-41. doi: 10.1007/s10495-013-0945-0.
506 Thymoquinone induces apoptosis in bladder cancer cell via endoplasmic reticulum stress-dependent mitochondrial pathway. Chem Biol Interact. 2018 Aug 25;292:65-75. doi: 10.1016/j.cbi.2018.06.013. Epub 2018 Jul 2.
507 Tetrandrine induces programmed cell death in human oral cancer CAL 27 cells through the reactive oxygen species production and caspase-dependent pathways and associated with beclin-1-induced cell autophagy. Environ Toxicol. 2017 Jan;32(1):329-343. doi: 10.1002/tox.22238. Epub 2016 Jan 29.
508 Fisetin-induced apoptosis of human oral cancer SCC-4 cells through reactive oxygen species production, endoplasmic reticulum stress, caspase-, and mitochondria-dependent signaling pathways. Environ Toxicol. 2017 Jun;32(6):1725-1741. doi: 10.1002/tox.22396. Epub 2017 Feb 9.
509 Methotrexate induces apoptosis through p53/p21-dependent pathway and increases E-cadherin expression through downregulation of HDAC/EZH2. Biochem Pharmacol. 2011 Feb 15;81(4):510-7. doi: 10.1016/j.bcp.2010.11.014. Epub 2010 Nov 27.
510 Actinomycin D upregulates proapoptotic protein Puma and downregulates Bcl-2 mRNA in normal peripheral blood lymphocytes. Anticancer Drugs. 2007 Aug;18(7):763-72. doi: 10.1097/CAD.0b013e3280adc905.
511 D-Penicillamine targets metastatic melanoma cells with induction of the unfolded protein response (UPR) and Noxa (PMAIP1)-dependent mitochondrial apoptosis. Apoptosis. 2012 Oct;17(10):1079-94.
512 Involvement of mitochondrial dysfunction in nefazodone-induced hepatotoxicity. Food Chem Toxicol. 2016 Aug;94:148-58. doi: 10.1016/j.fct.2016.06.001. Epub 2016 Jun 8.
513 Improved apoptotic cell death in drug-resistant non-small-cell lung cancer cells by tumor necrosis factor-related apoptosis-inducing ligand-based treatment. J Pharmacol Exp Ther. 2014 Mar;348(3):360-71. doi: 10.1124/jpet.113.210054. Epub 2013 Dec 17.
514 Transcriptome-based functional classifiers for direct immunotoxicity. Arch Toxicol. 2014 Mar;88(3):673-89.
515 Polyunsaturated fatty acids synergize with lipid droplet binding thalidomide analogs to induce oxidative stress in cancer cells. Lipids Health Dis. 2010 Jun 2;9:56. doi: 10.1186/1476-511X-9-56.
516 Gene expression profiling in Ishikawa cells: a fingerprint for estrogen active compounds. Toxicol Appl Pharmacol. 2009 Apr 1;236(1):85-96.
517 Reduction of phosphoinositide-phospholipase C beta1 methylation predicts the responsiveness to azacitidine in high-risk MDS. Proc Natl Acad Sci U S A. 2009 Sep 29;106(39):16811-6. doi: 10.1073/pnas.0907109106. Epub 2009 Sep 10.
518 Differential expression of microRNAs and their predicted targets in renal cells exposed to amphotericin B and its complex with copper (II) ions. Toxicol Mech Methods. 2017 Sep;27(7):537-543. doi: 10.1080/15376516.2017.1333554. Epub 2017 Jun 8.
519 Effect of quercetin on apoptosis of PANC-1 cells. J Korean Surg Soc. 2013 Dec;85(6):249-60. doi: 10.4174/jkss.2013.85.6.249. Epub 2013 Nov 26.
520 Integrated 'omics analysis reveals new drug-induced mitochondrial perturbations in human hepatocytes. Toxicol Lett. 2018 Jun 1;289:1-13.
521 Benzo[a]pyrene-induced changes in microRNA-mRNA networks. Chem Res Toxicol. 2012 Apr 16;25(4):838-49.
522 Comparison of the global gene expression profiles produced by methylparaben, n-butylparaben and 17beta-oestradiol in MCF7 human breast cancer cells. J Appl Toxicol. 2007 Jan-Feb;27(1):67-77. doi: 10.1002/jat.1200.
523 The in vitro pharmacology of the peripherally restricted opioid receptor antagonists, alvimopan, ADL 08-0011 and methylnaltrexone. Naunyn Schmiedebergs Arch Pharmacol. 2007 May;375(3):205-20. doi: 10.1007/s00210-007-0146-x. Epub 2007 Mar 6.
524 A G protein-biased ligand at the ?-opioid receptor is potently analgesic with reduced gastrointestinal and respiratory dysfunction compared with morphine. J Pharmacol Exp Ther. 2013 Mar;344(3):708-17.
525 Association of ABCB1/MDR1 and OPRM1 gene polymorphisms with morphine pain relief. Clin Pharmacol Ther. 2008 Apr;83(4):559-66.
526 The effect of mitragynine on cAMP formation and mRNA expression of mu-opioid receptors mediated by chronic morphine treatment in SK-N-SH neuroblastoma cell. J Ethnopharmacol. 2013 Jun 21;148(1):135-43. doi: 10.1016/j.jep.2013.03.078. Epub 2013 Apr 19.
527 In vitro functional characterization of a panel of non-fentanyl opioid new psychoactive substances. Arch Toxicol. 2020 Nov;94(11):3819-3830. doi: 10.1007/s00204-020-02855-7. Epub 2020 Jul 31.
528 Cannabinoid receptor type 2 agonists induce transcription of the mu-opioid receptor gene in Jurkat T cells. Mol Pharmacol. 2006 Apr;69(4):1486-91. doi: 10.1124/mol.105.018325. Epub 2006 Jan 24.
529 Regulation of opioid and cannabinoid receptor genes in human neuroblastoma and T cells by the epigenetic modifiers trichostatin A and 5-aza-2'-deoxycytidine. Neuroimmunomodulation. 2012;19(3):180-6. doi: 10.1159/000331474. Epub 2012 Jan 18.
530 Cytochrome P-450 enzymes and FMO3 contribute to the disposition of the antipsychotic drug perazine in vitro. Psychopharmacology (Berl). 2000 Sep;151(4):312-20.
531 Identification of the human liver enzymes involved in the metabolism of the antimigraine agent almotriptan. Drug Metab Dispos. 2003 Apr;31(4):404-11.
532 Evaluation of fresh and cryopreserved hepatocytes as in vitro drug metabolism tools for the prediction of metabolic clearance. Drug Metab Dispos. 2004 Nov;32(11):1247-53. doi: 10.1124/dmd.104.000026. Epub 2004 Jul 30.
533 Identification and functional analysis of common human flavin-containing monooxygenase 3 genetic variants. J Pharmacol Exp Ther. 2007 Jan;320(1):266-73. doi: 10.1124/jpet.106.112268. Epub 2006 Oct 18.
534 Genetic polymorphisms of human flavin monooxygenase 3 in sulindac-mediated primary chemoprevention of familial adenomatous polyposis. Clin Cancer Res. 2004 Dec 15;10(24):8357-62. doi: 10.1158/1078-0432.CCR-04-1073.
535 Pharmacogenomics variation in drug metabolizing enzymes and transporters in relation to docetaxel toxicity in Lebanese breast cancer patients: paving the way for OMICs in low and middle income countries. OMICS. 2013 Jul;17(7):353-67. doi: 10.1089/omi.2013.0019. Epub 2013 Jun 11.
536 Binding of antidepressants to human brain receptors: focus on newer generation compounds. Psychopharmacology (Berl). 1994 May;114(4):559-65. doi: 10.1007/BF02244985.
537 Response to fluoxetine and serotonin 1A receptor (C-1019G) polymorphism in Taiwan Chinese major depressive disorder. Pharmacogenomics J. 2006 Jan-Feb;6(1):27-33. doi: 10.1038/sj.tpj.6500340.
538 Serotonin-1A receptor gene polymorphism and the ability of antipsychotic drugs to improve attention in schizophrenia. Adv Ther. 2010 May;27(5):307-13. doi: 10.1007/s12325-010-0035-4. Epub 2010 Jun 8.
539 Mechanisms of regulation of agonist efficacy at the 5-HT(1A) receptor by phospholipid-derived signaling components. J Pharmacol Exp Ther. 2001 Jun;297(3):1025-35.
540 5-Hydroxytryptamine1A receptor occupancy by novel full antagonist 2-[4-[4-(7-chloro-2,3-dihydro-1,4-benzdioxyn-5-yl)-1-piperazinyl]butyl]-1,2-benzisothiazol-3-(2H)-one-1,1-dioxide: a[11C][O-methyl-3H]-N-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl)-N-(2-pyridinyl)cyclohexanecarboxamide trihydrochloride (WAY-100635) positron emission tomography study in humans. J Pharmacol Exp Ther. 2002 Jun;301(3):1144-50.
541 Functional characterization of N-octyl 4-methylamphetamine variants and related bivalent compounds at the dopamine and serotonin transporters using Ca(2+) channels as sensors. Toxicol Appl Pharmacol. 2021 May 15;419:115513. doi: 10.1016/j.taap.2021.115513. Epub 2021 Mar 27.
542 Dopamine transporter gene associated with diminished subjective response to amphetamine. Neuropsychopharmacology. 2005 Mar;30(3):602-9. doi: 10.1038/sj.npp.1300637.
543 Pharmacological Chaperones of the Dopamine Transporter Rescue Dopamine Transporter Deficiency Syndrome Mutations in Heterologous Cells. J Biol Chem. 2016 Oct 14;291(42):22053-22062. doi: 10.1074/jbc.M116.749119. Epub 2016 Aug 23.
544 Evaluation of first generation synthetic cannabinoids on binding at non-cannabinoid receptors and in a battery of in?vivo assays in mice. Neuropharmacology. 2016 Nov;110(Pt A):143-153. doi: 10.1016/j.neuropharm.2016.07.016. Epub 2016 Jul 20.
545 Pharmacological characterization of the aminorex analogs 4-MAR, 4,4'-DMAR, and 3,4-DMAR. Neurotoxicology. 2019 May;72:95-100. doi: 10.1016/j.neuro.2019.02.011. Epub 2019 Feb 15.
546 Pyrethroid pesticide-induced alterations in dopamine transporter function. Toxicol Appl Pharmacol. 2006 Mar 15;211(3):188-97. doi: 10.1016/j.taap.2005.06.003. Epub 2005 Jul 11.
547 Proteomic analysis of anti-cancer effects by paclitaxel treatment in cervical cancer cells. Gynecol Oncol. 2005 Jul;98(1):45-53. doi: 10.1016/j.ygyno.2005.04.010.
548 RNA sequence analysis of inducible pluripotent stem cell-derived cardiomyocytes reveals altered expression of DNA damage and cell cycle genes in response to doxorubicin. Toxicol Appl Pharmacol. 2018 Oct 1;356:44-53.
549 Inhibition of BRD4 attenuates tumor cell self-renewal and suppresses stem cell signaling in MYC driven medulloblastoma. Oncotarget. 2014 May 15;5(9):2355-71.
550 Cell-based two-dimensional morphological assessment system to predict cancer drug-induced cardiotoxicity using human induced pluripotent stem cell-derived cardiomyocytes. Toxicol Appl Pharmacol. 2019 Nov 15;383:114761. doi: 10.1016/j.taap.2019.114761. Epub 2019 Sep 15.
551 Linking site-specific loss of histone acetylation to repression of gene expression by the mycotoxin ochratoxin A. Arch Toxicol. 2018 Feb;92(2):995-1014.
552 Changes in protein tyrosine phosphatase type IVA member 1 and zinc finger protein 36 C3H type-like 1 expression demonstrate altered estrogen and progestin effect in medroxyprogesterone acetate-resistant and estrogen-independent breast cancer cell models. Steroids. 2009 Apr-May;74(4-5):404-9. doi: 10.1016/j.steroids.2008.12.005. Epub 2008 Dec 25.
553 Coordinate up-regulation of TMEM97 and cholesterol biosynthesis genes in normal ovarian surface epithelial cells treated with progesterone: implications for pathogenesis of ovarian cancer. BMC Cancer. 2007 Dec 11;7:223.
554 Bisphenol A and bisphenol S induce distinct transcriptional profiles in differentiating human primary preadipocytes. PLoS One. 2016 Sep 29;11(9):e0163318.
555 Regulators of G-Protein signaling RGS10 and RGS17 regulate chemoresistance in ovarian cancer cells. Mol Cancer. 2010 Nov 2;9:289. doi: 10.1186/1476-4598-9-289.
556 Expression profile analysis of human peripheral blood mononuclear cells in response to aspirin. Arch Immunol Ther Exp (Warsz). 2005 Mar-Apr;53(2):151-8.
557 Hesperidin delays cell cycle progression into the G0/G1 phase via suspension of MAPK signaling pathway in intrahepatic cholangiocarcinoma. J Biochem Mol Toxicol. 2022 Apr;36(4):e22981. doi: 10.1002/jbt.22981. Epub 2022 Jan 4.
558 The effect of DNA methylation inhibitor 5-Aza-2'-deoxycytidine on human endometrial stromal cells. Hum Reprod. 2010 Nov;25(11):2859-69.
559 Comparison of transcriptome expression alterations by chronic exposure to low-dose bisphenol A in different subtypes of breast cancer cells. Toxicol Appl Pharmacol. 2019 Dec 15;385:114814. doi: 10.1016/j.taap.2019.114814. Epub 2019 Nov 9.
560 Functional lipidomics: Palmitic acid impairs hepatocellular carcinoma development by modulating membrane fluidity and glucose metabolism. Hepatology. 2017 Aug;66(2):432-448. doi: 10.1002/hep.29033. Epub 2017 Jun 16.
561 The neuroprotective action of the mood stabilizing drugs lithium chloride and sodium valproate is mediated through the up-regulation of the homeodomain protein Six1. Toxicol Appl Pharmacol. 2009 Feb 15;235(1):124-34.
562 Increased mitochondrial ROS formation by acetaminophen in human hepatic cells is associated with gene expression changes suggesting disruption of the mitochondrial electron transport chain. Toxicol Lett. 2015 Apr 16;234(2):139-50.
563 Identification of a transcriptomic signature of food-relevant genotoxins in human HepaRG hepatocarcinoma cells. Food Chem Toxicol. 2020 Jun;140:111297. doi: 10.1016/j.fct.2020.111297. Epub 2020 Mar 28.
564 Endoplasmic reticulum stress impairs insulin signaling through mitochondrial damage in SH-SY5Y cells. Neurosignals. 2012;20(4):265-80.
565 Alternatives for the worse: Molecular insights into adverse effects of bisphenol a and substitutes during human adipocyte differentiation. Environ Int. 2021 Nov;156:106730. doi: 10.1016/j.envint.2021.106730. Epub 2021 Jun 27.
566 No evidence for binding of clozapine, olanzapine and/or haloperidol to selected receptors involved in body weight regulation. Pharmacogenomics J. 2007 Aug;7(4):275-81. doi: 10.1038/sj.tpj.6500418. Epub 2006 Sep 19.
567 N'-(arylsulfonyl)pyrazoline-1-carboxamidines as novel, neutral 5-hydroxytryptamine 6 receptor (5-HT?R) antagonists with unique structural features. J Med Chem. 2011 Oct 27;54(20):7030-54. doi: 10.1021/jm200466r. Epub 2011 Sep 26.
568 5-HT6 receptor binding sites in schizophrenia and following antipsychotic drug administration: autoradiographic studies with [125I]SB-258585. Synapse. 2002 Sep 1;45(3):191-9.
569 Inhibition of cholesterol metabolism underlies synergy between mTOR pathway inhibition and chloroquine in bladder cancer cells. Oncogene. 2016 Aug 25;35(34):4518-28. doi: 10.1038/onc.2015.511. Epub 2016 Feb 8.
570 Nicotine-induced survival signaling in lung cancer cells is dependent on their p53 status while its down-regulation by curcumin is independent. Mol Cancer. 2010 Aug 20;9:220.
571 Dihydromyricetin suppresses tumor growth via downregulation of the EGFR/Akt/survivin signaling pathway. J Biochem Mol Toxicol. 2023 Jun;37(6):e23328. doi: 10.1002/jbt.23328. Epub 2023 Feb 19.
572 Oxidative stress induces parallel autophagy and mitochondria dysfunction in human glioma U251 cells. Toxicol Sci. 2009 Aug;110(2):376-88. doi: 10.1093/toxsci/kfp101. Epub 2009 May 18.
573 Effect of toll-like receptor 7 and 9 targeted therapy to prevent the development of hepatocellular carcinoma. Liver Int. 2015 Mar;35(3):1063-76. doi: 10.1111/liv.12626. Epub 2014 Jul 30.
574 Low-expressional IGF1 mediated methimazole-induced liver developmental toxicity in fetal mice. Toxicology. 2018 Sep 1;408:70-79. doi: 10.1016/j.tox.2018.07.004. Epub 2018 Jul 7.
575 Nitric oxide modifies global histone methylation by inhibiting Jumonji C domain-containing demethylases. J Biol Chem. 2013 May 31;288(22):16004-15. doi: 10.1074/jbc.M112.432294. Epub 2013 Apr 1.
576 RIZ1 is epigenetically inactivated by promoter hypermethylation in thyroid carcinoma. Cancer. 2006 Dec 15;107(12):2752-9. doi: 10.1002/cncr.22325.
577 Epigenetic changes in individuals with arsenicosis. Chem Res Toxicol. 2011 Feb 18;24(2):165-7. doi: 10.1021/tx1004419. Epub 2011 Feb 4.
578 Functional and structural characterization of axonal opioid receptors as targets for analgesia. Mol Pain. 2016 Mar 1;12:1744806916628734. doi: 10.1177/1744806916628734. Print 2016.
579 Regulation of beta-adrenergic receptor signaling by S-nitrosylation of G-protein-coupled receptor kinase 2. Cell. 2007 May 4;129(3):511-22. doi: 10.1016/j.cell.2007.02.046.
580 Clinical response to morphine in cancer patients and genetic variation in candidate genes. Pharmacogenomics J. 2005;5(5):324-36. doi: 10.1038/sj.tpj.6500327.
581 Beta-arrestin 2 modulates resveratrol-induced apoptosis and regulation of Akt/GSK3? pathways. Biochim Biophys Acta. 2010 Sep;1800(9):912-8. doi: 10.1016/j.bbagen.2010.04.015. Epub 2010 May 7.
582 Dopamine D4 receptor gene exon III polymorphism and interindividual variation in response to clozapine. Int J Neurosci. 2005 Nov;115(11):1539-47. doi: 10.1080/00207450590957863.
583 Polymorphisms TaqI A of the DRD2, BalI of the DRD3, exon III repeat of the DRD4, and 3' UTR VNTR of the DAT: association with childhood ADHD in male African-Caribbean cocaine dependents?. Am J Med Genet B Neuropsychiatr Genet. 2007 Dec 5;144B(8):1034-41. doi: 10.1002/ajmg.b.30540.
584 Gene expression analysis of precision-cut human liver slices indicates stable expression of ADME-Tox related genes. Toxicol Appl Pharmacol. 2011 May 15;253(1):57-69.
585 Induction of hypomethylation and molecular response after decitabine therapy in patients with chronic myelomonocytic leukemia. Blood. 2008 Feb 15;111(4):2382-4. doi: 10.1182/blood-2007-07-103960. Epub 2007 Nov 30.
586 Mapping genes that contribute to daunorubicin-induced cytotoxicity. Cancer Res. 2007 Jun 1;67(11):5425-33. doi: 10.1158/0008-5472.CAN-06-4431.
587 Population-based in vitro hazard and concentration-response assessment of chemicals: the 1000 genomes high-throughput screening study. Environ Health Perspect. 2015 May;123(5):458-66. doi: 10.1289/ehp.1408775. Epub 2015 Jan 13.
588 Synergistic effect of JQ1 and rapamycin for treatment of human osteosarcoma. Int J Cancer. 2015 May 1;136(9):2055-64.
589 Ciprofloxacin mediates cancer stem cell phenotypes in lung cancer cells through caveolin-1-dependent mechanism. Chem Biol Interact. 2016 Apr 25;250:1-11.
590 Quercetin in elimination of tumor initiating stem-like and mesenchymal transformation property in head and neck cancer. Head Neck. 2013 Mar;35(3):413-9. doi: 10.1002/hed.22982. Epub 2012 Mar 16.
591 Retinoic acid represses a cassette of candidate pluripotency chromosome 12p genes during induced loss of human embryonal carcinoma tumorigenicity. Biochim Biophys Acta. 2005 Oct 15;1731(1):48-56. doi: 10.1016/j.bbaexp.2005.08.006. Epub 2005 Sep 1.
592 The antipsychotic chlorpromazine suppresses YAP signaling, stemness properties, and drug resistance in breast cancer cells. Chem Biol Interact. 2019 Apr 1;302:28-35. doi: 10.1016/j.cbi.2019.01.033. Epub 2019 Jan 28.
593 Arsenic trioxide induces differentiation of cancer stem cells in hepatocellular carcinoma through inhibition of LIF/JAK1/STAT3 and NF-kB signaling pathways synergistically. Clin Transl Med. 2021 Feb;11(2):e335. doi: 10.1002/ctm2.335.
594 Altered expression of genes identified in rats with prostatic chronic inflammation in a prostate spheroid model treated by estradiol/testosterone. J Toxicol Sci. 2021;46(11):515-523. doi: 10.2131/jts.46.515.
595 Antiepileptic drugs are endocrine disruptors for the human fetal testis ex vivo. Toxicol Sci. 2023 Sep 28;195(2):169-183. doi: 10.1093/toxsci/kfad076.
596 Effects of Exposure to Acetaminophen and Ibuprofen on Fetal Germ Cell Development in Both Sexes in Rodent and Human Using Multiple Experimental Systems. Environ Health Perspect. 2018 Apr 16;126(4):047006. doi: 10.1289/EHP2307.
597 Cyclosporine A--induced oxidative stress in human renal mesangial cells: a role for ERK 1/2 MAPK signaling. Toxicol Sci. 2012 Mar;126(1):101-13.
598 Dose- and time-dependent effects of phenobarbital on gene expression profiling in human hepatoma HepaRG cells. Toxicol Appl Pharmacol. 2009 Feb 1;234(3):345-60.
599 Distinctive profiles of gene expression in the human nucleus accumbens associated with cocaine and heroin abuse. Neuropsychopharmacology. 2006 Oct;31(10):2304-12. doi: 10.1038/sj.npp.1301089. Epub 2006 May 3.
600 The role of acetaldehyde in mediating effects of alcohol on expression of endogenous opioid system genes in a neuroblastoma cell line. FASEB J. 2008 Mar;22(3):662-70. doi: 10.1096/fj.07-8346com. Epub 2007 Oct 12.
601 Gene expression profile of the nucleus accumbens of human cocaine abusers: evidence for dysregulation of myelin. J Neurochem. 2004 Mar;88(5):1211-9. doi: 10.1046/j.1471-4159.2003.02247.x.
602 Human Mincle Binds to Cholesterol Crystals and Triggers Innate Immune Responses. J Biol Chem. 2015 Oct 16;290(42):25322-32. doi: 10.1074/jbc.M115.645234. Epub 2015 Aug 20.
603 Transcriptional signature of human macrophages exposed to the environmental contaminant benzo(a)pyrene. Toxicol Sci. 2010 Apr;114(2):247-59.
604 p-(4-Azipentyl)propofol: a potent photoreactive general anesthetic derivative of propofol. J Med Chem. 2011 Dec 8;54(23):8124-35. doi: 10.1021/jm200943f. Epub 2011 Nov 10.
605 Cloning of cDNAs encoding the human gamma-aminobutyric acid type A receptor alpha 6 subunit and characterization of the pharmacology of alpha 6-containing receptors. Mol Pharmacol. 1996 Feb;49(2):253-9.
606 Characterization of DOK1, a candidate tumor suppressor gene, in epithelial ovarian cancer. Mol Oncol. 2011 Oct;5(5):438-53. doi: 10.1016/j.molonc.2011.07.003. Epub 2011 Jul 26.
607 Heterogeneity of GABA(A) receptor-mediated responses in the human IMR-32 neuroblastoma cell line. J Neurosci Res. 2000 May 15;60(4):504-10. doi: 10.1002/(SICI)1097-4547(20000515)60:4<504::AID-JNR9>3.0.CO;2-Y.
608 [3H]Ethynylbicycloorthobenzoate ([3H]EBOB) binding in recombinant GABAA receptors. Neurotoxicology. 2003 Dec;24(6):817-24. doi: 10.1016/S0161-813X(03)00051-2.
609 Gene expression profiling of human primary astrocytes exposed to manganese chloride indicates selective effects on several functions of the cells. Neurotoxicology. 2007 May;28(3):478-89.
610 Epigenetic modulation of endogenous tumor suppressor expression in lung cancer xenografts suppresses tumorigenicity. Int J Cancer. 2007 Jan 1;120(1):24-31. doi: 10.1002/ijc.22073.
611 A phase I study of hydralazine to demethylate and reactivate the expression of tumor suppressor genes. BMC Cancer. 2005 Apr 29;5:44.
612 Intramitochondrial calcium regulation by the FHIT gene product sensitizes to apoptosis. Proc Natl Acad Sci U S A. 2009 Aug 4;106(31):12753-8. doi: 10.1073/pnas.0906484106. Epub 2009 Jul 21.
613 Genome-wide pharmacogenomic study of citalopram-induced side effects in STAR*D. Transl Psychiatry. 2012 Jul 3;2(7):e129. doi: 10.1038/tp.2012.57.
614 Acetaminophen selectively suppresses peripheral prostaglandin E2 release and increases COX-2 gene expression in a clinical model of acute inflammation. Pain. 2007 Jun;129(3):279-86.
615 Quercetin reduces oxidative damage induced by paraquat via modulating expression of antioxidant genes in A549 cells. J Appl Toxicol. 2013 Dec;33(12):1460-7. doi: 10.1002/jat.2812. Epub 2012 Sep 20.
616 The differential effects of bupivacaine and lidocaine on prostaglandin E2 release, cyclooxygenase gene expression and pain in a clinical pain model. Anesth Analg. 2008 Jan;106(1):321-7, table of contents.
617 Chemical inhibitors of cytochrome P450 isoforms in human liver microsomes: a re-evaluation of P450 isoform selectivity. Eur J Drug Metab Pharmacokinet. 2011 Mar;36(1):1-16.
618 Inhibition of CYP2E1 catalytic activity in vitro by S-adenosyl-L-methionine. Biochem Pharmacol. 2005 Apr 1;69(7):1081-93.
619 Characterization of primary human hepatocytes, HepG2 cells, and HepaRG cells at the mRNA level and CYP activity in response to inducers and their predictivity for the detection of human hepatotoxins. Cell Biol Toxicol. 2012 Apr;28(2):69-87.
620 An in vitro model of human acute ethanol exposure that incorporates CXCR3- and CXCR4-dependent recruitment of immune cells. Toxicol Sci. 2013 Mar;132(1):131-41.
621 Proteomic analysis of hepatic effects of phenobarbital in mice with humanized liver. Arch Toxicol. 2022 Oct;96(10):2739-2754. doi: 10.1007/s00204-022-03338-7. Epub 2022 Jul 26.
622 Inhibition of cytochrome P450 enzymes participating in p-nitrophenol hydroxylation by drugs known as CYP2E1 inhibitors. Chem Biol Interact. 2004 Apr 15;147(3):331-40.
623 Cannabidiol induces antioxidant pathways in keratinocytes by targeting BACH1. Redox Biol. 2020 Jan;28:101321. doi: 10.1016/j.redox.2019.101321. Epub 2019 Sep 5.
624 Comprehensive transcriptome profiling of BET inhibitor-treated HepG2 cells. PLoS One. 2022 Apr 29;17(4):e0266966. doi: 10.1371/journal.pone.0266966. eCollection 2022.
625 P450 3A-catalyzed O-dealkylation of lapatinib induces mitochondrial stress and activates Nrf2. Chem Res Toxicol. 2016 May 16;29(5):784-96.
626 Cissus quadrangularis ethanol extract upregulates superoxide dismutase, glutathione peroxidase and endothelial nitric oxide synthase expression in hydrogen peroxide-injured human ECV304 cells. J Ethnopharmacol. 2012 Sep 28;143(2):664-72.
627 Rofecoxib modulates multiple gene expression pathways in a clinical model of acute inflammatory pain. Pain. 2007 Mar;128(1-2):136-47.
628 Manganese superoxide dismutase is a promising target for enhancing chemosensitivity of basal-like breast carcinoma. Antioxid Redox Signal. 2014 May 20;20(15):2326-46. doi: 10.1089/ars.2013.5295. Epub 2013 Nov 14.
629 Estrogen-like activity of metals in MCF-7 breast cancer cells. Endocrinology. 2003 Jun;144(6):2425-36. doi: 10.1210/en.2002-221054.
630 Cross-talk between non-genomic and genomic signalling pathways--distinct effect profiles of environmental estrogens. Toxicol Appl Pharmacol. 2010 Jun 1;245(2):160-70. doi: 10.1016/j.taap.2010.02.015. Epub 2010 Mar 4.
631 Bidirectional cross talk between ERalpha and EGFR signalling pathways regulates tamoxifen-resistant growth. Breast Cancer Res Treat. 2006 Mar;96(2):131-46. doi: 10.1007/s10549-005-9070-2. Epub 2005 Oct 27.
632 Sensitivity of human dental pulp cells to eighteen chemical agents used for endodontic treatments in dentistry. Odontology. 2013 Jan;101(1):43-51.
633 The dual ErbB1/ErbB2 inhibitor, lapatinib (GW572016), cooperates with tamoxifen to inhibit both cell proliferation- and estrogen-dependent gene expression in antiestrogen-resistant breast cancer. Cancer Res. 2005 Jan 1;65(1):18-25.
634 Antitumoral activity of liraglutide, a new DNMT inhibitor in breast cancer cells in vitro and in vivo. Chem Biol Interact. 2021 Nov 1;349:109641. doi: 10.1016/j.cbi.2021.109641. Epub 2021 Sep 14.
635 Estrogen receptor alpha mediates the proliferative but not the cytotoxic dose-dependent effects of two major phytoestrogens on human breast cancer cells. Mol Pharmacol. 2001 Sep;60(3):595-602.
636 Novel retinoic acid metabolism blocking agents have potent inhibitory activities on human breast cancer cells and tumour growth. Br J Cancer. 2007 Apr 23;96(8):1204-15. doi: 10.1038/sj.bjc.6603705. Epub 2007 Mar 27.
637 Prediction of the combined effects of multiple estrogenic chemicals on MCF-7 human breast cancer cells and a preliminary molecular exploration of the estrogenic proliferative effects and related gene expression. Ecotoxicol Environ Saf. 2018 Sep 30;160:1-9. doi: 10.1016/j.ecoenv.2018.05.025. Epub 2018 May 21.
638 The differential effects of neuroleptic drugs and PACAP on the expression of BDNF mRNA and protein in a human glioblastoma cell line. Acta Neurobiol Exp (Wars). 2017;77(3):205-213.
639 Tea polyphenols ameliorates neural redox imbalance and mitochondrial dysfunction via mechanisms linking the key circadian regular Bmal1. Food Chem Toxicol. 2017 Dec;110:189-199. doi: 10.1016/j.fct.2017.10.031. Epub 2017 Oct 20.
640 LncRNA SNHG12 ameliorates bupivacaine-induced neurotoxicity by sponging miR-497-5p to upregulate NLRX1. Hum Exp Toxicol. 2022 Jan-Dec;41:9603271221089001. doi: 10.1177/09603271221089001.
641 Mechanism of arsenic trioxide inhibiting angiogenesis in multiple myeloma. J Huazhong Univ Sci Technolog Med Sci. 2006;26(1):43-6. doi: 10.1007/BF02828035.
642 In vitro inhibition of CYP1A2 by model inhibitors, anti-inflammatory analgesics and female sex steroids: predictability of in vivo interactions. Basic Clin Pharmacol Toxicol. 2008 Aug;103(2):157-65.
643 Effects of capsaicin and dihydrocapsaicin on human and rat liver microsomal CYP450 enzyme activities in vitro and in vivo. J Asian Nat Prod Res. 2012;14(4):382-95.
644 Drug interaction study of flavonoids toward CYP3A4 and their quantitative structure activity relationship (QSAR) analysis for predicting potential effects. Toxicol Lett. 2018 Sep 15;294:27-36.
645 Stiripentol. Expert Opin Investig Drugs. 2005 Jul;14(7):905-11.
646 Inhibition of human cytochrome P450 enzymes by 1,4-dihydropyridine calcium antagonists: prediction of in vivo drug-drug interactions. Eur J Clin Pharmacol. 2000 Feb-Mar;55(11-12):843-52.
647 Mechanism-based inhibition of human liver microsomal cytochrome P450 1A2 by zileuton, a 5-lipoxygenase inhibitor. Drug Metab Dispos. 2003 Nov;31(11):1352-60.
648 Predictive three-dimensional quantitative structure-activity relationship of cytochrome P450 1A2 inhibitors. J Med Chem. 2005 Jun 2;48(11):3808-15.
649 Influence of glutathione S-transferase A1, P1, M1, T1 polymorphisms on oral busulfan pharmacokinetics in children with congenital hemoglobinopathies undergoing hematopoietic stem cell transplantation. Pediatr Blood Cancer. 2010 Dec 1;55(6):1172-9. doi: 10.1002/pbc.22739.
650 The influence of coordinate overexpression of glutathione phase II detoxification gene products on drug resistance. J Pharmacol Exp Ther. 2000 Aug;294(2):480-7.
651 Cell-type-specific responses to chemotherapeutics in breast cancer. Cancer Res. 2004 Jun 15;64(12):4218-26.
652 Glutathione S-transferase pi as a target for tricyclic antidepressants in human brain. Acta Biochim Pol. 2004;51(1):207-12.
653 Arsenic suppresses gene expression in promyelocytic leukemia cells partly through Sp1 oxidation. Blood. 2005 Jul 1;106(1):304-10.
654 Histamine up-regulates phosphodiesterase 4 activity and reduces prostaglandin E2-inhibitory effects in human neutrophils. Inflamm Res. 2000 Nov;49(11):600-9. doi: 10.1007/s000110050637.
655 In vitro and in vivo irinotecan-induced changes in expression profiles of cell cycle and apoptosis-associated genes in acute myeloid leukemia cells. Mol Cancer Ther. 2005 Jun;4(6):885-900.
656 Cyclic GMP-dependent protein kinase activation and induction by exisulind and CP461 in colon tumor cells. J Pharmacol Exp Ther. 2001 Nov;299(2):583-92.
657 Induction of heme oxygenase-1 by cobalt protoporphyrin enhances the antitumour effect of bortezomib in adult T-cell leukaemia cells. Br J Cancer. 2007 Oct 22;97(8):1099-105. doi: 10.1038/sj.bjc.6604003. Epub 2007 Sep 25.
658 The human colon cancer methylome shows similar hypo- and hypermethylation at conserved tissue-specific CpG island shores. Nat Genet. 2009 Feb;41(2):178-186.
659 Molecular mechanisms controlling the rate and specificity of catechol O-methylation by human soluble catechol O-methyltransferase. Mol Pharmacol. 2001 Feb;59(2):393-402. doi: 10.1124/mol.59.2.393.
660 Effects of modafinil on the sleep EEG depend on Val158Met genotype of COMT. Sleep. 2010 Aug;33(8):1027-35. doi: 10.1093/sleep/33.8.1027.
661 Tolcapone increases plasma catecholamine levels in patients with Parkinson's disease. Parkinsonism Relat Disord. 2001 Apr;7(2):93-96. doi: 10.1016/s1353-8020(00)00027-4.
662 The relative role of CYP3A4 and CYP3A5 in eplerenone metabolism. Toxicol Lett. 2019 Oct 15;315:9-13.
663 Characterization of the structural determinants required for potent mechanism-based inhibition of human cytochrome P450 1A1 by cannabidiol. Chem Biol Interact. 2014 May 25;215:62-8.
664 Retinoids activate the RXR/SXR-mediated pathway and induce the endogenous CYP3A4 activity in Huh7 human hepatoma cells. Toxicol Sci. 2006 Jul;92(1):51-60.
665 The novel azole R126638 is a selective inhibitor of ergosterol synthesis in Candida albicans, Trichophyton spp., and Microsporum canis. Antimicrob Agents Chemother. 2004 Sep;48(9):3272-8.
666 Application of higher throughput screening (HTS) inhibition assays to evaluate the interaction of antiparasitic drugs with cytochrome P450s. Drug Metab Dispos. 2001 Jan;29(1):30-5.
667 Cetirizine and loratadine-based antihistamines with 5-lipoxygenase inhibitory activity. Bioorg Med Chem Lett. 2004 Nov 15;14(22):5591-4.
668 Mechanism-based inactivation of CYP3A by HIV protease inhibitors. J Pharmacol Exp Ther. 2005 Feb;312(2):583-91.
669 Studies of the toxicological potential of capsinoids, XIII: inhibitory effects of capsaicin and capsinoids on cytochrome P450 3A4 in human liver microsomes. Int J Toxicol. 2010 Mar;29(2 Suppl):22S-6S.
670 Investigation of the effects of axitinib on the pharmacokinetics of loperamide and its main metabolite N-demethylated loperamide in rats by UPLC-MS/MS. Chem Biol Interact. 2019 Sep 1;310:108744. doi: 10.1016/j.cbi.2019.108744. Epub 2019 Jul 9.
671 The influence of curcumin, quercetin, and eicosapentaenoic acid on the expression of phase II detoxification enzymes in the intestinal cell lines HT-29, Caco-2, HuTu 80, and LT97. Nutr Cancer. 2012 Aug;64(6):856-63.
672 Proteomic analysis of antiproliferative effects by treatment of 5-fluorouracil in cervical cancer cells. DNA Cell Biol. 2004 Nov;23(11):769-76.
673 Genistein and bisphenol A exposure cause estrogen receptor 1 to bind thousands of sites in a cell type-specific manner. Genome Res. 2012 Nov;22(11):2153-62.
674 Glutathione-S-transferase genotypes and the adverse effects of azathioprine in young patients with inflammatory bowel disease. Inflamm Bowel Dis. 2007 Jan;13(1):57-64. doi: 10.1002/ibd.20004.
675 Gene expression profiling of 30 cancer cell lines predicts resistance towards 11 anticancer drugs at clinically achieved concentrations. Int J Cancer. 2006 Apr 1;118(7):1699-712. doi: 10.1002/ijc.21570.
676 Association of polymorphism in alcohol dehydrogenase and interaction with other genetic risk factors with alcoholic liver cirrhosis. Drug Alcohol Depend. 2010 Jun 1;109(1-3):190-7. doi: 10.1016/j.drugalcdep.2010.01.010. Epub 2010 Feb 18.
677 Inhibition of human glutathione S-transferases by dopamine, alpha-methyldopa and their 5-S-glutathionyl conjugates. Chem Biol Interact. 1994 Jan;90(1):87-99.
678 Folate deficiency in normal human fibroblasts leads to altered expression of genes primarily linked to cell signaling, the cytoskeleton and extracellular matrix. J Nutr Biochem. 2007 Aug;18(8):541-52. doi: 10.1016/j.jnutbio.2006.11.002. Epub 2007 Feb 22.
679 A high concentration of genistein down-regulates activin A, Smad3 and other TGF-beta pathway genes in human uterine leiomyoma cells. Exp Mol Med. 2012 Apr 30;44(4):281-92.
680 High-throughput ectopic expression screen for tamoxifen resistance identifies an atypical kinase that blocks autophagy. Proc Natl Acad Sci U S A. 2011 Feb 1;108(5):2058-63.
681 Identification of biomarkers and outcomes of endocrine disruption in human ovarian cortex using In Vitro Models. Toxicology. 2023 Feb;485:153425. doi: 10.1016/j.tox.2023.153425. Epub 2023 Jan 5.
682 Bone marrow osteoblast damage by chemotherapeutic agents. PLoS One. 2012;7(2):e30758. doi: 10.1371/journal.pone.0030758. Epub 2012 Feb 17.
683 Gene expression signatures after ethanol exposure in differentiating embryoid bodies. Toxicol In Vitro. 2018 Feb;46:66-76.
684 The effect of the new SERM arzoxifene on growth and gene expression in MCF-7 breast cancer cells. Mol Cell Endocrinol. 2004 Apr 30;219(1-2):27-36. doi: 10.1016/j.mce.2004.02.003.
685 Adenosine receptor expression in rheumatoid synovium: a basis for methotrexate action. Arthritis Res Ther. 2012 Jun 8;14(3):R138. doi: 10.1186/ar3871.
686 New 2,6,9-trisubstituted adenines as adenosine receptor antagonists: a preliminary SAR profile. Purinergic Signal. 2007 Sep;3(4):339-46. doi: 10.1007/s11302-007-9068-9. Epub 2007 Sep 19.
687 Methotrexate-mediated activation of an AMPK-CREB-dependent pathway: a novel mechanism for vascular protection in chronic systemic inflammation. Ann Rheum Dis. 2016 Feb;75(2):439-48. doi: 10.1136/annrheumdis-2014-206305. Epub 2015 Jan 9.
688 Single-cell Transcriptome Mapping Identifies Common and Cell-type Specific Genes Affected by Acute Delta9-tetrahydrocannabinol in Humans. Sci Rep. 2020 Feb 26;10(1):3450. doi: 10.1038/s41598-020-59827-1.
689 Genomic profiling uncovers a molecular pattern for toxicological characterization of mutagens and promutagens in vitro. Toxicol Sci. 2011 Jul;122(1):185-97.